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Abstract
Magnetic stimulation has been applied to bone regeneration and frac-
ture non-union treatments, however, the cellular and molecular mech-
anisms of repair still require better understanding. In this study,
a three-dimensional (3D) collagen model has been developed using
plastic compression (PC), which produces dense, cellular, and me-
chanically strong native collagen structures. Osteoblast cells (MG-63,
UMR-106, MC3T3-E1), bioactive nano-hydroxyapatite (nHA) and
magnetic iron oxide nanoparticles (IONPs), were incorporated into
the collagen gels to produce a range of cell-laden models. A magnetic
bio-reactor to support cell growth under static magnetic fields (SMFs)
was designed and fabricated by 3D printing. The influences of SMFs
on cell proliferation, differentiation, extracellular matrix production,
mineralisation and gene expression were evaluated. Results demon-
strated that SMFs and IONPs stimulated the proliferation, alkaline
phosphatase (ALP) production and level of mineralisation of MG-63
cells in vitro. Transmission Electron Microscopy (TEM) examination
showed some changes in microstructure of collagen fibres subjected
to SMFs. Real-time polymerase chain reaction (PCR) investigation
further determined the effects of SMFs on the expression of Runt-
related transcription factor 2 (Runx2), osteonectin (ON), and bone
morphogenic protein 2 and 4 (BMP-2 and BMP-4). The stimulating
effects were identified as the combination of SMFs and IONPs, which
can enhance the osteogenesis process in vitro. The results indicated
that the magnetic stimulation influences the matrix/cell interactions,
and is capable of encouraging gene expression. Therefore, the colla-
gen model developed in this study not only offers a novel 3D bone
model to better understand the effects of magnetic stimulation on os-
teogenesis, but also paves the way for further applications in tissue
engineering and regenerative medicine.
Impact statement
This is the first study on investigating the mechanisms of static mag-
netic fields and magnetic nanoparticles on bone regeneration appli-
cations. This study provides an insight understanding how magnetic
fields affect the osteoblasts at molecular levels, the osteogenesis, and
hence the regeneration process.
The key outcomes of this study are described as below.
1. A magnetic bio-reactor with moderate intensity was designed
and used for in vitro studies.
2. A 3D collagen based bone model was developed, which offers the
possibility of incorporating various biofactors and supports cell
growth.
3. With the incorporation of iron oxide nanoparticles, the prolifer-
ation, differentiation and mineralisation of osteoblasts in 3D col-
lagen scaffolds have been stimulated under static magnetic fields.
4. The stimulation of the osteogenesis process of osteoblasts in 3D
collagen model can be contributed to the complex interactions
between nanoparticles, extracellular matrix and cells, hence the
up-regulation of several key genes in osteoblasts.
In vitro 3D tissue models bridge the gap between in vitro 2D and
in vivo models. It not only overcomes the limitations of current 2D
model system, but also reduces the uses of animal models. The 3D
model developed in the current study can be served as a platform
for testing varies of techniques, cells and biofactors in vitro, as it
mimics the structure of bone extracellular matrix, as well as being
biocompatible and biodegradable. Collagen plastic compression is a
simple but reliable technique, which can be reproduced for large scale.
The plastic compressed collagen model can be further synthesised into
multi-layer with varies cells and biofactors to better mimic the real
tissue structure.
Therefore, the collagen model developed in this study offers not only
a novel 3D platform to better understand magnetic stimulation on
osteogenesis, but also paves the way for further applications in tissue
engineering and regenerative medicine.
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Chapter 1
Introduction and Literature Review
1.1 Introduction
Every year, approximately 850,000 patients suffer from bone fracture in the UK.
The rate of non-union is suggested to be 5-10%, and the cost to the National
Health Service (NHS) of treating non-union has been reported to range between
£7,000 and £79,000 per person [Mills & Simpson, 2013]. Moreover, it also has
been estimated that 10 % of the 7.9 million annual fracture patients in the US
experiences non-union and/or delayed unions, which have a substantial economic
and quality of life impact [Kwong & Harris, 2008]. Bone regeneration is a physi-
ologic process that replaces the injured bone with new bone thereby renewing
the biological and mechanical properties to the injured site. It is a compli-
cated metabolic process, which requires the interaction of many factors, including
growth and differentiation factors, hormones, cytokines, and extracellular com-
ponents. If these factors are inadequate or interrupted, healing will be delayed
or impaired, resulting in a non-union of the bone.
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For more than a century, investigators have been developing alternative treat-
ments that aim at resolving the bone fracture healing process, by physical or
biological methods. The physical strategy includes the use of mechanical stimu-
lation [Chao et al., 1998; Claes et al., 1998; Kenwright & Goodship, 1989], elec-
trical stimulation [Brighton et al., 1985; Haddad et al., 2007; Mollon et al., 2008],
electromagnetic and static magnetic stimulation [Aaron et al., 2004; Ryaby, 1998;
Trock, 2000], and low-intensity ultrasound stimulation [Busse et al., 2002; Duarte,
1983]. The biological approach involves the use of osteoconductive biomaterials,
such as tricalcium phosphate, hydroxyapatite and bioactive glasses [Jones et al.,
2006; Ohgushi et al., 1992] and growth factors (platelet derived growth factor
(PDGF), fibroblast growth factor (FGF), insulin-like growth factor 1 (IGF-1) and
the transforming growth factor-beta (TGF-β) super-family) [Hollinger & Wong,
1996; Lind, 1998].
Magnetic stimulation has been applied on bone regeneration applications
through the mechanism of mechanotransduction. It has been proposed that static
magnetic fields (SMFs) are capable of stimulating the osteogenesis of osteoblasts,
by influencing their proliferation, differentiation, extracellular matrix production
and mineralisation [Cai et al., 2015; Chiu et al., 2007; Meng et al., 2013; Rosen,
2003]. Despite the success of SMFs stimulations in several in vivo and in vitro
studies, there remains two major concerns. Firstly, it is believed that bone re-
sponds to dynamic rather than static loading, and the stimulation is related to
the peak strain magnitude and the loading frequency [Rubin & Lanyon, 1985].
Therefore in some of the cases, SMFs failed to demonstrate a positive effect on cell
2
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proliferation, differentiation and other factors. Secondly, for the situations where
SMFs successfully stimulate the osteogenesis process, the molecular mechanisms
of this phenomenon are not well understood.
Tissue models can be used to evaluate the effect of magnetic stimulation on os-
teogenesis. There are various types of three-dimensional (3D) tissue models used
in laboratory studies, such as porous tissue scaffolds (sponge or foam), fibrous
scaffolds (electrospun fibres) and custom scaffolds made by computer-aided de-
sign (CAD). For these types of scaffolds/models, cells are normally being seeded
on the surfaces of the substrates. On the other hand, hydrogels have an estab-
lished track record as potential 3D models for tissue regeneration applications,
with the ability of incorporating cells/bio-factors directly inside the 3D construct,
providing a more extracellular matrix (ECM)-like environment.
Collagen hydrogels have a long track record as potential 3D scaffolds for tissue
regeneration applications. Collagen molecules can interact with each other as well
as with other ECM molecules to provide a huge range of structures and functions,
however, the conventional hydrogels are weak in mechanical stabilities. Plastic
compression [Brown et al., 2005] has been used to increase the collagen hydrogels
density, hence increase the physiology relevance of the hydrogels for local cells.
The plastic compressed collagen gels offer several advantages compared to the
conventional collagen hydrogels. First of all, by applying the load on top of the
collagen gel, the aqueous component can be removed from the gel, leading to an
increase in mechanical strength and collagen density of the compressed scaffolds.
Besides, the compression has minimal impacts on the viability of pre-seeded cells,
3
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which maintains over 90% after compression [Brown et al., 2005]. Furthermore,
the plastic compressed collagen gels have thickness of 100-200 µm, providing the
possibility to produce multi-layer scaffolds. In addition, the fabrication process is
extremely rapid and non-reversible, upon the removal of the loads, the water does
not return to the collagen fibre, therefore known as the term “plastic”. Further-
more, cells incorporated within this dense structure have also been demonstrated
to have better proliferation [Ghezzi et al., 2011b], differentiation [Buxton et al.,
2008] and mineralisation ability [Marelli et al., 2011].
The aim of this study was to develop a reliable 3D collagen model to investi-
gate the effects of SMFs on osteogenesis in vitro. There are three main objectives:
1. To design a magnetic bio-reactor with moderate intensity to support cell
growth under SMFs in vitro.
2. To develop a 3D bio-mimetic collagen based bone model with the ability to
incorporate various cells and bio-factors.
3. To study the effects of SMFs and IONPs on the osteogenesis process of cells
incorporated within the 3D collagen model, as well as the mechanisms at
molecular levels.
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1.2 Bone Physiology
Bone is a highly specialised connective tissue which forms the basis of the skele-
ton. It is a dense composite consisting of a soft organic matrix together with
complex mineral. Bone is also a highly vascular dynamic tissue which under-
goes constant remodelling and chemical exchange with the rest of the body. It
is therefore subject to continual changes in its structure and composition, due to
both cellular and external mechanical activities.
Bone has many different complex functions. First of all, it constitutes the
rigid skeleton of the body. Secondly, it protects the internal organs from physi-
cal damage, including the brain, lungs and heart. Besides, the skeleton provides
physical support and related movement. It also acts as a reservoir of inorganic
ions that are recruited by physiological systems.
According to the hierarchical levels of organisation, bone can be categorised
into 5 main levels (shown in Figure 1.1):
1. The subnanostructure (below a few hundred nanometers), composed of min-
eral, collagen, and non-collagenous organic proteins.
2. The nanostructure (from a few hundred nanometers to 1 µm), includes
fibrillar collagen and embedded mineral.
3. The sub-microstructure(1 - 10 µm): lamellae.
4. The microstructure (from 10 to 500 µm), which includes the haversian sys-
tems, osteons and single trabeculae.
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5. The macrostructure: cancellous and cortical bone.
1.2.1 Collagen Matrix
Collagen is a family of proteins with 29 types having been identified to date
[Domb & Kumar, 2011; Gordon & Hahn, 2010]. For most soft and hard connective
tissues, collagen fibrils and their networks play a dominant role in maintaining
the biologic and structural integrity of ECM, as well as being highly dynamic and
undergoing constant remodelling [Cen et al., 2008]. The differences in density,
packing and orientation results in distinctively varying mechanical properties in
tissues such as bone, skin, tendon and cartilage [Cheema et al., 2011; Domb &
Kumar, 2011; Gordon & Hahn, 2010]. There are several groups of collagens found
in human body, which have been categorised by different functions:
1. The most abundant group within the collagen family is the fibril forming
collagens (types I, II, III, V, and XI). They can be assembled into highly
organised supra molecular fibrils. For example, type I collagen has been
found in bone, tendon and the cornea. In bone, type I collagen can asso-
ciate with HA crystals and provides rigid and shock-resistant tissues with
high Young’s modulus. While in tendon, it behaves with low rigidity and
high deformation to rupture. Besides, type I collagen shows optical prop-
erties in cornea [Cen et al., 2008]. Collagen type II is the most commonly
form found in cartilage tissue.
2. Network-forming collagens, such as type IV, is commonly acting as the
principal component of basement membranes. Other examples include type
6
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Figure 1.1: The structure of bone. The sub-nanostructure composed of three main
materials, includes crystals, collagens, and non- collagenous organic proteins. The
mineralised collagen fibril is the basic building block of bone, at the nanostructure,
collagen fibres are in the size range of 100 nm to 1 mm. At the sub-microstructure,
collagen fibrils are ordered into arrays to form bone lamellae with 3 - 7 µm
thick. The formation of osteons can be observed at the microstructure. At the
macrostructure level, bone is separated into the cortical and cancellous types.
Figure reproduced with permission from Ritchie et al. [2005].
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VIII (subendothelium of vascular walls) and type X (endochondrial growth
plates).
3. There are also fibril associated collagens, like type IX, XII, XIV, XVI, XIX
and XX. These types of collagen tend to be located on the surface of colla-
gen fibrils in a tissue specific manner.
4. Type VI is a micro fibrillar collagens that forms a distinct network of fine
filaments throughout most connective tissues, while the short chain collagen
(types X and VIII) forms hexagonal networks [Kielty & Grant, 2003].
Type I collagen is the most abundant protein found in bone. It contains two
α1 chains and one α2 chain which forms a triple helix. Each α chain contains
over 1050 amino acids with a molecular weight of approximately 95,000 g/mol,
and consisting of an amino acid sequence with a repeating structure (Gly-X-Y).
Glycine (Gly) is found at every third residue along the chain, which is impor-
tant for an undistorted structure. X is usually a proline (Pro), and Y is often
a hydroxyproline (Hyp) [Viguet-Carrin et al., 2006]. This composition leads to
the stability of the collagen triple helix [Kar et al., 2006]. Collagen has the abil-
ity of organising into a hierarchy of fibrils with diameters up to several hundred
nanometers and complex fibrillar, liquid crystal-like architectures [Hulmes, 2002;
Kirkwood & Fuller, 2009].
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Hodge & Petruska [1963] studied stained natural and synthetic collagen fib-
rillar structures under TEM, and proposed a structural model that represents
the basis of all current concepts of collagen structure. They proposed that the
triple helical molecules are arranged in a staggered array such that a gap exists
between the NH2-terminus of one triple helical molecule and the COOH-terminus
of the next. In two dimensions this results in a zone of densely packed molecules
(overlap zone) and a zone of less densely packed molecules (gap zone) due to the
presence of the gaps (as illustrated in Figure 1.2). The characteristic D (65 - 67
nm) periodicity provides resistance to tensile stress.
Collagen exists with controlled orientations in bone. Woven bone consists of
randomly oriented collagen fibrils, and lamellar bone composed with highly ori-
entated collagen fibres [Kini & Nandeesh, 2012]. The mechanisms which guide
the spatial arrangement of collagen fibres have not been fully understood yet.
In 1975, Jones et al. [1975] attempted to investigate this phenomenon. They
observed that collagen fibres were oriented in the same direction as osteoblasts.
However, they have not been able to identify whether the cells controlled the
orientation of the collagen fibres or vice versa. Kadler et al. [2008] proposed that
collagen fibres were formed at the nano-scale by self-assembly. While, on a macro
scale, Martinez et al. [1999] provided clear evidence that collagen fibres orientate
following external loading patterns. As a result, many researchers still focus on
determining the mechanisms which regulate collagen fibril assembly, and whether
cells influence this process.
It has been reported that the spatial arrangement of collagen fibres can be
9
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Figure 1.2: A schematic diagram illustrating the organisation of collagen fibrils.
From bottom to top: the triple helix structure which contains three polypep-
tide chains; the tropocollagen molecule which are long rods comprising three
polypeptide chains; the packing of tropocollagen molecules; collagen fibrils with
its characteristic cross-striated (banding) fibrillar structure. Figure reproduced
with permission from Vaughan [1970].
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regulated by several in vivo and in vitro factors. Procollagen molecules have re-
cently been shown to undergo liquid crystalline ordering in solution, prior to fibril
assembly [Kirkwood & Fuller, 2009]. This may provide an explanation for the liq-
uid crystal-like architectures of different connective tissues [Hulmes, 2002]. One
of the characteristic features of liquid crystals is that they can be ordered in elec-
tric and magnetic fields [Brown et al., 1971]. The earliest investigation on the in
vitro alignment of collagen systems was conducted by using an electrical gradient
[Benjamin et al., 1964]. Later on, several groups developed ways to align collagen
fibres by using varies techniques. The most common studies among these tech-
niques involves exposing collagen solution to a strong static magnetic field with
strength higher than 1T during gelation [Dubey et al., 2001; Guido & Tranquillo,
1993; Kotani et al., 2000; Torbet & Ronziere, 1984]. Here, the fibrils formed in a
direction of perpendicular to the field (shown in Figure 1.3a and 1.3b). Possible
explanations of this phenomenon have been investigated. In the study of Worces-
ter [1978] and Pauling [1979], they proposed that each collagen molecule has a
small negative diamagnetic susceptibility, in which peptide bonds and aromatic
residues are the main potential sources of anisotropy. The regular organisation of
such molecules leads to a large enough negative diamagnetic susceptibility along
the fibres to affect such alignment under magnetic field [Torbet & Ronziere, 1984].
1.2.2 Bone Cells
There are three main type of cells in bone, namely osteoblasts, osteocytes, and
osteoclasts. They are responsible for the bone production, maintenance and mod-
11
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(a)
(b)
Figure 1.3: Microstructure of collagen fibres (a) with 0T and (b) with 8T exterior
SMFs. The arrow indicates the direction of the magnetic field. Scale bar = 250
um. Figure reproduced with permission from Kotani et al. [2000].
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elling, respectively. Osteoblasts are the major cellular component of bone, with
the responsibility of forming and replacing new bone matrix [Pritchard, 1972].
They deposit collagen matrix and release minerals that combine to make the
bone mineral. Once osteoblasts create the new bone around themselves, they are
trapped inside of the bone matrix and can no longer move or form bone, this is
how osteocytes are created. The responsibility of osteocytes is to maintain bone
density by sensing mechanical strains and damage [Pritchard, 1972]. Osteoclasts
are located at the bone surface and responsible for the absorption of bone matrix.
Their main function is to degrade small pieces of bone tissue, resorbing bone via
two distinct processes, including the acidification and the secretion of various
proteases, and the breaking up of both inorganic and organic parts of the bone
[Kini & Nandeesh, 2012]. In healthy adult humans, the rate of bone formation,
which is accomplished by the osteoblasts, should be equal to the rate of bone
absorption, by the osteoclasts, resulting in a renewal of 5 - 10 % of the bone
volume per year [Hernandez-Gil et al., 2006].
Osteoblasts are large cells (20-30 µm), with a basophilic cytoplasm, large nu-
cleus, a substantial rough and large endoplasmic reticulum (as they synthesise
large quantities of proteins), golgi apparatus, mitochondrial and lysosomes scat-
tered throughout the cytoplasm (as shown in Figure 1.4 ) [Hernandez-Gil et al.,
2006].
There are several functions of osteoblasts. First of all, osteoblasts synthe-
sise the organic matrix or osteoid materials at a rate of 2 to 3 µm per day, and
mineralise at a rate of 1 to 2 µm per day. Osteoblasts also secrete a complex
13
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Figure 1.4: A sketch of an osteoblast. The nucleus of the cell is placed charac-
teristically to one side of the cell. the cell contains a developed Golgi apparatus,
mitochondria, ribosome and rough endoplasmic reticulum. Figure reproduced
with permission from Revell [2012].
ECM containing collagenous and non-collagenous proteins, bone morphogenetic
protein (BMPs), and growth factors. Besides, osteoblasts synthesise the bone ma-
trix due to their location, morphology and histochemistry. By taking up of amino
acids, glucose and sulphate groups through the cytoplasmic process, osteoblasts
can also produce collagen matrix, proteins and glycoproteins to form the osteoid
[Pritchard, 1972]. Moreover, osteoblasts also have several roles in calcification.
They can act as the origin of matrix vesicles, store calcium in their mitochondria
and pass this to the matrix, and transport calcium ions in and out of bone fluid.
The presence of a relatively high concentration of calcium in osteoblasts suggests
that these cells transport calcium from the blood stream to calcifying matrix.
Furthermore, they can direct the arrangement of extracellular matrix fibrils as
well as synthesise growth factors [Hernandez-Gil et al., 2006].
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Figure 1.5: Osteogenic lineage, originating from mesenchymal stem cells (MSCs)
in a sequence of steps controlled by transcription factors, growth factors, ECMs
proteins and the parallel expression of specific genes and proteins. Figure repro-
duced with permission from [Epstein et al., 1995].
Osteoblasts undergo a complex differentiation process in a sequence progress-
ing from mesenchymal stem cells (MSCs), osteoprogenitor, preosteoblasts to dif-
ferentiated osteoblasts (mature osteoblasts) (shown in Figure 1.5) [Webster et al.,
2007]. There are three phases in the differentiation process, as identified by Lian
& Stein [1992] (shown in Figure 1.6). They differentiate through a characterised
temporal sequence of expression osteoblastic markers.
In the initial phase, three genes have been identified to control the rate of
proliferation, known as c-fos (a proto-oncogene of the retroviral oncogene v-fos),
c-myc (a regulator gene that codes for a transcription factor, which plays a role in
cell cycle progression, apoptosis and cellular transformation) and c-jun (a protein
encoded by the JUN gene). They are up-regulated together with the transcription
factor core-binding factor a1, (Cbfa1, also known as Runt-related transcription
factor 2 or Runx2) and osterix [Lian & Stein, 1992]. Runx2 is a multifunctional
transcription factor that controls skeletal development by regulating the differ-
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Figure 1.6: Temporal changes in expression of osteoblast cell genes. Cell cycle-
regulated genes (green) include Runx2 and Osterix, and osteoblast phenotype
differentiation genes (blue) include Collagen type I, ALP, BSC, OC, ON, OP.
Adapted from Lian & Stein [1992]. Figure reproduced with permission from Lian
& Stein [1992].
entiation of osteoblasts and the expression of many extracellular matrix protein
genes during osteoblast differentiation. As the expression precursor cells differ-
entiate, they express proteins specific to their function in the cellular membrane.
The expression of Runx2 is the first indication of osteogenic differentiation [Grant
& Ralston, 1997]. Interestingly, maintained expression of Runx2 produces a re-
duction in cortical bone mass and increased trabecular bone mass mineralisation
[Maruyama et al., 2007], indicating that while this factor is essential for osteoblast
lineage specificity, its prolonged expression actually hinders subsequent osteoblast
differentiation. At the end of this stage, the expression of osterix, type I collagen
and growth factors, such as transforming growth factor β (TGF - β) and fibrob-
last growth factor (FGF), are actively synthesised [Aubin & Triffitt, 2002]).
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Other than providing a scaffold for mineral deposition, type I collagen is
essential for osteoblast functionality based on the fact that dysfunctional fibril
formation impairs the subsequent stages of osteoblast phenotypic development.
Through the interaction with α2β1 integrin, collagen influences the activation of
the osteocalcin promoter within the nucleus [Xiao et al., 1998], while also acti-
vates the mitogen-activated protein kinase (MAPK) signalling pathway, leading
to phosphorylation of Runx2.
Alkaline phosphatase (ALP) has an important role in the matrix development
stage, and its expression coincides with the synthesis of type I collagen. ALP acts
locally to increase the phosphate concentration via hydrolysis of mono-phosphate
esters (inorganic phyrophophate) at high pH, which together with calcium ions
form the substrate for hydroxyapatite formation [Harris, 1990].
Finally, during the mineralisation stage, proteins such as bone sialoprotein
(BSP), osteonectin (ON), osteopontin (OP) and osteocalcin (OC) reach a max-
imal level. BSP and ON belong to the Small Integrin Binding Ligand N-linked
Glycoprotein (SIBLING) gene family, which contain Arg-Gly-Asp (RGD) motifs
in their structure. They can bind to various matrix constituents and cell types.
Studies showed that BSP acts as a nucleation factor for hydroxyapatite formation
and deposition [Hunter & Goldberg, 1993]. ON is a promoter of hydroxyapatite
crystal formation, only when it is connected to the collagen by binding to its
discrete fibrillar sites [Roach, 1994]. OP is another glycoprotein with a RGD se-
quence. OP is secreted in mineralising and non-mineralising tissues, and in both
normal and pathological states. Conversely to BSP and ON, OP is believed to
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act as an inhibitor of mineralisation as it hinders hydroxyapatite nucleation, by
preventing premature precipitation of calcium phosphate crystals [Roach, 1994].
Additionally, owing to a RGD sequence in peptide structure, OP serves as a
cell-matrix/matrix-mineral mediator. Another non-collagenous protein, OC can
interact with calcium and hydroxyapatite by regulating the process of minerali-
sation and bone remodelling [Roach, 1994]. In the study of Owen et al. [1990],
OC have been considered as a marker of late osteoblastic differentiation.
Since the first attempt of isolation and in vitro culture of osteoblast cells from
the adult human bone as conducted by Bard et al. [1972], a significant improve-
ment in the knowledge of osteoblastic cell culture has been made. A variety of
cell culture systems have been successfully used to study the biological behaviour
of osteoblasts. Each system can provide unique advantages of increasing the un-
derstanding of bone development, differentiation, gene expression and responses
to local and synthetic factors. Laboratory investigations commonly based on the
employment of primary cultures of osteoblastic cells derived from fetal calvaria
or subperiosteal fetal long bones, established clonal cell lines from cells isolated
from bone tumours (typically osteosarcoma, ROS 17/2.8 or UMR-106; human
MG-63) and non-transformed cell lines (MC3T3-E1 or UMR-201 cell lines).
The primary cell cultures undergo changes which mimic osteoblastic differ-
entiation in vivo, thus providing insights into the stage-wise regulation of gene
expression in osteoblastic cells. However, it is noticeable that depending on the
cell system and culture conditions, temporal aspects of the osteoblast differen-
tiation varies dramatically. One of the problems of using primary cultures is
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that they contain a heterogeneous mixture of osteoblastic cells at different stages
of differentiation and cells of other lineages (including fibroblastic cells) [Aubin
et al., 1993]. Thus the uses of primary cells have been limited. Furthermore, it
is also important to note that the source and the age of the bone, the medium,
culture system, and the isolation system all affect the sensitivity of the cells [Stern
& Krieger, 1983]. For example, cells obtained through the enzymatic isolation
proliferate faster than cells from outgrowth cultures, but the ALP activity is com-
parable in cells from both isolation types [Voegele et al., 1999]. Contradictory
results in terms of ALP activity were found in another study where the enzyme
level was higher in cells obtained from outgrowth culture [Jonsson et al., 1999].
Osteosarcomas are malignant bone tumours consisting of cells with abnor-
mal cellular functions. Osteosarcoma cell lines refer to the cells derived from
bone tumours. These cells share some osteoblastic features, therefore they have
been widely used in vitro as osteoblastic cell models. The most commonly used
osteosarcoma cell lines include UMR-106, MG-63, ROS 17/2 and ROS 17/2.8.
UMR-106 is a cell line derived from a transplantable rat P-induced malignant
osteogenic sarcoma. This cell line has been extensively characterised with prop-
erties of enrichment in ALP activity, type I collagen production and the ability
to mineralise. On the other hand, MG-63 cell lines, which were derived from a
human osteosarcoma, revealed an immature osteoblast phenotype and undergo
temporal development in long term culture [Billiau et al., 1977]. This cell line
display rapid cell growth without exhibiting contact inhibition [Heremans et al.,
1978]. MG-63 cell lines have been used as an experimental model to study a vari-
ety of different osteoblastic functions such as adhesion [Heino et al., 1989], ECM
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synthesis [Franceschi et al., 1988], alkaline phosphatase activity [Boyan et al.,
1989; Franceschi et al., 1985] and osteocalcin production [Lajeunesse et al., 1990].
Moreover, due to their immature phenotype, MG-63 cells can be considered as
a suitable cell model to investigate the differentiation process into a mature os-
teoblast phenotype. However, inconsistency exists in the literature regarding the
mineralisation capabilities of MG-63 cells in monolayer. For example, Clover &
Gowen [1994] and Pierschbacher et al. [1988] indicated that MG-63 cells do not
mineralise over the cultured period. This may limit the use of osteosarcoma cells
as models for matrix mineralisation.
MC3T3-E1 is a clonal non-transformed cell line established from mouse cal-
varia. This cell line exhibits high ALP activity and is capable of synthesising col-
lagen matrix. In addition, this cell line was shown to undergo temporal changes
from proliferation to nodule formation and mineralisation in a similar manner as
in intramembranous osteogenesis in vivo [Sudo et al., 1983]. Although MC3T3-
E1 cells experience a similar proliferation stage as human primary cells, the gene
expression differs significantly from each other. This is due to species-specific
differences in gene regulation [Quarles et al., 1992; Wang et al., 1999].
1.2.3 Cell/Matrix Interactions
The ECM normally provides more than just a structural support, it also provide
cells with chemical and physical cues, to allow cell attachment and migration, to
deliver and retain cells and biochemical cues, to enable diffusion of vital cell nu-
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trients and expressed products, and to exert mechanical and biological influences
to induce certain cell behaviour. Potentially, by providing ECM with different
chemical cues (such as growth factors, biocompatible nanoparticles) and physical
conditions (such as matrix stiffness, topography), the cell behaviour can be al-
tered. Cellular responses to mechanical signals include differentiation, migration,
proliferation, and alterations in cell-cell and cell-matrix adhesion [Mason et al.,
2012].
Cells communicate with their ECM through integrins. Intergrins are a fam-
ily of cell surface receptors that associate with both internal and external envi-
ronment of the cell, among which, α1β1, α2β1, α10β1 and α11β1 can interact
with collagen molecules [White et al., 2004]. For example, α2β1 integrin has
been found to be essential in the organisation and deposition of fibrillar colla-
gen. Following ligand binding, the cytoplasmic domains of integrins connect to
the cytoskeleton of the cell and trigger the assembly of signalling complexes.
Conversely, the binding of intracellular cytoplasmic components influences cell
adhesiveness by altering integrin conformation. Thus, a large variety of complex
signalling events can be transduced by integrins in a bidirectional manner across
the cell membrane. These events serve to modulate and coordinate many aspects
of cell behaviour, such as proliferation, shape, polarity, motility, gene expres-
sion, and differentiation [Askari & Humphries, 2004]. In this way, cell can sense
the changes in the ECM, such as change in stiffness [Mason et al., 2012], fibril
diameter and alignment [Muthusubramaniam et al., 2012]. For example, when
matrix stiffness increases, the cell-substrate adhesion increases. In the study of
Muthusubramaniam et al. [2012], it has been found that larger fibril diameter
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lead to the up-regulation of several gene expressions and markers.
1.3 Three-dimensional Bone Tissue Models
1.3.1 Two-dimensional towards Three-dimensional Tissue
Models
The commonly used tissue models include in vivo (animal) and in vitro models.
In vivo models often refer to the processes performed within a living organism.
In biological research, it often refers to animal models to study the biological
behaviours within a complete and intact system. In vivo models provide the
advantages that the implanted biomaterials will be subjected to the real phys-
iological environment. However, the in vivo models are normally complex and
have limited access, as well as having ethical, costs and time issues. Because
of the inherent difficulties encountered during in vivo evaluations, the majority
of research has been conducted using in vitro models. In vitro models provide
a simpler way for the analysis of tissue components away from the intact living
organism. When compared to the in vivo models, in vitro models are easy to
access, they can help to reduce the cost/waste of animal models, and can also be
incorporated/synthesised with different test variables. The in vitro models can
be further categorised into two types, two-dimensional (2D) or three-dimensional
(3D), distinct by whether the cells have been seeded on or within a cell adherent
material.
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2D tissue models normally refer to the system where cell monolayers are cul-
tured on a stiff or flat surface. Conventional 2D in vitro tests can be performed in
tissue culture plastics, which provide the advantages of low cost and high speed.
2D models can serve as simple and easy systems to assess the effects of materials
on cultured cells, however, they still differ from the natural tissue in several ways.
First of all, the 2D models lack cell/matrix interactions and cell/cell attachments
when compared to the natural tissue. Cells in most natural tissue environments
are embedded within the ECM. This matrix supports cells within a structured
scaffold and exhibits environmental cues to interstitial cells. However, the 2D
models cannot provide the function of a natural ECM. Secondly, the substrate
stiffness is different in 2D and natural matrix. The cells seeded on 2D models
normally attach to the surface of the model in one plane only, therefore they
receive high resistance from the attached plane not the others. While in the real
tissue environment, the cells are interacting with the surrounding environment
and experiencing physiological forces from all dimensions. Thirdly, the concen-
tration of essential nutrients available to cells in 2D and real tissue environment
differ from each other due to the variance in density. In 2D models, the culture
medium with nutrients are not available to the cell surfaces that attached to the
model surface. While in the real 3D environment, nutrients delivered to the cells
have to diffuse through the dense matrix, resulting in a concentration gradient.
This concentration gradient can favour the biological behaviours of the cultured
cells. Therefore, the 2D model may not fully represent the real situation in nat-
ural tissue. These limitations have motivated researchers to develop in vitro 3D
models for laboratory biological studies.
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Culturing cells in a 3D environment has attracted a lot of interest. It is evident
that many cells behave differently when cultured in 3D, and often adopt more in
vivo-like morphologies. Culturing cells in 3D radically alters the mechanical sig-
nals from those provided in 2D, thus affecting cell-receptor ligation, intercellular
signalling and critical cell behaviours such as cellular migration. The 3D envi-
ronment also influences the diffusion and adhesion of proteins, growth factors,
and enzymes, which ensures cell viability and can influence cell functions [Nisbet
et al., 2008]. Maintaining cells in 3D systems, such as spheroids, micromass and
pellets, promotes progression in osteoblastic differentiation leading to osteoblast
cell maturation [Jahn et al., 2010; Kale et al., 2000]. For instance, osteoblast
cell phenotype progression was observed for human osteoblast cells in pellet and
spheroids cultures compared to monolayer cultures. Human bone precursor or
osteoblast cells in spheroids, formed by induction with TGF-β1, had increased
osteonectin and alkaline phosphatase gene expression and collagen synthesis com-
pared to monolayer cells [Kale et al., 2000].
1.3.2 Types of Three-dimensional Tissue Models
There are various types of 3D tissue models used in laboratory studies, such
as porous tissue scaffolds (sponge or foam), fibrous scaffolds (electrospun fibres)
and custom scaffolds made by computer-aided design (CAD). Porous tissue scaf-
folds/models, possess high porosity, interconnected structure and are easy to
manufacture, however, they usually employ highly toxic solvents, experience low
pore interconnectivity and sometimes weak mechanical properties (due to highly
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porous structures). Fibrous scaffolds produce large surface area-volume ratio and
high inter-fibre distances for nutrition and gas exchange, however, they may lack
mechanical integrity and experience limited cell infiltration due to small pore size.
As for the customised models using CAD techniques, they have the advantages
of controlled matrix architecture such as size, shape, interconnectivity, geome-
try and orientation, as well as the required pore size, mechanical properties and
degradation kinetics. However, the technique is highly dependent on the equip-
ment, and the choices of materials are restricted.
Fibrous structure tissue models have been widely applied in tissue engineering
applications. Fibrous structures have advantages of large specific surface area,
small pore size, flexibility in surface functionalities, and high mechanical perfor-
mance [Huang et al., 2003]. Among a lot of techniques for fabricating fibrous
models, electrospinning has attracted great attention own to the ease of opera-
tion, feasibility with various polymers and the resemblance to the ECM nano-
structure. Electrospun fibres provide more bonding site to the cells, they can
enhance cell adhesion [Jiang et al., 2012; Stevens, 2008], cell proliferation as well
as differentiation [Yoshimoto et al., 2003]. There is a wide range of biodegradable
and biocompatible synthetic or natural polymers that can be used for producing
electrospun nanofibres. Synthetic polymers can be categorised into hydrophilic
and hydrophobic. Hydrophilic polymers include poly (vinylpyrrolidone) (PVP)
[Xiao et al., 2014], poly (vinylalcohol) (PVA) [Wang et al., 2004], poly (ethylene
oxide) (PEO) [Lu et al., 2006], and hydrophobic polymers include poly(l-lactic
acid) (PLLA) [Yin et al., 2010], polycaprolactone (PCL) [Chakrapani et al., 2012],
polystyrene (PS) [Huang et al., 2012] and poly(lactic-co-glycolic acid) (PLGA)
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[Katti et al., 2004]. There are also several natural polymers derived for electro-
spinning, such as type I collagen [Matthews et al., 2002], gelatin [Mo et al., 2000]
and chitosan [Bhattarai et al., 2005].
One problem associated with electrospun fibres is that cells cultured on these
scaffolds often adhere to the surface of the scaffold with minimum penetration, as
illustrated in Figure 1.7. It is evident that electrospun fibres usually promote the
assembly of thin tissues on their surface and do not allow proper infiltration of
the cells to the core of the matrix [Dvir et al., 2011; Goh et al., 2013]. However,
it is worth noting that the electrospun fibre scaffolds are still uniquely different
from 2D models, as the cells seeded on fibres receive nutrients and growth cues
three-dimensionally [Nisbet et al., 2008]. Besides, the diameters of the electro-
spun fibres are usually produced at the upper limits of the 50 - 500 nm range
seen in natural ECM (human bone ECM, for example, have an average diameter
of 20 nm) [Dvir et al., 2011], which is not favourable for cell attachment and
growth. In addition, the most common materials for electrospun fibres are syn-
thetic polymers. Many polymers are only soluble in scarce and expensive solvents
at high temperature (above 60 ◦C) [Matthews et al., 2002]. This limits the use
of these polymers in fibre production. Besides, a variety of solvents used in elec-
trospinning systems are fire and explosion hazards, which is another important
drawback of solution technology [Malakhov et al., 2009].
To emulate natural ECM better in terms of structural and functional proper-
ties, as well as to promote cell/matrix interaction at the molecular level, 3D scaf-
folds were created by molecular self-assembly by using natural or synthetic poly-
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Figure 1.7: Illustration of cells seeded on electrospun fibre meshes.
mers. Natural polymers include alginate [Rowley et al., 1999], gelatin [Yamamoto
et al., 2001], chitosan [Berger et al., 2004], fibrinogen [Ahmed et al., 2008],
hyaluronic acid [Gurski et al., 2009] and collagen [Cen et al., 2008]. Synthetic
materials include poly(ethylene oxide) (PEO) [Patel & Amiji, 1996], poly(vinyl
alcohol) (PVA) [Yoshii et al., 1999] and polypeptides [Markland et al., 1999].
Synthetic polymers can be reproducibly produced with specific molecular weights,
block structures, degradable linkages, and cross-linking modes [Drury & Mooney,
2003]. They are generally cost-efficient and have good availability. However, there
always remains a concern about the degradation product of these materials after
implantation. On the other hand, hydrogels formed by natural derived materials
are more frequently used. This is due to the fact that they are either compo-
nents of or have macromolecular properties similar to the natural ECM. These
materials are naturally recognised by cells, and more likely to stimulate physi-
ological responses in cells. For example, collagen is the most abundant protein
27
1. INTRODUCTION AND LITERATURE REVIEW
found in bone and some other of mammalian tissue ECM, it plays a dominant
role in maintaining the biologic and structural integrity of bone ECM [Cen et al.,
2008]. Natural proteins such as type-I collagen contains binding sites recognised
by cell membrane integrin. Particularly, α1β1 and α2β1 play important roles in
dictating cell behaviours. The presence of collagen molecules in the tissue model
increases the biological relevance of the construct, and encourages cells to behave
as they would in their native ECM environment.
The advantages and disadvantages of using hydrogels as a 3D tissue model/scaffold
are listed as below. First of all, they can be designed to be highly biocompatible
and biodegradable. Secondly, they contain pores large enough to accommodate
living cells, allowing good transport of nutrient to and from the cells. However, a
significant disadvantage of hydrogels is their relatively weak mechanical strength.
They posses difficulties in handling, sterilising and stabilising.
1.4 Collagen Plastic Compression
1.4.1 Collagen Hydrogels
In order to better mimic the ECMs and accommodate cells in such a 3D structure,
further understanding of how to control the assembly of this bio-mimetic struc-
ture is required. Native type I collagen can be extracted into acid solutions; the
solubilised collagen monomers are known to spontaneously self-assemble in vitro
at neutral pH and room temperature to form native type fibrils [Yuan & Veis,
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1973]. Most tissues can be simplified and defined by its predominant features
(such as matrix stiffness, cell density, biocompatible factors and growth factor).
By incorporating these features into collagen based scaffolds, tissue specific mod-
els can be produced.
Collagen hydrogels have an established track record as potential scaffolds for
tissue modelling and regeneration applications. One of the main advantages of
collagen as a scaffold material is its ability of incorporating cells directly inside
its 3D environment (as shown in Figure 1.8). In addition, during tissue or or-
gan development and repair processes, collagen can interact directly with cells
to influence several cellular activities, including adhesion, growth, differentiation,
mineralisation of ECM, as well as the expression of growth factors and cytokines.
This provides the desired properties as a ECM-like scaffold, including water re-
tention capacity, nano/micro-porosity to allow cells to grow and arrange in 3D,
biodegradability, and pore inter-connectivity to allow free flow of oxygen and nu-
trients [Dutta & Dutta, 2009; Tomasek et al., 2002]. Due to these advantages,
a large number of applications of collagen gels can be seen, such as nerve guide
tube for peripheral nerves [Phillips et al., 2005] and scaffolds for connective tis-
sues [Brown, 2013].
However, some properties of collagen hydrogels may limit their application.
For example, collagen density in those gels is only measured as approximate 0.2
to 0.5 % of wet weight, with large excess of fluid (>98%). This results in poor
mechanical properties, the lack of orientated architecture, and limited direct cell
contact [Brown et al., 2005]. When cells being seeded within collagen hydrogels,
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Figure 1.8: Illustration of cells incorporated within PC collagen hydrogels.
they can expel some of this excess fluid and increase the collagen density [Bell
et al., 1979]. However, this process can take several days, and only gives a modest
increase in mechanical strength with limited precision and control. Therefore the
direct use of collagen hydrogels scaffolds remains an imperfect solution.
1.4.2 Plastic Compression
In order to construct a mechanically strong collagen based scaffold, as well as
maintain all the properties, a novel approach known as plastic compression (PC)
has been developed by Brown et al. [2005]. Many studies have demonstrated the
suitability of PC collagen scaffolds in tissue engineering applications, such as skin
[Hu et al., 2010], bone [Buxton et al., 2008] and cornea [Mi et al., 2010]. The
PC process can be achieved by compressing conventional collagen gels, leading to
the controlled expulsion of interstitial liquid. Figure 1.9 represents the schematic
view of plastic compression process.
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PC allows for the fabrication of dense collagen constructs, which mimic the
ECM fibrillary density, microstructure, and biological properties. For example, a
conventional collagen hydrogels is made from a collagen solution with a density
of 2 mg/ml, and the resultant hydrogel contains 0.2 % collagen and 99.8 % water.
With a single plastic compression system, collagen density in the resultant model
can increase to 11 - 18 % [Brown et al., 2005]. Furthermore, this construct has
been tested to persist for at least 5 weeks in vivo [Mudera et al., 2007]. Within
this dense tissue, cells can migrate through the construct while maintaining the
overall dimension and the shape of the model. The migration of cells within the
PC collagen construct are related to the oxygen concentration gradients (Cells
migrate from lower to higher partial pressure of oxygen) [Ardakani et al., 2014]
as well as substrate stiffness (towards stiffer regions) [Hadjipanayi et al., 2009b].
The plastic compressed collagen gels offer several advantages compared to the
conventional collagen hydrogel. First of all, by applying the load on top of the
collagen gel, the aqueous component can be removed from the gel, leading to an
increase in mechanical strength and collagen density of the compressed scaffolds.
Besides, the compression does not affect the viability of pre-seeded cells, with
over 90 % viability after compression [Brown et al., 2005]. This can be contribute
to the controlled compression of the sample and the high permeability of the
construct to the cell essential molecules. Furthermore, the plastic compressed
collagen gels have a thickness of100-200 µm, providing the possibility to produce
multi-layer scaffolds. In addition, the fabrication process is extremely rapid and
non-reversible, upon the removal of the loads, the water does not return to the
collagen fibre, therefore known as the term "plastic".
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Figure 1.9: Schematic view of plastic compression (PC) process. Diagram shows
the conventional assembly of PC of pre-formed collagen gels. The liquid in the
collagen hydrogel was expelled by application of compressive mechanical loads.
Figure reproduced with permission from Brown et al. [2005].
1.4.3 Cell Response within PC Models
By culturing cells inside PC collagen hydrogels with dense structure, their cell
behaviour can be influence, particularly the cell proliferation, differentiation and
mineralisation. Below are some highlighted findings.
1.4.3.1 Proliferation
Plastic compression produces dense collagen structures by compression, the load
applied does not affect the viability of the cells seeded within the model. Gen-
erally, the cell viability was found to be more than 90 % after compression (for
human dermal fibroblasts (HDFs)), with even higher percentage by using differ-
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ent cell types [Brown et al., 2005]. Since the cells can survive in the construct,
they start to proliferate naturally. The proliferation can be affected by several
factors. First of all, the initial cell seeding density can affect proliferation ability.
Bitar et al. [2007] studied the relationship between cell density and proliferation
by seeding 1 × 105 - 1 × 108 /ml cells. They found that low cell density (1 × 105
/ml) results in higher proliferation rate. Hadjipanayi et al. [2009a] studied the
relationship between seeding 1 × 106 - 20 × 106 /ml cells, and they proved that
higher cell density led to a lower proliferation rate. Given a same size of scaffold,
large cell number would reach sufficient cell density quickly, hence inducing con-
tact inhibition. Secondly, the cell proliferation is also directly regulated by the
stiffness of the matrix. Hadjipanayi et al. [2009a] found increased cell prolifera-
tion with increasing collagen density, and the collagen density is also proportional
to matrix stiffness. In gels of 0.7% collagen, there was an 87% increase in cell
number (within 48 h), this was reduced to 25% in gels of 0.4% density, and no
proliferation was measured at 0.2% (uncompressed), due to the low matrix stiff-
ness. In the study of Ghezzi et al. [2011b], they also demonstrated a significant
improvement in cell proliferation within dense collagen scaffolds when compared
to collagen hydrogels.
1.4.3.2 Differentiation
Cells seeded in PC collagen also exhibit higher differentiation ability when com-
pared to conventional hydrogels. Stimulation of differentiation towards mature
osteoblasts and osteocytes was reported by Buxton et al. [2008]. By providing the
pre-osteoblasts with a dense fibrillar environment, they were encouraged to com-
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mit to osteogenic differentiation and further enhance the rigidity of the matrix.
This has been achieved by up-regulating the expression of BSP, ALP, Collagen I,
MMP-13 and Runx-2 in vitro.
1.4.3.3 Mineralisation
Dense collagen structure can also influence the mineralisation of osteoblasts in
vitro. Buxton et al. [2008] demonstrated that osteoblasts in PC scaffolds min-
eralised earlier and faster than conventional collagen hydrogels. One of the ex-
planations is that high collagen fibrillar density can provide a micro-environment
more favourable to crystal formation. Marelli et al. [2011] further determined the
correlations between the collagen fibrillar densities and the mineralisation level.
They demonstrated that higher collagen fibrillar density led to higher carbonated
hydroxylapatite formation within reconstituted collagen gels. Increased collagen
density was in fact correlated with increased fibre entanglement, fibril-to-fibril
contact points and reduced roughness. These changes in the gel microstructure
had a significant effect on mineralisation level.
1.4.4 Further Engineering in Plastic Compression
Collagen gels can be hybridised at the point of self-assembly with several molecules
of interest. When further introducing bio-factors into PC collagen gels, os-
teoblasts have been reported to have enhanced biological properties. For example,
Chicatun et al. [2011] introduced chitosan into a PC system with MC3T3-E1 cells.
Results demonstrated increased ALP production, level of mineralisation as well
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as mechanical properties. However, they found no significant effects on cell prolif-
eration when chitosan was introduced into the scaffolds. Bioactive glass particles
also have been blended with collagen [Marelli et al., 2010]. They demonstrated
that the presence of 45S5 bioglass within dense collagen models resulted in an ac-
celerated 3D mineralisation and differentiation. Furthermore, the incorporation
of silk fibrion and anionic fibrin derived polypeptides have been demonstrated to
have the ability to promote osteogenic differentiation of MSCs in collagen gels
[Ghezzi et al., 2011a; Marelli et al., 2014].
Table 2.3 summaries some key observations in PC systems when using various
types of cells, cell density and the incorporation of additional materials.
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Cell Type Cell Density/ml Materials Key Observations References
HDFs 0.33 × 106 N/A High cell viability, functional mechanical properties Brown et al. [2005]
MG-63 1 × 105 - 1 × 108 N/A Low cell density results in higher proliferation rate Bitar et al. [2007]
Pre-osteoblasts 3 × 105 N/A Enhanced expression of BSP,ALP,Col1,Runx2 Buxton et al. [2008]
HDFs 1 × 106 - 20 × 106 N/A Higher cell density led to a lower proliferation rate Hadjipanayi et al. [2009a]
HDFs 2.11 × 105 N/A Increased viability, metabolic activity Ghezzi et al. [2011b]
HDFs 23.2 × 106 N/A Up-regulated expression of VEGFs Hadjipanayi et al. [2011]
Chondrocytes 3 × 105 Chitosan Increased cell viability Imaizumi et al. [2007]
MC3T3-E1 2.11 × 105 nBG Enhanced metabolic activity and ALP production Marelli et al. [2011]
Table 1.1: Summary of various cell type, density and additional materials used in PC
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Plastic compression of collagen hydrogels provide a mechanically strong and
dense collagen structure, therefore can be better served as a 3D model for in vitro
studies. However, there are also some limitations associated with this approach.
Standard PC techniques bring scaffolds to in vivo levels of matrix density (11 -
18% collagen density) [Cheema et al., 2011], however the mechanical properties
of such scaffolds still fall far from those found in tissues. A compressed collagen
sheet have a break strength of 0.6 ± 0.11 MPa and a Yong’s modulus of 1.5 ±
0.36 MPa [Brown et al., 2005], a double compressed collagen sheet can push the
Young’s modulus up to 4.7 ± 0.6 MPa [Neel et al., 2006], however, these values
are still far below the collagen fibres in natural tissue, which is 0.2 - 0.5 GPa
[van der Rijt et al., 2006]. Another problem associated with increased collagen
density is that, the mass transfer of nutrients decreased, leading to potential cell
death [Nazhat et al., 2007]. One way to maintain suitable oxygen concentrations
throughout the scaffold was incorporating micro-channelling within these matri-
ces, such as unidirectional aligned soluble phosphate based glass fibres [Nazhat
et al., 2007]. Besides, although collagen hydrogels translate force to cells embed-
ded within the scaffold very well, as the collagen matrix stiffens and remodels,
less force is translated through, possibly due to the stress-shielding. Overall, PC
collagen hydrogels can be served as useful 3D scaffolds/models for tissue engi-
neering and regeneration applications, to test the properties of biomaterials and
cell responses, for proliferation, differentiation, mineralisation, and other biologi-
cal behaviours, over time. However, improvements are needed to further develop
this approach.
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1.5 Bone Regeneration
1.5.1 Bone Fracture
Bone fracture occurs when local stresses in a part of bone exceed the ultimate
strength of the tissue. A fracture results in the discontinuity of the bone ma-
trix and is normally accomplished with soft tissue damage, torn blood vessels,
bruised muscles and a lacerated periosteum. The causes of bone fracture vary
from trauma, infection, tumours and compromised blood supply, among which
the direct trauma is the most common factor. Most fractures caused by direct
trauma are either single or multiple. Fractures can also occur from pathological
conditions due to the underlying bone or systemic disease, which can cause one
or many of the bones of the skeleton system to be abnormal and more suscepti-
ble to fracture. Pathological fractures may occur through diseases such as bone
tumours, osteoporotic bone, osteomyelitis and osteomalacia [Revell, 2012].
1.5.2 Bone Regenration
The bone healing and regeneration process normally involves three phases, the
inflammatory phase, the reparative (including soft and hard callus formation)
and remodelling phase.
When a fracture occurs, the bone, the associated soft tissues, including the
periosteum and its surrounding muscles are torn, and the blood vessels crossing
the fracture line are ruptured. The injury initiates an inflammatory response,
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which is necessary for the healing to progress. The immune cells produce several
factors and cytokines within that time, including Interleukin 1 (IL1), IL6, IL8,
IL12, platelet derived growth factor (PDGF), tumour necrosis factor α (TNFα),
vascular endothelial growth factor (VEGF), CXC Receptor 4 (CXCR4) and os-
teopontin/secreted phosphoprotein 1 (SPP1), which are essential for mobilisa-
tion and chemotaxis of other cells, angiogenesis and osteogenesis [Park & Barbul,
2004]. Then an accumulation of a haematoma within the medullary canal be-
tween the fracture ends occurs, and rapidly coagulates to form a clot [Gray et al.,
1995]. The acute inflammatory response peaks within the first 24 h and completes
after 7 days. Angiogenesis happens through the secretion of several essential fac-
tors, such as fibroblast growth factor β (βFGF), VEGF and insulin-like growth
factor 1 (IGF-1) [Knighton & Fiegel, 1989]. These factors induce the forma-
tion of capillaries within the clot and the loose aggregate of fibroblasts which
forms the granulation tissue [Tonna & Cronkite, 1961]. Then the platelets and
macrophages enter the fracture site and begin to secret inflammatory cytokines.
These cytokines recruit MSCs and osteoprogenitors or chondroprogenitors from
various locations, including the bone marrow, muscle and the periosteum. These
MSCs then proliferate and differentiate into osteogenic cells.
The reparative phase starts after inflammation and normally lasts for a few
weeks. Initially, cartilaginous tissue forms a soft callus which gives the fracture a
stable structure. The progenitor cells residing in the cambial layer of periosteum
and endosteum differentiate into osteoblast cells, which subsequently deposit wo-
ven bone via intramembranous ossification. The formed callus can rapidly enve-
lope the bone ends and leads to a gradual increase in the stability of the fracture
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fragments. At the same time, the granulation tissue formed after the fracture is
replaced by fibrocartilagenous tissue. This process is initiated by several growth
factors, including BMPs, IGF1, PDGF, transforming growth factor-beta (TGF-
β) super-family and fibroblast growth factor 1 (FGF-1) [Bostrom et al., 1995;
Yu et al., 2010]. These growth factors can stimulate fibroblast and chondrocyte
proliferate and differentiate. Then the hard callus formation starts in the next
stage and lasts until the fragments are united by a new bone, which normally
takes 3 - 4 months.
Although the hard callus is a rigid structure providing biomechanical stability,
it does not fully restore the biomechanical properties of normal bone. In order
to achieve this, the fracture healing cascade initiates the next phase, to remodel
the hard callus into a lamellar bone structure with a central medullary cavity.
The remodelling process is carried out by a balance of hard callus resorption by
osteoclasts, and lamellar bone deposition by osteoblasts. Although this process
is initiated as early as 3 - 4 weeks in animal and human models, the remodelling
may take years to complete and achieve a fully regenerated bone structure. In the
normal adult, a cortical bone fracture takes approximately 12 weeks to heal while
the remodelling phase can take several years [Browne, 1988]. Within children,
the rate is normally quicker than in the adult, which consolidation taking 4 - 6
weeks [Adems & Hamblen, 1992].
To make bone remodelling successful, an adequate blood supply and a gradual
increase in mechanical stability are crucial. This is demonstrated in cases where
neither is achieved, resulting in the development of an atrophic fibrous non-union
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(with no obvious callus formed). However, in cases where there is good vascular-
ity but unstable fixation, the healing process progresses to form a cartilaginous
callus and results in a hypertrophic non-union.
Figure 1.10a and 1.10b summarise the healing process of bone fracture.
1.5.3 Fracture Non-union
There is currently no accepted standardised definition of fracture non-union
among orthopaedic surgeons. According to the definition provided by the Food
and Drug Administration (FDA), a minimum time of 9 months has to elapse
since the initial injury and there should be no signs of healing for the final three
months for diagnosis of fracture non-union [Morshed, 2014].
The causes of non-unions can be complicated, such as problems with opera-
tive and non-operative interventions, comprising inadequate mobilisation of the
fracture, distraction of fracture fragments by fixation devices or traction, re-
peated manipulations or excessive early motion of fractures, excessive periosteal
stripping, and damage to other soft tissues during operative exposure. Besides,
contamination time during operation, smoking, diabetes can also lead to non-
union of fracture sites [Einhorn, 1995; Victoria et al., 2009].
Fracture healing can be affected by the following factors. First of all, the type
of bone involved. Cortical and cancellous bone respond to fractures differently. In
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(a)
(b)
Figure 1.10: Immediately after fracture a blood clot forms and the inflammatory
response is triggered. The inflammatory phase is typified by the haematoma
and oedema, cells invade the fracture site. In the reparative phase, soft tissue
compromising of cells embedded in glycoproteins and collagen matrix around
and between the bone ends which is made up of internal callus. The cells are
derived from the proliferation of osteoprogenitor cells in the endosteal layer and
the external callus. Blood supply is from the periosteum, until the centrifuge
supply from the endosteal is restored and regenerated. Vasularisation continue
to increase as both the internal and external calluses are converted into woven
bone by endochondral or intramemebraneous ossification. In the remodelling
stage, the external periosteal collar is gradually resorbed whilst the medullary
canal is reshaped into its original hollow form. Vascularisation is returned to
normality. Figure reproduced with permission from Oryan et al. [2013].
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cancellous bone, union occurs at points of contact, as cancellous bone has many
contact points with rich blood and cells, it normally unites rapidly. Cortical bone
healing is complex when compared to cancellous bone healing. The healing pro-
cess can be categorised into two mechanisms depending upon the local conditions.
If mobilisation is rigid, end-to-end healing of the cortical surfaces occurs with very
little external callus. However, if the fragments have widespread displacement,
the healing process is accompanied by the formation of callus. Secondly, the heal-
ing can also be affected by the degree of local trauma. Local trauma and trauma
to the soft tissue cause a decrease in the number of MSCs and their differentiation
abilities, the healing rate of the fracture site also depends on the healing of the
surrounding soft tissues. Thirdly, the degree of immobilisation can have an im-
pact on the fracture healing. Inadequate immobilisation leads to delayed union,
disruption of the initial fibrin scaffolding and failure in callus formation. Besides,
if infection is superimposed upon a fracture, the local defences are mobilised in
order to eliminate the infection and therefore hinder the rate of healing. The
healing rate is also dependent on the age of the patient. Young people heal more
quickly than elderly. Studies have shown that in older rats, the expression of
BMP-2 is lower when compared to other rats. Besides, serum from older donors
was found to be a less potent stimulator of osteoblast differentiation when com-
pared with that from younger patients [Kwong & Harris, 2008].
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1.6 Stimulation Techniques for Bone Regenera-
tion
1.6.1 Biological Stimulations
1.6.1.1 Osteoinductive Factors
Although the molecular basis for fracture healing is not fully understood, it has
been identified that several growth factors and cytokines are involved in the pro-
cess of bone repair and remodelling. Bone regeneration can be regulated by a
variety of growth factors such as PDGF, fibroblast growth factor (FGF), IGF-1
and the TGF-β super-family, which includes BMPs and growth and differentia-
tion factors (GDFs) [Sathyendra & Darowish, 2013].
FGFs have an anabolic effect on bone, as they are mitogens of osteoblasts, vas-
cular endothelial cells and fibroblasts. It has been demonstrated that FGFs can
induce MSCs to differentiate into preosteobalsts and prechondrocytes [Bostrom
et al., 1999]. Moreover, FGFs have been shown to enhance the callus size and the
strength of the repaired fracture.
PDGFs have been demonstrated to have a stimulating effect on fracture heal-
ing. The functions of PDGFs include: stimulating the protein synthesis in os-
teoblasts, favouring the bone resorption, enhancing collagen synthesis, affecting
the fibroblasts and smooth muscle cells [Hernandez-Gil et al., 2006]. For example,
when treated with PDGFs using rabbits tibial osteotomy models, more mechani-
cally stable callus and mature osteoblast formation can be observed [Sathyendra
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& Darowish, 2013].
IGF-1 can trigger osteoblasts proliferation, enhance collagen synthesis and
inhibit collagen degradation, as well as mediate the osteoblast-osteoclast interac-
tion in bone [Papachroni et al., 2009]. Overexpression of IGF-I in bone under the
osteocalcin or collagen type I promoter increases bone formation [Bikle, 2008]. It
also has been reported that the expression of IGFs can be enhanced by mechan-
ical loading both in vivo and in vitro. For example, by applying a mean strain
of 2664 µstrain (loaded) and 350 µstrain (sham-loaded) in rats tibia, the propor-
tion of IGF-I mRNA was found to be 29.3 ± 12.9 % for loaded tibia, 16.7 ± 4.4
% for sham-loaded tibia and 14.7 ± 4.2 % for control tibia [Reijnders et al., 2007].
The TGF-β family is a group of proteins which are highly abundant in bone
tissue. They have a broad range of cellular activities, including the control of
proliferation and differentiated phenotype, and the synthesis of the osteoid ma-
trix. Investigations have shown that several members of these morphogens can
promote the differentiation of MSCs into the osteogenic and chondrogenic lin-
eages. A study demonstrated that TGF-βs can increase the fracture callus size
and bending strength in rabbits with mid-tibial osteotomies, however, no effects
on the stiffness, bone mineral content and Harversian canal diameter have been
observed [Lind et al., 1993]. Moreover, Cho et al. [2002] conducted an in vivo
investigation on the expression of TGF-βs on a mouse tibial over 28 days. Results
demonstrated that several members of the TGF-β family are actively involved in
fracture healing. For example, TGF-β1 is constitutively expressed from day 3 to
day 21, TGF-β2 and TGF-β3 showed maximal expression on day 7.
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Among several types of growth factor which can affect the fracture healing,
BMPs are the most promising ones for clinical use [Schmitt et al., 1999]. BMPs
can aid the transformation from connective tissue into bone tissue, mediate the
recruitment of cells to the repair site, with the potential to stimulate maturation
of mesenchymal osteoprogenitor cells to osteoblasts, in addition to influencing
the proliferation of these cells at various stages of the healing process [Bodamyali
et al., 1998; Yamaguchi et al., 2000]. Cho et al. [2002] studied the temporal ex-
pression of members of the BMPs during fracture healing using a mouse tibia
model over a 28-day period. Within 24 hours of the fracture occurred, there was
an increase in the activity of BMP-2, suggesting its role as an early response in
the cascade of healing events. Through the period of day 14 to 21, when the re-
sorption of calcified cartilage and osteoblastic recruitment were the most active,
there were increased expressions of BMP-3, BMP-4, BMP-7, and BMP-8. More-
over, BMP-5 and BMP-6 were constitutively expressed from day 3 to day 21.
BMP-2s have been shown to induce osteoblastic differentiation by acting on the
MSCs, increasing the expression of the osteogenitic transcription factors osteix
and Runx2 [Phimphilai et al., 2006]. Urist [1965] reported that BMP-4 is consid-
ered as a factor related to the healing of bone fractures, and this growth factor has
been widely studied since then. Sato et al. [1999] further suggested that BMP-2
and BMP-4 accelerate differentiation of the cells into osteogenic/chondrogenic
cells, as well as lead to bone-like structure formation with associated increase
in osteoblast differentiation and improved mineralisation of constructs; BMP-6
was detected in differentiated chondrocytes, and the expression can last for a few
weeks until cartilage callus was resorbed and replaced by bone.
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1.6.1.2 Osteoconductive Materials
Osteoconduction is a process that supports the ingrowth of the sprouting capil-
laries, perivascular tissue and osteoprogenitor cells from the recipient host bed
into the 3D structure of an implant or graft [Einhorn, 1995]. Osteoconductive
materials include calcium phosphate ceramics, such as hydroxyapatite (HA), tri-
calcium phosphate (TCP) and bioactive glasses, or natural materials, such as
coral. The rational of these materials is that, normal osteoblasts or osteoblastic
cell lines have the ability to form bone on the appropriate surface. That surface
must have the necessary physical and chemical composition to support the at-
tachment, migration and differentiation of the cells. Therefore the investigations
of these materials on the stimulation of bone formation and repair have been
conducted for many years.
HA has been widely studied as an osteoconductive material for bone healing
applications as it shares the similar composition with bone. Immature bone has
deficient amounts of calcium and hydroxyl ions. With age, the bone crystal pro-
gresses to the stoichiometric hydroxyapatite formula of Ca10(PO4)6(OH)2 [Pos-
ner, 1978]. Naturally formed apatite has carbonate substitutions (CO32−), with
additional substitution of sodium (Na+), magnesium (Mg2+), potassium (K+).
fluoride (F−), chloride (Cl−), and trace elements such as strontium (Sr2+), lead
(Pb2+) and barium (Ba2+). CO32− are the most abundant ions found in bone
minerals, and can substitute for the phosphate and hydroxyl group in apatite
[Driessens et al., 1983]. There has been increasing interest in using precipitated
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nano scale HA particles (nHA) for bone regeneration therapies, own to the fact
that it mimics the size of HA crystals in natural bone more closely. nHA has
been demonstrated to promote the adhesion, proliferation and differentiation of
osteoblasts in vitro [Huang et al., 2004; Murugan & Ramakrishna, 2005; Wei &
Ma, 2004].
The first calcium-phosphate based bone graft substitute approved by FDA was
the Interpore (Interpore International Irvine California) [Bucholz et al., 1989]. In-
terpore is a predominantly HA biomatrix formed by the conversion of a marine
coral calcium phosphate to crystalline HA. The structure formed can serve as
a template for host bone and new bone formation, presumably on the basis of
its chemical and architectural composition. Clinical trails have been conducted
to demonstrate the effects of this material in the treatment of osseous defects
and fractures with loss of the bone [Bucholz et al., 1989]. Other examples of the
clinically approved material include Collagraft (Collagen Corporation, Palo Alto,
California), which is a mixture HA, TCP and fibrillar collagen.
On the other hands, infection is one of the reasons that causes fracture non-
union. Nano zinc oxide (nZnO), with its well demonstrated antimicrobial proper-
ties [Brayner et al., 2006], can be introduced into the system to enhance fracture
non-union by reducing bacterial growth. The antimicrobial property of nZnO can
be contribute to the generation of reaction oxygen species and damage cell mem-
brane with subsequent interaction of the nanoparticles with intracellular contents.
In addition to the antimicrobial property, recent studies from Memarzadeh et al.
[2015] also demonstrated a stimulating effects of nZnO on the proliferation and
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ALP activity of osteoblastic cell lines. These results support the use of nZnO
incorporated scaffolds as an outstanding candidate for promoting bone growth
and inhibiting infection.
1.6.2 Physical Stimulations
1.6.2.1 Mechanical Stimulations
Tracing back to the 19th century, Cowin [1986] firstly hypothesised that bone
remodels in response to stress and strain, due to the fact that the structure of
bone adapts to changes in its stress environment. This process is also known as
mechanotransduction, which involves the conversion of a biophysical force into a
biochemical response leading to changes in gene expression and cellular adapta-
tion.
Mechanotransduction can be categorised into four distinct phases, including
mechanocoupling, biochemical coupling, transmission of signal and the effector
cell response. Mechanical loads first cause deformations in bone that stretch bone
cells, and also create fluid movement within the canaliculae of bone [Duncan &
Turner, 1995]. In biochemical coupling, mechanical forces can be transferred
to osteoblasts through several mechanosensors, includes integrins, calcium chan-
nels, cell-cell adhesion elements (cadherins, gap junctions), surface processes (pri-
mary cilia, stereocilia), other membrane elements (caveolae, surface receptors),
cytoskeleton constituents (microfilaments, microtubules, intermediate filaments),
ECM elements (collagen, fibronectin, proteoglycans, basement membrane) and
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other cell-ECM adhesions (focal adhesions) [Frost, 2003]. Osteoblasts, osteocytes,
and bone lining cells may act as sensors of mechanical signals and may commu-
nicate the signal through cell processes. These cells also produce paracrine fac-
tors that may signal osteoprogenitors to differentiate into osteoblasts [Duncan &
Turner, 1995]. At the molecular level, mechanotranduction also induces secretion
of growth factors, including IGF, VEGF, PDGF, FGF, TGF-β and the BMPs,
which are considered to be principal local regulators of osteogenesis [Papachroni
et al., 2009].
In bone, external mechanical loads cause local deformations in the tissue,
which is known as the strain. The amount of strain influences the cellular re-
sponse, the formation of capillaries, and the resultant tissue formed at a fracture
site [Sathyendra & Darowish, 2013], hence can potentially lead to increased bone
volume, bone strength [Robling et al., 2000] and bone formation rate [Kotani
et al., 2002; Schriefer et al., 2005] in vitro and in vivo. A number of reports have
suggested that ion channels in the membrane are strain-sensitive. In vivo loading
can also increase the gene expression of vital matrix proteins such as osteocalcin
(OC), collagen type I and alkaline phosphate (ALP) [Moalli et al., 2000; Pavlin
et al., 2001]. These studies indicated that mechanical strain transduction may be
related to direct mechanical deformation of ultrastructural organelles or proteins,
which would convert mechanical signals into biochemical information.
It is worth noting that the effects of mechanical loading are dependant upon
the magnitude, duration, and rate of the applied load. Some amount of strain at
the fracture site is beneficial to healing, whereas excessive strain will result in for-
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mation of granulation tissue or fibrous tissue and eventually disrupt the healing
process [Wallace et al., 1994]. Lanyon [1984] and Rubin & Lanyon [1985] studied
the response of bone during normal loading in vivo. Strains smaller than 500
µstrains were not found to have a stimulation effect, and those between 500 and
1500 appeared to maintain bone mass and strains over 1500 µstrains increased
bone mass, while peaked at 3000 µstrains. Application of over 10 000 µstrain
results in a de-differentiation of the osteoblasts [Jones et al., 1991]. When the
strain increases to above 30 000 µstrains, microcracks and even failure of the
bone can be observed. However, most of the cell culture mechanostimulus sys-
tems have been designed to deliver peak strains in the range of 10,000 - 100,000
µstrains [Brown, 2000], which were 5 - 100 times greater than the normal strain
level found in living cells [Duncan & Turner, 1995].
1.6.2.2 Magnetic Stimulations
Pulsed electromagnetic fields (PEMFs) have also been identified to play a role
in bone fracture healing treatments through the similar principles as mechani-
cal stimulation applications. Application of PEMFs to the fracture site is meant
to induce currents in the high conductive extracellular fluids as well as mechan-
otransduction. Much evidence has suggested that PEMFs can enhance a number
of activities of osteoblasts, i.e., proliferation [De Mattei et al., 1999], differentia-
tion [Landry et al., 1997], extracellular matrices [Heermeier et al., 1998], expres-
sion of bone morphogenic protein 2 and 4 [Bodamyali et al., 1998], net flux and
the uptake of calcium [Fitzsimmons et al., 1994]. There are a number of USA
FDA approved devices aimed to enhance bone fracture related diseases by using
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PEMFs, including the Physio-Stim by Orthofix, the EBI Bone Healing system by
Biomet Inc and the Orthologic (OL) 1000 by OrthoLogic.
There are several mechanisms proposed for the effects of PEMFs on bone
healing. Firstly, PEMFs have been shown to stimulate the calcification of the
fibrocartilage of the gap between the bony segments. Secondly, the PEMFs have
been demonstrated to have an inhibitory effect on the resorptive phase, leading
to the early formation of osteoids and calluses. Thirdly, PEMFs can have an
effect on increasing rate of bone formation by osteoblasts [Shupak et al., 2003].
However, some studies failed to show the effects of PEMFs on fracture healing
applications. For example, PEMFs with 0.3 T/s, 15 Hz were ineffective in the
treatment of un-united tibia fractures [Shupak et al., 2003]. Although PEMFs
treatment have been succeeded in lots of clinical applications, the fundamental
understanding of the ways in which magnetic forces are transduced into cellular
and molecular events is still under investigation.
Static magnetic fields (SMFs) have also been demonstrated to have the ability
to promote bone healing. SMFs have been identified to affect a number of biolog-
ical functions in osteoblasts, such as proliferation, differentiation, extracellular
matrix synthesis and mineralisation [Cai et al., 2015; Chiu et al., 2007; Meng
et al., 2013; Rosen, 2003]. At the molecular level, it has been proposed that
the magnetic force can affect the molecular structure of excitable membranes,
hence modify the function of embedded ion specific channels. This process can
be achieved by the activation of mechanosensitive Ca2+ ion channels or the reori-
entation of the cytoskeleton [Dobson et al., 2006]. However, despite the success
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of SMFs stimulations with several in vitro studies, there remains a concern that
bone responds to dynamic loading rather than static, it is believed that the stim-
ulation is related to the peak strain magnitude and the loading frequency [Rubin
& Lanyon, 1985]. Therefore in some cases, the SMFs failed to demonstrate a
stimulating effect on cell proliferation, etc.
An overview of the details of magnetic stimulation will be provided in the
following sections, including the use of static magnetic fields as well as magnetic
nanoparticles.
1.7 Magnetic Stimulation
1.7.1 Static Magnetic Fields
SMFs can be categorised into three classifications, by their magnetic field strength,
including weak (< 1 mT), moderate (1 mT - 1T) and strong (1T - 5T) [Rosen,
2003]. Each type of SMFs influence biological systems differently.
Biogenic magnetite, which presents in various bacteria (such as E.Coli), cells
(such as fibroblasts), and organs (such as brain), can respond to weak magnetic
field of the Earth (about 5 µT) [Hong, 1995]. For example. weak SMFs have been
demonstrated to enhance the eﬄux of Ca2+ ions in chick brain and therefore the
brain functions [Dini & Abbro, 2005]. Several studies tried to explain the biolog-
ical effects of weak SMFs [Gartzke & Lange, 2002; Kavaliers & Ossenkopp, 1994;
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Markov et al., 1993; Reiter, 1993]. Belyaev et al. [1997] proposed that the effects
of low magnetic field is related to high frequency oscillations in the cell nuclei.
Lednev [1996] further explained that the bioeffect induced by low magnetic field
is proportional to the polarization degree of the ion’s vibration.
Moderate intensity SMFs are capable of influencing a number of biological
systems, due to the fact that many inorganic and organic compound in the cells/
cell membranes have some degree of diamagnetic properties. Moderate inten-
sity SMFs have an effect on the molecular structure of excitable membranes,
potentially by rotating the membrane’s phospholipid molecules, hence modify
the function of embedded ion-specific channels. This could lead to, for example,
changes in cellular shape [Chionna et al., 2003], cytoskeleton arrangement [Para-
disi et al., 1993], ion flux [Rosen, 1996], ion channels [Ottaviani et al., 2002] and
formation of cell protrusions [Ross et al., 1989]. For osteoblasts, these changes
can up-regulate the osteogenesis process.
Differences in exposure systems, conditions and cell types complicate the eval-
uation of the effects of SMFs on biological behaviours. The effects as regards to
the proliferation of osteoblasts are not significant, with decreased and unchanged
cell proliferation having been documented with different intensities of SMFs, and
different cell types and exposure time. For instance, Chiu et al. [2007] found that
the proliferation of MG-63 cells was inhibited by SMFs (400 mT) after 3 days,
and Cunha et al. [2012] indicated a reduced cell number of MG-63 by SMFs (320
mT) after 7 days. Imaizumi et al. [2007] demonstrated that the proliferation of
MC3T3-E1 was unchanged after 1 day but decreased by the exposure to SMFs
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(250 mT) after 4 and 7 days. Reduced cell viability has also been observed in the
studies of Paradisi et al. [1993] and Chionna et al. [2003]. On the other hand,
SMFs can have no effects on the cell proliferation at all. After treatment with
SMFs with 160 mT, the proliferation of primary calvaria cells, ROS 17/2.8, and
UMR-106 was not altered [Yamamoto et al., 2003] after 4, 6, 8 and 10 days,
similar conclusions can be drawn from the studies of Yoshizawa et al. [2002] and
Aldinucci et al. [2003]. Other cell types have also been investigated. Hsu &
Chang [2010] demonstrated that, under a exposure of 290 mT SMFs alone, the
proliferation of dental pulp cells (DPCs) was not affected up to 7 days, and de-
creased afterwards. Jouni et al. [2013] found that the viability and proliferation
of rat bone MSCs were decreased under SMFs of 4, 7 and 15 mT after 3 days,
and the decrease rate was related to the magnetic field intensity. However, one
exception was reported by Cai et al. [2015]. They observed increased cell prolif-
eration of MC3T3-E1 cells when exposed under 100 mT SMFs between 4 hours
and 7 days of culture. Generally, it can be concluded that the biological effects
of moderate intensity SMFs on cells are non-toxic, however, the effects of SMFs
on cell proliferation are dependent on the magnetic field strength and exposure
time. Enhanced proliferation can be observed with short culture period (within
7 days) and low magnetic field intensity (100 mT).
SMFs are generally believed to have a positive influence on cell differentiation.
Yamamoto et al. [2003] studied the effects of SMFs on calvaria cells, ROS 17/2.8,
and UMR-106, and results indicated that SMFs can promote the ALP produc-
tions after 10 days. Besides, it was shown that moderate SMFs promoted the
differentiation of MG-63 cells with increased expression of ALP and ECMs pro-
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duction [Chiu et al., 2007; Feng et al., 2010]. In the study of Huang et al. [2006],
they examined the effect of 400 mT SMFs on the expression of several genes in
MG-63 cells, the data suggested that the local regulatory factors produced by
SMFs treated cells, including collagen Type I, ALP and OP were greater than
those of the untreated ones after only 3 days. However, Imaizumi et al. [2007]
found that the SMFs have no significant effects on cell differentiation by using
MC3T3-E1 cells. After SMFs treatment of 250 mT, the ALP activity was not
altered after 4 days. Ba et al. [2011] had gained similar results that the ALP
production of MC3T3-E1 cells was not promoted by SMFs. However, Cai et al.
[2015] found that by exposing under 100 mT, the ALP production of MC3T3-E1
cells can be promoted after 14 days. Meng et al. [2010] also indicated a stimulat-
ing effect of SMFs on the differentiation of MC3T3-E1 cells after 14 days. It can
be concluded that the SMFs can have a significant influence on the differentiation
of certain types of osteoblasts, especially MG-63 cells, and this is possibility due
to the up-regulation of several key genes including collagen Type I, ALP and
osteopontin (OP). SMFs can also affect the differentiation of MC3T3-E1 cells,
however, this happens slower than that of the MG-63 cells.
Many studies have indicated that SMFs exposure can enhance the level of
mineralisation [Huang et al., 2006; Imaizumi et al., 2007]. Imaizumi et al. [2007]
demonstrated that by exposing under 250 mT SMFs for 1 month, the minerali-
sation level increased significantly in MC3T3-E1 cells. Furthermore, significant
increase in the mineralisation level of ROS 17/2.8, and UMR-106 were observed
after 8 days of culture Yamamoto et al. [2003]. Huang et al. [2006] further ex-
palined that the promotion in the mineralisation level was caused by promoting
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the expression of osteonectin (ON) and osteocalcin (OC).
Table 1.2 summaries the major effects of SMFs on cultured cells. The bioef-
fects of moderate intensity SMFs are exposure system and cell type dependent.
The SMFs alone can only enhance cell proliferation at a relatively low intensity
(100 mT) and within a short period of time (7 days). The SMFs has a signif-
icant influence on cell differentiation, but this effect is cell type and exposure
time dependent. The ALP production of MC3T3-E1 cells cannot be enhanced
significantly within a short period of culturing time. The effects of SMFs on cell
mineralisation are consistence, regardless the cell type, magnetic field strength
and exposure time.
Strong SMFs have been demonstrated to have an impact on the alteration of
the preferred orientation of a variety of diamagnetic anisotropic organic molecules
[Rosen, 2003]. Hirose et al. [2003] reported that A172 cells embedded in collagen
gel were oriented perpendicular to the direction of strong SMFs of 10 T. In ad-
dition, Kotani et al. [2002] showed that after exposure to 8 T high SMFs, both
MC3T3-E1 cells in vitro and the newly formed bones in vivo were oriented to the
SMFs direction. In the same study, they also demonstrated that the differentia-
tion and matrix synthesis of MC3T3-E1 cells were accelerated.
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Cell Type SMFs Intensity Exposure time Effects References
MSCs 4, 7, 15 mT 1-3 days Reduced cell proliferation Jouni et al. [2013]
DPCs 290 mT 1-7 days Unchanged proliferation Hsu & Chang [2010]
Rat Calvaria Cells 160 mT 2-20 days Increased ALP Yamamoto et al. [2003]
UMR-106 160 mT 2-20 days Unchanged proliferation, increased level of mineralisation Yamamoto et al. [2003]
ROS 17/2.8 160 mT 2-20 days Increased level of mineralisation, ALP production Yamamoto et al. [2003]
MC3T3-E1 100 mT 1 - 21 days Increased proliferation, ALP production Cai et al. [2015]
MC3T3-E1 250 mT 1 - 7 days Decreased cell number, unchanged ALP, increased mineralisation Imaizumi et al. [2007]
MG-63 320 mT 1-7 days Reduced cell number Cunha et al. [2012]
MG-63 400 mT 1-3 days Inhibited proliferation, enhanced ALP production Chiu et al. [2007]
MG-63 400 mT 1-5 days Inhibited proliferation, enhanced ALP and ECM synthesis Feng et al. [2010]
MG-63 400 mT 1-3 day Increased the expression of Collagen type I, ALP, OP Huang et al. [2006]
Table 1.2: Summary of major effects of moderate intensity SMFs on cells.
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1.7.2 Magnetic Nanoparticles
The fundamental source of material magnetism is the magnetic moments of elec-
trons, which constitute electron shells of atoms and form electron structure of
molecules and crystals [Skomski, 2008]. If the electron shell of an isolated atom is
not closed, the atoms will experience non-zero magnetic moment. The iron atom,
for example, has a strong magnetic moment due to unpaired electrons in its 3D
orbits. There are several categories of magnetisms, including diamagnetic, param-
agnetic, ferromagnetic, ferrimagnetic and antiferromagnetic. Ferromagnetic ma-
terials are strongly attracted by magnetic fields and can be magnetised to become
permanent magnets, producing magnetic fields themselves. Like ferromagnetism,
ferrimagnets retain their magnetisation in the absence of a field. However, unlike
ferromagnets, neighbouring pairs of electron spins in ferrimagnetic materials tend
to point in opposite directions, resulting in smaller magnetisation. Paramagnetic
substances are weakly attracted to an applied magnetic field, whereas diamag-
netic substances are weakly repelled. Antiferromagnets have a zero net magnetic
moment due to opposite electrons.
Magnetic nanoparticles (MNPs) have been widely applied into biomedical ap-
plications. They have controllable sizes ranging from a few nanometres up to
tens of nanometres, which can be compared to those of a cell (10 - 100 µm),
a virus (20 - 450 nm), a protein (5 - 50 nm) or even a gene (2 nm wide and
10 - 100 nm long). Due to the small sizes, MNPs can achive the activation of
individual ion channels or surface receptors on specific cells precisely. MNPs can
be manipulated by an external magnetic field without direct contact. Miltenyi
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et al. [1990] demonstrated that when MNPs are attracted to a high magnetic flux
density, these particles can attract biomolecules or living cells in vitro. This "ac-
tion at a distance", combined with the intrinsic penetrability of magnetic fields
into human tissue, can be applied to reach the internal organisms of the human
body [Pankhurst et al., 2003]. They can be manipulated to penetrate into tissues
deeply under SMFs, reaching a single cell and acting directly on its organelles
without being shielded by the membrane potential [Sapir et al., 2014]. Stress
parameters of the MNPs can also be varied dynamically simply by varying the
strength of the applied field.
MNPs can be categorised into metallic nanoparticles, magnetic alloys and
magnetic oxides nanoparticles. Metallic nanoparticles exhibit interesting prop-
erties in many applications own to the larger magnetisation compared to metal
oxides or alloys. Among many metallic materials, iron, cobalt and nickel are the
most widely studied. Metals like cobalt and nickel are seldom used in clinical
applications, as they can be toxic if used in vivo without a biocompatible coat-
ing. Iron, on the other hand, is relatively safe to be applied in vivo, as well as
exhibiting high magnetic moment density of 220 emu/g. However, there still re-
mains a complicated task to prepare nanoparticles consisting of pure iron as they
often contain oxides, carbides and other impurities; besides, metallic nanoparti-
cles are not air stable and are easily oxidised, resulting in the change or loss of
their magnetisation. Although iron metal itself is a good candidate for magnetic
applications, it is seldom used as a core material for the synthesis of magnetic
nanoparticles unless they are coated with an inert, protective coating. Iron is ex-
ceptionally vulnerable to corrosion in the presence of water, resulting in rusting,
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for instance.
Magnetic alloys, such as iron platinum (FePt), are more popular as core mate-
rials for magnetic nanoparticles compared to pure iron metal. FePt possess high
uniaxial magnetocrystalline anisotropy, making them exhibit large coercively at
room temperature. The surface chemistry of FePt nanoparticles allows for bind-
ing of carboxylate and amine based surfactants which may be utilised to improve
the water solubility. Sun et al. [2000] demonstrated that polyethylene glycol
(PEG) coated FePt nanoparticles are stable in biological media such as phosphate-
buffered saline (PBS), however, there remains an unclear understanding about the
toxicity of the FePt nanoparticles, as well as limited reports of cytotoxicity assays.
Magnetic oxides exist in many forms like iron oxide, cobalt oxide and nickel
oxide. It has been well documented in the literature that nanoparticles such as
CoFe2O4, NiFe2O4 have been used in many biomedical applications. However,
the use of these mixed oxide nanoparticles can be hampered by the high toxicity
of these transition metals. Iron oxide nanoparticles (IONPs), on the other hand,
presents low toxicity and are well tolerated in the human body. Iron oxide fluids
have also demonstrated good cardiovascular tolerance, their infusion has been
shown not to change blood pressure, heart rate or respiratory rate [Lübbe et al.,
2001].
The use of iron oxide based nanoparticles in biomedicine has received con-
siderable attention in a wide range of applications, such as magnetic resonance
imaging (MRI) [De et al., 2011], magnetic drug delivery and magnetic hyperther-
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mia [Huang et al., 2012], as they are non-toxic and relatively safe for clinical use.
Iron oxides exist in many forms in nature, such as magnetite (Fe3O4), maghemite
(γ-Fe3O4) and hematite(α-Fe2O3). Magnetite nanoparticles have ferromagnetic
properties, maghemite have ferrimagnetic properties and hematite are weakly
ferromagnetic or antiferromagnetic in nature, therefore magnetite nanoparticles
have the strongest magnetisation when compared to the other two [Teja & Koh,
2009]. Magnetite possesses a magnetic moment density of 90 emu/g (bulk) and
30 - 50 emu/g (nanoparticles). Magnetite is also one of the iron oxides approved
by the FDA for in vivo use. Iron oxide nanoparticles (IONPs) with a diameter
between 2 - 20 nm display superparamagnetic behaviour at room temperature
[Cornell & Schwertmann, 2003].
Although IONPs are considered as biocompatible and appear to be promis-
ing for various biological applications, it is important to know the safe dosage
of IONPs for such uses, i.e, their toxic potential is still a major concern. The
total body iron store is ∼ 4000 mg in a normal male adult. Small quantities of
iron may not pose iron-linked toxicity issues, but higher amounts may lead to
increased plasma iron concentration, hence the formation of oxidative stress and
various toxicities [Glickstein et al., 2006].
The toxicity of IONPs induced is dependent on the concentration. Studies
from Karlsson et al. [2008] showed that IONPs (20-30 nm) are safe and non-
cytotoxic to cells with concentrations up to 80 µg/ml in vitro. Naqvi et al. [2010]
also studied the toxicity of IONPs (30 nm) in vitro. Their results indicated that
these IONPs do not show toxicity effect at concentrations up to 100 µg/mL. By
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further increasing the concentration to 25-200 µg/mL, the cell viability reduced
to 95 %. When the IONPs concentrations have been increased to 300-500 µg/mL,
the cell viability further reduced to 55-65 %.
Surface modifications of IONPs, such as alginate [Ma et al., 2007], silica [Chek-
ina et al., 2011] and chitosan [Kievit et al., 2009], can be employed to enhance the
biocompatibility of IONPs. Gupta & Wells [2004] examined the cytotoxicity of
uncoated and poly(ethylene glycol) (PEG) coated IONPs with concentrations of
0 - 1000 ug/ml. Uncoated IONPs (10 - 15 nm) showed significant loss in viability
of about 25 % at concentration of 250 µg/ml, whereas PEG-coated IONPs (40 -
50 nm) revealed no cytotoxic effects to cells up to 1000 µg/ml. One possible ex-
planation for the enhancement in cell viability can contribute to the hydrophilic
property of PEG, and it protects uncoated IONPs from interacting with cells or
proteins. Some in vivo studies also evaluated the toxicity of IONPs. Kim et al.
[2006] found that intraperitoneally injected SiO2 coated IONPs (50 nm) were
found to be safe at 25-100 µg/ml dose for 4 weeks.
Table 1.3 summarises some of the main findings from previous studies about
the toxicity of uncoated and coated IONPs in vitro.
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Coating Material Size (nm) Concentration (µg/ml) Results References
Uncoated 20 - 30 80 non-toxic Karlsson et al. [2008]
Uncoated 30 0 - 250 no cytotoxicity up to 100 µg/ml, 55-65 % cell viability with 250 µg/ml Hussain et al. [2005]
Uncoated 10 - 15 0 - 1000 75 % cell viability with 250 µg/ml Gupta & Wells [2004]
PEG 40 - 50 0 - 1000 non-toxic up to 1000 µg/ml Gupta & Wells [2004]
Tween 80 30 25 - 5000 non-toxic up to 100 µg/ml, 90 % viability up to 200 µg/ml, 55 - 65 % up to 500 ug/ml Naqvi et al. [2010]
Dextran 15 50 reduce proliferation Berry et al. [2003]
Albumin 9.6 50 induce proliferation Berry et al. [2003]
Silica 50 25 - 100 non-toxic Kim et al. [2006]
Chitosan 13.8 123.52 Cell viability reduced to 10 % Ge et al. [2009]
Table 1.3: Summary of toxicity of IONPs with and without biocompatible coatings.
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1.8 Thesis Objective and Structure
1.8.1 Objectives
The aim of this thesis is to devise a reliable 3D bone model for the in vitro
evaluation of the effects of SMFs on the osteogenesis process. The objectives of
this thesis are listed as below:
1. To develop a biocompatible magnetic bio-reactor with moderate intensity
to support cell growth in vitro.
2. To develop a 3D model, with suitable scaffold, cell lines and biofactors in-
corporated, for the in vitro stimulations of osteoblasts under static magnetic
fields. The biological behaviours, including cell proliferation, differentiation
and mineralisation will be investigated.
3. To evaluate the mechanism of static magnetic field stimulation on the molec-
ular levels. This includes the study of gene expression, and the microstruc-
tural analysis of the 3D model, especially the cell/matrix interactions.
1.8.2 Structure
The structure of the thesis is outlined below:
1. In Chapter 2, details of experimental materials and methods will be pro-
vided, including the design and fabrication of the magnetic bio-reactor,
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magnetic nanoparticles, 3D collagen models, and the in vitro evaluation for
the biological behaviours of osteoblastic cell lines, such as proliferation, dif-
ferentiation, mineralisation, gene expression and microstructural analysis.
2. In Chapter 3, a magnetic bio-reactor with moderate intensity (100 - 160
mT) will be designed. ANSYS Maxwell will be applied to simulate the
magnetic field strength, and 3D printing technique will be employed to fab-
ricate the reactor.
3. In Chapter 4, the development of the 3D model will be demonstrated, this
includes the investigations of the scaffolds, cell lines and biofactors. The
effects of SMFs will also be studied.
4. In Chapter 5, the effects of the SMFs and the incorporation of IONPs on
osteogenesis will be examined. The proliferation, differentiation and miner-
alisation of osteoblasts when seeded within collagen scaffolds. The mecha-
nisms of SMFs on osteoblasts at molecular levels will then be investigated.
This includes the examination of cell/matrix interactions and the expres-
sion of Runx-2, ON, BMP-2 and BMP-4.
5. In Chapter 6, a general discussion and conclusion of the thesis will be given,
as well as suggestions for future studies.
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Chapter 2
Development of the Experimental
Techniques
2.1 Overview
This chapter details the development of the materials and methods used to evalu-
ate the magnetic stimulation on osteogenesis, including the set-up of the magnetic
bio-reactor, the preparation of iron oxide nanoparticles (IONPs), the fabrication
of 3D PC collagen scaffolds and the in vitro biological evaluations of bone cells.
This includes, the alamarBlue (AB) assays for proliferation, alkaline phosphatase
(ALP) for differentiation, alizarin red s staining (ARS) for mineralisation, poly-
merase chain reaction (PCR) for gene expression, Histology for cellular responses
and transmission electron microscopy (TEM) for micro-structural analysis.
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2.2 Materials
For IONPs fabrication, iron (II) chloride tetrahydrate (FeCl2·4H2O) (<99.0 %),
iron (III) chloride hexahydrateand (FeCl3·6H2O) (97%), and ammonium hydrox-
ide solution (28.0 - 30.0%) were purchased from Sigma-Aldrich and used as re-
ceived without any further treatment.
For collagen gel preparation, 10X Eagles MEM solution was purchased from
Gibco, Paisley, UK, and Dulbeccos Modified Eagles Medium (DMEM) was pur-
chased from Sigma-Aldrich. Rat tail type I collagen in acetic acid (protein con-
centration of 2.10 mg/ml) was ordered from First Link, Birmingham, UK. sodium
hydroxide (NaOH), which was used to neutralise the mixture, was also purchased
from Sigma-Aldrich.
For cell culture, MG-63 (Homo sapiens, osteosarcoma, ATCC), UMR-106
(Rattus norvegicus, osteosarcoma, ATCC) and MC3T3-E1 (Mus musculus, pre-
osteoblast, ATCC) were used in this study. DMEM, fetal bovine serum (FBS),
penicillin-streptomycin (P/S) L- glutamine (L-G) and trypsin/EDTA were pur-
chased from Sigma-Aldrich.
For in vitro assays, alamar blue (alamarBlue, Bio-Rad) was used to mea-
sure the cell proliferation activity, 4- nitrophenyl phosphate disodium, trizma
hydrochloride and MgCl2 were used for the quantification of the ALP produc-
tion, alizarin red s (ARS) reagent, cetylpyridinium chloride, haemotoxylin and
eosin (H & E) reagent were used for cell staining. RNeasy Mini Kit (Qiagen
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74104 and 74106) was used for PCR studies. All chemicals were ordered from
sigma without further treatment.
2.3 Methods
2.3.1 Computational Simulation of Magnetic Field Strength
In this study, ANSYS Maxwell has been employed to simulate the magnetic field
strength of several designs, and helped to select the one with desired range.
ANSYS Maxwell is an industry leading electromagnetic field simulation software
for the design and analysis of a wide range of electromagnetic or magneto-static
devices. In the case of static magnetic field, the magneto-static solver can be
applied. ANSYS Maxwell magnetic field formulation is founded on Maxwell’s
equation:
∇× ~E = −d
~B
dt
(Faraday′sLaw) (2.1)
∇× ~H = ~J(Ampere′sLaw) (2.2)
∇× ~B = 0(Gauss′sLaw) (2.3)
in which ~E is the electric field strength, ~B is the magnetic flux density, ~H is
the magnetic field strength, and ~J is the electric current density.
In the case of SMFs, the current flowing through can be considered as steady
or zero, therefore the Faraday’s law will not be employed. On the other side,
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the relations between the magnetic field strength and magnetisation, ~M can be
described as below:
~B = µ0( ~H + ~M) (2.4)
So the equations applied for the magneto-static solver are:
∇× ~H = ~J (2.5)
∇× ~B = 0 (2.6)
~B = µ0( ~H + ~M) (2.7)
The details of the simulation are described briefly as below. Firstly, the type
of solver has to be determined. In the case of 3D static magnetic field, the 3D
magnetostatic solver was selected. Secondly, the bio-reactor has to be computa-
tional designed and modelled. Then the following parameters may be defined for
a material, includes, relative permeability, bulk conductivity, magnetic coercivity
and composition. Thirdly, the boundary conditions in 3D has to be assigned.
The boundary conditions define behaviour of the magnetic field at the interfaces
or the edges of the problem region. For the boundaries on the interface between
objects, H field is continuous across the boundary; for exterior boundaries of solu-
tion domain, H field is tangential to the boundary and flux cannot cross it. Then
the mesh can be applied on the object. Maxwell uses the finite element method
(FEM) to solve Maxwell equations. In order to obtain the set of algebraic equa-
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tions to be solved, the geometry of the problem is discretised automatically into
basic building blocks, such as tetrahedra in 3D. The assembly of all tetrahedra
is referred to as the finite element mesh of the model or simply the mesh. Mesh
plays important role in accuracy of the computed results. In the current study,
the mesh is automatically refined to achieve the required level of accuracy in field
computation. Finally, the analysis set-up has to be added. In this case, the B
field (in Tesla) has been selected.
2.3.2 Magnetic Field Strength Validation by Tesla Meter
The actual magnetic field strength was measured by a Digital AC/DC Magnetic
Field Gauss Meter (BST600, Hangzhou BST Magnet Co. Ltd) (shown in Figure
2.1). The magnetic field of the bio-reactor was measured at nine points of the
field to create a distribution map, as illustrated in Figure 2.2. Points A, D and G
are 1 cm from the left magnet, whereas points C, F and K are 1 cm apart from
the right magnet. Point B, E and H locate at the central vertical axis of the field.
Points A, B, C and G, H, K are 1 cm from the top-edge and the bottom edge,
respectively. Points D, E and F are at the central horizontal axis of the field. E is
the centre point of the whole field. The pink area in the middle has a diameter of
2 cm, which represent the location of the scaffold. Five repeating readings were
taken at each point.
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Figure 2.1: Illustration of the tesla metre. The tesla meter has a working range
of 0 - 2000 mT with a resolution of 0.1 mT.
Figure 2.2: Illustration of tested points in the magnetic fields. Points A, D and
G are 1 cm from the left magnet, points C, F and K are 1 cm away from the
right magnet. Point B, E and H locate at the central vertical axis of the field.
Points A, B, C and G, H, K are 1 cm from the top-edge and the bottom edge,
respectively. Points D, E and F are at the central horizontal axis of the field. E
is the centre point of the whole field. The pink area in the middle has a diameter
of 2 cm, which represents the location of the scaffold.
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2.3.3 Permanent Magnets Selection
The use of a permanent magnet provides an important advantage for bone cell
stimulation in that it does not require a power device and thereby reduces the
unexpected continuations or thermal effects on treated cells. SMF has been iden-
tified as capable of affecting a number of biological behaviours of osteoblast cells,
and it is particularly interesting to researchers because it can be easily achieved
with permanent magnets. Neodymium magnets (NdFeB) and samarium-cobalt
magnets (SmCo) have been applied in clinic studies [Cai et al., 2015; Kim et al.,
2005; Riley et al., 2001], due to their biocompatibility and strong intensity. Table
2.1 summarises the magnetic properties of two commonly used neodymium mag-
nets, NdFeB30 and NdFeB35, and two types of commonly used samarium-cobalt
magnets, SmCo24 and SmCo28. These magnets will be analysed and compared
in the following study to develop a suitable magnetic bio-reactor.
Property NdFeB30 NdFeB35 SmCo24 SmCo28
Remanence (Br) /mT 1080 1170 950 1030
Coercive force (Hcb) / kA/m 796 867 700 756
Intrinsic coercive force (Hcj) /kA/m ≥ 955 ≥ 955 ≥ 1433 ≥ 1435
Max. energy product (BH) kJ/m3 223 263 175 207
Table 2.1: Magnetic properties of NdFeB30, NdFeB35, SmCo24 and SmCo28.
2.3.4 3D Printing
Once the magnets had been set up with the desired strength, the design was 3D
printed by Selective Laser Sintering (SLS) technique. SLS is a powder based 3D
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model fabrication method for rapid prototyping and rapid tooling, can achieve
large-scale production [Kumar, 2003]. Generally, laser beams are used to heat
the materials (in powders) in predetermined sizes and shapes. The laser beam is
selectively scanned over the powder following the cross-sections of the computer-
aided design (CAD) models. After the first layer is scanned, a second layer of
loose powder is deposited over it, and the process is repeated from the bottom to
top until the product is completed. The conventional materials used in SLS tech-
nique are polymers and nylon. In this study, SLS (EOSINT P100, layer height of
0.1 mm) has been employed.
2.3.5 Synthesis and Preparations of Iron Oxide Nanopar-
ticles
The size and shape of magnetite particles are generally controlled by the synthesis
method. A variety of methods have been reported in the literature on the synthe-
sis of magnetite nanoparticles, including co-precipitation [Mascolo et al., 2013],
thermal decomposition [Lu et al., 2008], sol-gel [Teja & Koh, 2009], microeulsion
and hydrothermal synthesis [Lu et al., 2007], in which the thermal decomposition
and co-precipitation are the most widely used methods.
Table 2.2 compares the synthetic conditions of four different methods.
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Synthetic method Co-precipitation Thermal decomposition Microemulsion Sol-gel
Size 10-50 nm 5-50 nm 4-15 nm 20-200 nm
Distribution broad narrow very narrow broad
Temperature 20-90 ◦C 100-320 ◦C 20-50 ◦C 40-120 ◦C
Period minute hours-days hours hours
Morphology Spherical Spherical Spherical with high porosity Cubic or spherical
Magnetisation 20-50 emu/g >20 emu/g >30 emu/g 10-40 emu/g
Advantages Simple conditionLarge quantities
Useful for protective coatings
and thin film deposition Uniform properties Desired shape and length
Disadvantages Uncontrolled oxidation Require high temperatures Surfactants are difficultto remove
Contains sol-gel
matrix components
Table 2.2: Summary of synthetic methods for iron oxides
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The thermal decomposition method relies on the pyrolysis of organic precur-
sors of iron, such as Fe (CO)5, which is toxic and hence may limit the biomedical
applications. As for the co-precipitation method, which mainly relies on the hy-
drolysis of ferric and ferrous ions under a proper molar ration, Fe2+ and Fe3+
ions are generally precipitated in alkaline solutions such as ammonium hydrox-
ide, sodium hydroxide and potassium hydroxide. The reactions occurs during the
magnetite formation are as follows:
For Fe3+,
Fe3+ + 3OH− = Fe(OH)3(s), (2.8)
Fe(OH)3(s) = FeOOH(s) + H2O, (2.9)
For Fe2+
Fe2+ + 2OH− = Fe(OH)2(s), (2.10)
2FeOOH(s) + Fe(OH)2(s) = Fe3O4(s) + 2H2O. (2.11)
Hence the overall reaction can be re-written as
2Fe3+ + Fe2+ + 8OH− = 2Fe(OH)3Fe(OH)2(s) −→ Fe3O4(s) + 4H2O (2.12)
IONPs were prepared by the co-precipitation method [Chekina et al., 2011].
The method involves addition of a base (NaOH or NH4OH) to ferric (Fe3+) and
ferrous (Fe2+) chloride solutions under ambient pressure at an elevated temper-
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ature. Briefly, 5.41 g of FeCl3·6H2O were mixed with 1.99 g of FeCl2·4H2O,
followed by an addition of NH4OH of 400 ml. The resulting solution was left to
grow for 30 mins and then washed 7 times by using centrifugation and DI water.
However, the particles obtained by this method are not uniform in size distribu-
tion and tend to agglomerate. In order to reduce the agglomeration, sonication
was introduced. The suspension was mixed under sonication (Digital Sonifier
250, Branson Ultrasonics, Danbury, CT, USA) at 40 W in between each wash.
Besides, permanent magnets was also employed under the suspension to enhance
the precipitation process.
The results regard to the characterisation of IONPs are attached in Appendix.
2.3.6 Synthesis and Preparations of Nano-hydroxylapatite
and Nano-zinc oxide
Nano-hydroxylapatite (nHA) with calcium/phosphate ratios of 1.67 was prepared
and synthesised based on a precipitation reaction between calcium hydroxide
(Ca(OH)2) and orthophosphoric acid (H3PO4) (both AnalaR grade, BDH, UK)
[Huang et al., 2007]. 0.3 M H3PO4 solution was added drop wise to 0.5 M Ca(OH)2
solution under continuous stirring at room temperature, the pH was kept above
10.5 by the addition of ammonia solution. Stirring was maintained for a further
16 h after the reactants had been added. The precipitate obtained was further
aged for one week.
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Nano-zinc oxide (nZnO) were synthesised using the flame pyrolysis method
as used by Johnson Matthey plc (JMTC).
2.3.7 Formation of Collagen Gel
By neutralising native acid soluble collagen, a hydrogel scaffold can be generated
due to collagen fibrillogenesis. In the fibrillogenesis process, collagen molecules
spontaneously assemble with neighbouring molecules in a quarter staggered ar-
rangements to form fibres, and those fibres form as collagen monomers in solution
continue to aggregate, until the fibrillogenesis is complete.
There are some key factors which can influence the fibrillogenesis process,
including the type of collagen used, the collagen density, the pH of the solu-
tion, the synthesis temperature and the incorporation of other biofactors (such
as cells, growth factors or biocompatible materials). The preferred temperature
for collagen fibrillogenesis is defined at 37 ◦C. Temperature higher than this can
potentially denature the collagen protein, whereas temperature lower than this
can delay the process. Besides, the desirable pH for fibrillogenesis to happen is
6.5 - 8. At low pH, collagen fibres are formed with poor structure; at high pH,
banding patterns of fibrils can be observed [Harris & Reiber, 2007].
Acellular collagen gels were made by titrating the pH of rat tail type I collagen
(2.10 mg/ml in acetic acid). To make a total volume of 10 ml solution, 8 ml of
acid soluble collagen was needed, with the addition of 1 ml 10 X DMEM. The
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obtained solution was neutralised with 1M or 5M NaOH, until a colour change
from yellow to pink was observed [Brown et al., 2005]. The neutralised gel re-
quires the same pH value to ensure a consistency. The remaining 1ml was made
up with DMEM (with and without cells). This collagen gel was then set in a 24
well plate with an amount of 1 ml per well, followed by incubation at 37◦C with
95 % relative humidity and 5 % CO2 for 30 minutes.
2.3.8 Plastic Compression
There are two methods developed for the fabrication of plastic compressed col-
lagen gels, downward flow compression [Brown et al., 2005] and upward flow
compression [Alekseeva et al., 2011]. Downward flow means the direction of the
fluid flow out of the collagen gels is towards the bottom of the set-up (as can be
observed from Figure 2.3, the liquid flows out from the bottom.). While upward
flow refers to that where the water will be sucked up from the top (As shown
in Figure 2.4). During the down flow process, customised shape and size of the
PC model can be fabricated, while upward flow can produce multiple models si-
multaneously and hence reduce the production time. Therefore, the upward flow
process has been employed.
The plastic compression protocol is modified from Brown et al. [2005]. Briefly,
collagen gels were set in 24-well plate and covered by several layers of filter paper
(Whatman grade I) on the top. A cylinder plunger roll (height=3.7 cm, diame-
ter=1.5 cm) made by filter paper (process shown in Figure 2.5) was laid on the
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Figure 2.3: Illustration of downward flow plastic compression (PC) process. Di-
agram shows the conventional assembly of PC of pre-formed collagen gels. The
liquid in the collagen hydrogel was expelled from the bottom by the application
of compressive mechanical loads on the top.
top of each gel for 5 minutes. Extra weights can be added on top of the filter
paper roll to accelerate the process, with approximately 15 g per well. The extra
liquid component was absorbed by the plunger and left a thin layer of collagen
gel with a thickness of 75-100 µm. IONPs can be embedded inside the collagen
matrix at the point of self-assembly. After the completion of plastic compression,
the plunger roll was removed. Cell medium (1 ml) was then added to each well
immediately to keep the samples hydrated. The filter paper discs separating the
plunger and the hydrogel can then be removed at this point. Samples were then
used or cultured as required.
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Figure 2.4: Illustration of upward flow collagen plastic compression (PC) process.
Collagen gels are neutralised in a 24-well plate, with several layers of filter paper
placed on top, then a paper roll made of filter paper serve as a weight to expel
the water component out of the collagen gel. Additional weights can be added
on top of the gel to accelerate the process. The weights used are 15g per well.
Figure 2.5: Illustration of the rolling process. The cylinder plunge rolls are made
by filter paper, with dimensions of height=3.7 cm, diameter=1.5 cm for each.
The size was chosen to fit in a single well of a 24-well plate. Customised plunge
size can be designed and fabricated by the same technique.
81
2. DEVELOPMENT OF THE EXPERIMENTAL TECHNIQUES
2.4 Characterisations
2.4.1 Transmission Electron Microscopy (TEM)
The investigation of the morphology of the IONPs was conducted by transmission
electron microscopy (TEM) (JEOL JEM-1011). TEM is a microscopy technique
where a beam of electrons is transmitted through an ultra-thin specimen, inter-
acting with the specimen as it passes through it. Depending on the density of
the specimen, electrons are either passing through or scattering away. An image
will be formed when the transmitted electrons hit onto an image device, such as
a fluorescent screen. In this study, IONPs in ethanol were collected using copper
grids coated with carbon film. The accelerating voltage applied was 200 keV.
A Philips CM120 transmission electron microscope was used to examine the
cellular structure of cell-seeded collagen tissues. Biological tissue is delicate and
must be protected in the harsh internal environment of the electron microscope
(high vacuum and a stream of electrons). Cell seeded collagen scaffolds were sta-
bilised in karnovsky’s fixative (2.5% glutaraldehyde/ 2% paraformaldehyde/ 0.1
M PBS) to preserve structure details, follow by dehydration and then infiltrated
with a liquid resin, which is hardened by gentle heat. Resin blocks containing
the tissue can therefore be sectioned and stained for observation in the TEM.
Firstly, pieces of the fixed tissue were placed in screw cap microtubes with PBS
and washed 3 times of 10 mins each. Secondly, the PBS was discarded and the
samples were postfixed in 1% osmium tetroxide solution for 1 hour at 4 ◦C. Then
osmium solution was removed with a pipette. Samples was washed 3 x 15 mins
with distilled water, followed by dehydration through graded ethanol solutions of
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30%, 50%, 70% and 90% with 2x 15 mins each, and finally in 100% ethanol 3x
15 min. The infiltration with liquid resin was achieved by infiltrating the tissue
in 40% resin for 3 hours, overnight in 60% resin and then 100% resin for 6 hours
at room temperature. After final infiltration, tissues were placed in labelled em-
bedding moulds with fresh resin and polymerised in the oven at 70 ◦C overnight
to be examined. The specimens were sectioned into 1 µm and used to find the
area of interest; then ultra thin sections (70nm) were taken to be placed on grid
for further examinations. The grids have then been stained in uranyl acetate for
2 hrs, followed by lead citrate for 5 min. The voltage applied was 80.0 kV.
2.4.2 Scanning Electron Microscopy (SEM)
Scanning electron microscopy (SEM) is a technique for surface structure char-
acterisation. Thin layers of neutralised collagen gels were prepared by adding
10 µl collagen solution onto the surface of each cover slip, followed by air dry-
ing. The collagen gels were treated with two conditions, one with SMFs and
one without SMFs. The morphological characterisation of the thin collagen gel
were investigated by using a Jeol JSM-6300 F with a field emission electron gun
operated at 5 kV. In order to enhance the electrical conductivity, the samples
were first coated with ultra-thin layers of gold atoms (120 seconds) by using a
rotary-pumped sputter coater (Quorum) before being mounted into the vacuum
chamber.
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2.5 In vitro Study
2.5.1 Cell Lines
Frozen cells were gently thawed and cultured in high glucose DMEM with 10 %
FCS, 1 % penicillin, and 1 % L- glutamine and were then maintained at 37◦C,
with 5 % CO2. MG-63, UMR-106 and MC3T3-E1 cells were used to assess the
effects of SMFs on biological behaviours. MG-63 cell lines were used to further
study various aspects of cellular responses to IONPs, nHA and nZnO incorpo-
rated into collagen scaffolds. Ethical considerations and guidelines were followed
regarding obtaining and usage of biological cell lines.
2.5.2 Subculture of Adherent Cell Lines
MG-63, UMR-106, MC3T3-E1 cell lines were stored in DMEM and incubated
at 37◦C, with 95 % relative humidity and 5 % CO2 until 80 % confluence was
achieved. For sub-culturing the adherent cell lines, cell culture medium was re-
moved and the monolayer of cells was washed with PBS (10 ml). Typsin was
added to the flask at 0.03 ml/cm2, 2 mins was then required for most cells to
detach, until culture medium was added to neutralise the trypsin. The cell sus-
pension was centrifuged at 800 rpm for 5 mins to pellet the cells. The supernatant
was removed and medium was added by gently mixing to disrupt the cell pellet.
Cells were then dispersed, suspended and counted using a haemocytometer.
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2.5.3 AlamarBlue Assay
The alamarBlue (AB) assay is a proven cell viability indicator that uses the nat-
ural reducing power of living cells to convert resazrin to the fluorescent molecule,
resorufin. Upon entering cells, resazurin is reduced to resorufin which shows a red
fluorescence. The non-fluorescent blue dye responds to the reductive environment
by forming a fluorescent red dye, and the fluorescence intensity of the dye can
be detected. The amount of fluorescence is proportional to the number of living
cells, and corresponds to the metabolic activity of the cells. In general, damaged
or non-viable cells have lower innate metabolic activity and thus generate a pro-
portional lower signal than healthy cells.
The proliferation of MG-63 cell lines was assessed by using Alamar Blue. The
reagent was diluted with normal growth medium (1:10 Dilution) and stored at
4◦C prior to use. Approximately 104 osteoblasts were seeded into the compressed
collagen scaffolds incorporated with nanoparticles. Seeded scaffolds were left for
periods of 1, 3, 7 and 14 days in the incubator (37◦C, with 5 % CO2). 1 mL of
DMEM was added to each well and replaced every two days. At each time point,
100 µl of the reagent was added into each well. The plate was then incubated
at 37◦C, with 5 % CO2 for a period of 2 h (optimal time for this study only) to
allow the reaction. Afterwards, 100 µl of the supernatant was then removed from
relevant wells (n=3) and added to a 96-well plate (Falcon). Fluorescence was
measured using a fluorescent plate reader (FLUOstar OPTIMA) at wavelengths
of 544 nm (excitation) and 590 nm (emission).
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2.5.4 Alkaline Phosphatase Quantification
Alkaline phosphatase (ALP) activity is an early indicator of osteogenesis. It is
one of the key substances that indicate whether osteoblasts have entered the
period of extracellular matrix development and maturation. The differentiation
ability of MG-63 cell lines can be identified by employing the Alkaline phosphate
(ALP) biochemical marker. The method of determination of ALP produced by
differentiating osteoblasts is based on the conversion of an artificial substrate of
ALP, paranitrophoenol phosphate. When dephosphorylated by ALP, it results in
a coloured (yellow) product.
In this project, approximately 104 cells were incorporated in 1 ml of collagen
gel with various nanoparticles, followed by compression and incubation at 37◦C,
with 5 % CO2. DMEM changes were carried out every two days. After incubation
for 7, 14 and 21 days, the scaffolds were removed into a 24-well plate and washed
by PBS. Equal amounts (500 µl) of substrate reagent was added to each well.
One tablet of 4-nitrophenyl phosphate disodium (Sigma, Dorset, UK) was mixed
with 8 mL 0.1 M trizma hydrochloride (3.94 g Tris in 500 ml DI water, pH=9.5)
and 15 µl of 2M MgCl2 (9.521 g MgCl2 in 50 ml DI water). The 24-well plate was
left at room temperature for 15 mins for the reaction to take place. 100 µl of 0.5
M NaOH (10 g NaOH in 500 ml DI water) was then used to stop the reaction.
Subsequently, 100 µl was removed from each well (n=3) and transferred into a
96-well plate and the absorbance read at 405 nm (reference at 670 nm) using a
plate reader (FLUOstar OPTIMA).
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2.5.5 Alizarin Red S Staining
Alizarin red s (ARS) staining has been used for decades to evaluate calcium-rich
deposits by cells in culture. Unlike von kossa’s staining, which visualises the
phosphate and carbonate anions, ARS can pick up the calcium content in tissue
through chelation. It is particularly versatile in that the dye can be extracted
(by cetylpyridinium chloride) from the stained monolayer and assayed. There-
fore ARS has been employed in this study to highlight regions of mineralised
collagen matrix. ARS reacts with the calcium cation to form a chelate, therefore
the calcium content in the tissue show an orange-red colour after staining, while
non-mineralised tissue present colour-less.
The samples were examined after 1, 21 and 42 days of culture. Scaffolds were
washed three times with PBS and fixed with 4% paraformaldehyde for routine
wax embedding and sectioning. The sectioning process was done by a microtome
with a thickness of 5 µm each. Sectioned samples were then been collected in
hot water and dried for 30 mins. After drying, specimens have to be de-waxed
by de-waxing and cleaning in xyline for 2 mins, followed by several washes of
100% ethanol, 90% ethanol and 70% ethanol. A protocol for staining has been
developed for this study. Basically, 1g ARS dye was dissolved in 50 ml deionized
water and the pH was adjusted to 4.1 - 4.3 with 10% ammonium hydroxide. 1
ml of ARS solution was added on each slide for 30 seconds and DI water was
used to wash off the excess dye adsorbed on the scaffold surface. If stained less
than 30s, the staining can be easily washed off by DI water; if overstained, the
mineralised modules are difficult to observe. Presence of mineral deposition (red-
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orange colour) was evaluated using a Nikon eclipse TE2000-5 optical microscope.
A method for quantifying the level of mineralisation has also been developed.
Briefly, the stained samples were desorbed with the use of 10% (w/v) cetylpyri-
dinium chloride in 10 mM sodium phosphate (pH 7.0). The dye was then collected
and absorbance read at 540 nm using a plate reader (FLUOstar OPTIMA).
2.5.6 Histology
Histology specimens were fixed with 4% paraformaldehyde for routine wax em-
bedding and sectioning. The sectioning process was done using a microtome with
a thickness of 5 um each. Sectioned samples were then collected in hot water
and dried for 30 mins. After drying, specimens have to be de-waxed and cleaned
in xylene for 2 mins, followed by several washes of 100% ethanol, 90% ethanol
and 70% ethanol. After air drying, haemotoxylin and eosin (H&E) was applied
for sample staining. A staining protocol was developed for this study. Briefly,
haemotoxylin was firstly added onto the sample surface for 30 seconds, followed
by rinsing under running water. Then eosin was then applied for another 30s,
followed by water rinsing. The optimal staining time (30s) was determined after
a series of trail experiments. If stained too short, the staining will be easily rinsed
off; whereas longer staining time resulting over-dyeing of the cells and tissue. Af-
ter staining, specimens have to be dehydrated by 70% ethanol, 90% ethanol and
100% ethanol and xyline for future storage, with cover slips mounted on top.
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Histology samples were examined under a Nikon eclipse TE2000-5 optical mi-
croscope to investigate the cellular responses between cells and nanoparticles.
Images were analysed by image analysis software (Image J) to further quantify
the cell number. Generally, three different sections were cut from each sample
with two magnifications (10X and 40X). The cell number in each image were
counted and plotted with average and standard deviation (n=3). The results
were also validated by a blind test.
2.5.7 Gene Expression
2.5.7.1 RNA Extraction
Isolation of RNA from cell-seeded collagen scaffolds was the first step in gene
expression quantification. RNeasy Mini Kit (Qiagen 74104 and 74106) was used
to extract the RNA from the samples. Firstly, 350 µl Buffer RLT (lysis buffer)
was added to the sample in a micro-centrifuge tube and mixed well to release
cells. Samples were stored at -80 ◦C if not used immediately. Secondly, 250 µl
ethanol (96 - 100 %) was added to the diluted RNA and mixed well by pipetting,
followed by transferring the samples (700 µl) to an RNeasy Mini spin column
placed in a 2 ml collection tube. 350 µl of Buffer RW1 (wash buffer) was then
added to the RNeasy column. 10 µl DNase I stock solution was added to 70
µl Buffer RDD (provides efficient on-column digestion of DNA and also ensures
that the RNA remains bound to the column). This was mixed well by gently
inverting the tube. Then the DNase I incubation mix (80 µl) was directly added
to the RNeasy column membrane and left for 15 mins at 20-30 ◦C. Then 350
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µl Buffer RW1 was added to the column, followed by 2× of 500 µl Buffer RPE
(concentrated wash buffer), with the addition of 4 volumes of 96 - 100 % ethanol
for a working solution, to wash the membrane. Centrifugation at ≥ 8000 × g
for 15 s was needed in between each step. Finally, the RNeasy spin column was
placed in a new 1.5 ml collection tube with an addition of 40 µl RNase-free water
directly to the spin column membrane, centrifuged for 1 mins at ≥ 8000 × g to
elute the RNA.
The isolated RNA was quantified by a Nanodrop spectrometer. The spec-
trometer is equipped with a lower pedestal, an upper pedestal and an arm. A
source fibre is embedded within the lower pedestal and a receiving fibre is embed-
ded in the upper pedestal. Light emitted from the LEDs transverses the sample,
and absorbance is measured using a silicon photodiode. Briefly, place 0.5 - 2 µl of
sample directly on top of the detection surface, when closing the arm, a column
between the ends of optical fibres are created due to surface tension. Thus the
measurement optical path is formed. The pedestal then moves to automatically
adjust for an optimal path length (0.05 - 1 mm). Then the concentration of nu-
cleic acid can be quantified.
2.5.7.2 Reverse Transcription with Elimination of Genomic DNA for
Quantitative, Real-Time PCR
To eliminate the genomic DNA, 2 µl of buffer GE, 50 ng of template RNA with
variable RNase-free water were used to make a total volume of 10 µl reaction.
The samples were incubated for 5 mins at 42 ◦C and then placed on ice imme-
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diately. Then the reverse transcriptase master mix was prepared by adding 4 µl
5× buffer BC3, 2 µl of RE3 Reverse Transcriptase Mix and 4 µl of RNase-free
water to make a total volume of 10 µl solution. This master mix was incubated
at 42 ◦C for 5 mins. Then the template RNA and reverse transcriptase master
were mixed together, followed by incubation at 42 ◦C for 15 mins and 95 ◦C for
5 mins. The rise in temperature was to denature RNA secondary structures that
will inhibit cDNA production. Then 30 µl RNase-free water was added to each
reaction and mixed by pipetting up and down several times.
The RT SYBR Green Mastermix was prepared as below. 0.5 µl of 10 µ mol of
forward primer and 0.5 µl of 10 µ mol of reverse primer was added together with
4 µl of SYBR Green and 3 µl of RNase-free water to make a 8 µl solution. Finally,
2 µl of the cDNA and 8 µl of the SYBR Green Master Mix was added into one
well to make one reaction. For PCR amplification, the following sets of specific
primers were designed via Primer-Blast (shown in Table 2.3). The procedures of
primer designing are listed as below. First of all, copy the sequence which has to
be amplified in PCR. Then set the range of acceptable lengths and melting tem-
perature of the PCR products, followed by the selection of Exon junction span.
Finally, a primer pair specific check has to be completed to exclude primers that
could amplify outside the target sequence.
The reaction conditions were modified as follows: incubation at 95 ◦C for 2
mins, denaturation at 95 ◦C for 10s, annealing at 60 ◦C for 5s and polymerisation
at 72 ◦C for 25s, followed by a final extension at 76 ◦C for 1s, for 45 cycles.
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Quantitative analysis was performed based on relative quantification and mod-
ified for this study. Briefly, the threshold cycle (Ct) value was calculated from
amplification plots, the ∆ Ct value for each sample was obtained by subtracting
the Ct values of housekeeping genes (GAPDH), respectively. The ∆ Ct values
calculated can then been plotted into graph and presented by box and whiskers
graph. The data are represented for triplicate readings.
2.5.8 Statistical Analysis
The experiments of biological property evaluation were performed in triplicate.
The results are represented as mean ± standard deviation for n=3 samples. Sta-
tistical analysis was carried out by analysis of variance (ANOVA) to determine
the presence of any significant differences between groups, and significant level
was set at p < 0.05.
2.6 Summary
The project described in this chapter was to develop a 3D model for the in vitro
evaluation of magnetic stimulation on osteogenesis. In this chapter, the setting-up
of the magnetic bio-reactor has been reviewed, which includes the employment of
computational simulations, the selection and comparison between different types
of permanent magnets, and the use of tesla meter to validate the simulation
results. Besides, the methods and materials used to develop the 3D collagen
model have been introduced, from the formation of collagen gel, to the plastic
92
2. DEVELOPMENT OF THE EXPERIMENTAL TECHNIQUES
Oligo Name µl for 100 µM Sequence (5’-3’)
GAPDH-F 803 5’ TGCACCACCAACTGCTTAGC 3’
GAPDH-R 744 5’ GGCATGGACTGTGGTCATGAG 3’
ACTB-F 619 5’CTGGAACGGTGAAGGTGACA 3’
ACTB-R 513 5’AAGGGACTTCCTGTAACAATGCA 3’
Runx2-F 511 5’ CCAACCCACGAATGCACTATC 3’
Runx2-R 470 5’ TAGTGAGTGGTGGCGACATAC 3’
ALP-F(1) 579 5’ GACCCTTGACCCCCACAAT 3’
ALP-R(1) 656 5’ GCTCGTACTGCATGTCCCCT 5’
ALP-F(2) 1046 5’ CGGATCCTGACCAAAAACC 3’
ALP-R(2) 1130 5’ TCATGATGTCCGTGGTCAAT 5’
Osteonectin-F(1) 482 5’ ATTGACGGGTACCTCTCCCA 3’
Osteonectin-R(1) 541 5’ GAAAAAGCGGGTGGTGCAAT 5’
Osteonectin-F(2) 462 5’ GCGAGTTTGAGAAGGTGTGC 3’
Osteonectin-R(2) 456 5’ TTTGCAAGGCCCGATGTAGT 5’
Osteonectin-F(3) 498 5’ CGTCCTGGTCACCCTGTATG 3’
Osteonectin-R(3) 525 5’ CTTCTTCACCCGCAGCTTCT 5’
BMP2-F(1) 425 5’,TTTCAATGGACGTGTCCCCG 3’
BMP2-R(1) 410 5’ AGCAGCAACGCTAGAAGACA 3’
BMP2-F(2) 536 5’ GGACGCTCTTTCAATGGACG 3’
BMP2-R(2) 695 5’ GCAGCAACGCTAGAAGACAG 5’
BMP2-F(3) 582 5’ TGTCTTCTAGCGTTGCTGCTT 5’
BMP2-R(3) 538 5’ GCAACTCGAACTCGCTCAGG 3’
BMP4-F(1) 525 5’ CGTCCAAGCTATCTCGAGCC 3’
BMP4-R(1) 566 5’ CGGAATGGCTCCATAGGTCC 3’
BMP4-F(2) 586 5’ TTGTCTCCCCGATGGGATTC 3’
BMP4-R(2) 591 5’ GAATGGCTCCATAGGTCCCTG 3’
BMP4-F(3) 492 5’ TCCAAGCTATCTCGAGCCTG 3’
BMP4-R(3) 543 5’ ATGGCTCCATAGGTCCCTGC 3’
Table 2.3: Primers designed and used for PCR studies.
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compression process. The protocol used for the in vitro studies have also been
described. Based on standard protocols, novel methods have been developed for
the current study. These developed methods can also be applied to future studies.
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Chapter 3
Development of a Magnetic
Bio-reactor for Magnetic
Stimulation
3.1 Overview
The objective of this chapter is to describe the design of a magnetic bio-reactor
with the desirable intensity. It has been proposed that SMFs with 1 mT to 1 T
are capable of influencing a number of biological systems, including proliferation,
differentiation and mineralisation of osteoblasts. From previous investigations (as
reviewed in Chapter 1), SMFs with field strength below 15 mT or 250 mT were
not able to enhance osteoblasts proliferation, whereas SMFs with field strength
between 100 mT and 160 mT had most effective effect. Therefore, the aim of this
chapter was to design and fabricate a magnetic bio-reactor with field strength
within this range. SMFs can be set up by employing permanent magnets. The
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magnetic field between two magnets depends on the dimensions and physical
properties of the magnets, as well as the relative position of the magnetic poles.
Therefore the effect of various parameters on the magnetic field strength will be
first studied. Then the designed magnetic bio-reactor will be constructed by SLS
technique, followed by validation using a Tesla meter. A map of strength distri-
bution will also be plotted.
3.2 Development of a Magnetic Bio-reactor
3.2.1 Computational Simulation of Magnetic Fields
In order to investigate the effects of different types of magnets, the relative po-
sition of the poles and the separation distances on the strength of the magnetic
field, several designs were tested. Four different types of magnets were involved,
NdFeB30, NdFeB35, SmCo24 and SmCo28. All other variables used are illus-
trated in Figure 3.1.
The first target was to investigate the effect of different types of magnets
on the magnetic field strength. NdFeB30 and NdFeB35 are the most commonly
used neodymium magnets in biomedical studies, Figure 3.2a and 3.2b represent
the difference in magnetic filed strength from these two types of magnets, given
that all other parameters were fixed. The magnetic field strength of interest is at
the centre of the design with a diameter of 2 cm. The magnetic field strength is
in the range of 62 - 184 mT and 72 - 215 mT, respectively.
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Figure 3.1: The separation distances used are 2, 4, and 8 cm, and the relative
position of magnetic poles varied are face to face and edge to edge. The pink circle
represents the location of the scaffolds with a diameter of 2 cm in cell petri-dish.
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Apart from neodymium magnets, samarium-cobalt magnets have also been
applied in clinic. SmCo24 and SmCo28 were modelled and simulated, with the
results presenting in Figure 3.3a and 3.3b. The magnetic filed strength generated
at the centre (with a diameter of 2 cm) is in the range of 57 - 169 mT and 61 -
181 mT, respectively.
Then the magnet to magnet distance and relative position of the magnetic
poles were investigated. NdFeB35 magnets were chosen for the following studies,
due to its highest strength when compared to others.
Firstly, the magnets were placed with a gap of 2 cm. In this case, two posi-
tions were studied, with N-S face to face and N-S edge to edge (shown in Figure
3.4a and 3.4b ). As can be observed, the B field at the centre of the face to face
case are in the range of 140 mT to 279 mT, which is larger than that in the edge
to edge case, which is 76 mT to 151 mT. The edge to edge position generated a
smaller field when compared to the face to face one.
As the distance increased to 4 cm, the B field decreased to 105 - 209 mT (face
to face) (figure 3.5a) , and 37 - 72 mT (edge to edge) (Figure 3.5b). A reduction
of the magnetic field strength can be observed when compared to the case where
the separation distance is 2 cm.
The third design is to further increase the separation distance to 8 cm. As is
shown in Figure 3.6a and 3.6b, the magnetic field with 8 cm gap generated a field
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(a)
(b)
Figure 3.2: The simulation of (a) NdFeB30 and (b) NdFeB35 magnets with in-
ternal gap of 4 cm. The magnetic field strength at the centre of the field is 62 -
184 mT and 72 - 215 mT, respectively.
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(a)
(b)
Figure 3.3: The simulation of (a) SmCo24 and (b) SmCo28 magnets with internal
gap of 4 cm. The magnetic field strength at the centre of the field is 57 - 169 mT
and 61 - 181 mT, respectively.
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(a)
(b)
Figure 3.4: The simulation of (a) face to face and (b) edge to edge position with
internal gap of 2 cm. The magnetic field strength at the centre of the field is 140
- 279 mT and 76 - 151 mT, respectively.
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(a)
(b)
Figure 3.5: The simulation of (a) face to face and (b) edge to edge position with
a distance of 4 cm. The B field at the centre of the field is 105 - 209 mT and 37-
72 mT, respectively.
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strength of 0.45 - 71 mT when the magnets are placed face to face, and 0.125 -
36 mT when the magnets were placed edge to edge.
Table 3.1 summaries the magnetic field strength from different designs.
Position Distance / cm Magnetic Field Strength / mT
Face to Face 2 140 - 210
4 105 - 209
8 0.45 - 71
Edge to Edge 2 76 - 151
4 37 - 72
8 0.125 - 36
Table 3.1: Summary of the simulation results from different designs.
As can be compared from the above results, the design with face to face posi-
tion, 4 cm internal gap give the closest value as the hypothesised magnetic filed
(100 - 160 mT). Therefore this design will be used for the following studies.
3.2.2 Designing of the Magnetic Bio-reactor
A magnet holder has to be designed to accommodate the magnets. There are two
pockets designed on the side of the holder to not only accommodate the magnets
but also prevent the magnets colliding with each other (as shown in Figure 3.7).
The magnets were fitted in two pockets with magnetic poles facing each other. A
3 cm diameter Petri-dish was able to successfully fit in the centre of the holder.
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(a)
(b)
Figure 3.6: The simulation of (a) face to face and (b) edge to edge SMFs with
a gap of 8 cm. The field strength at the centre of the field is 0.45 - 72 mT and
0.125 - 36 mT, respectively.
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Figure 3.7: Initial design of the magnets holder. The holder is made of aluminium,
with an internal diameter of 4 cm, and the magnets can be inserted from two sides
of the holder.
However, there are some potential problems encountered with this design.
First, the pocket deign would lead to higher possibility of infections for the cells,
due the gap between the pockets and the magnet. Exposing the magnets outside
the reactor is also not safe. Second, it is difficult to ensure that the cell Petri-
dish is located in the centre of the magnetic field, as the size of the Petri-dish is
slightly smaller than the inner space of the holder.
Based on the feedback from the initial design, a modified version was fabri-
cated. The CAD model is shown in Figure 3.8a. The problem introduced by the
side pockets from the initial design can be eliminated by placing the magnets
inside the holder, with two thin barriers preventing the magnets from moving.
Besides, a Petri-dish platform was designed to hold the Petri-dish in the centre of
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the magnetic field. The actual dimensions are shown in Figure ??. In addition,
the holder has to be strong enough to hold the magnets in place, as well as to
be biocompatible for biological studies. Therefore, Nylon (PA 2200) was selected
as the candidate material. Figure 3.8b represents final the 3D printed bio-reactor.
3.2.3 Final Validation of the Magnetic Bio-reactor
The magnetic holder was tailor-made and fabricated, there remained an issue of
the effects of the Nylon holder barriers on the magnetic field strength. It was
therefore necessary to simulate the magnetic field strength of the final reactor.
The simulated results were shown in Figure 3.9. As can be seen, the field strength
of the new design was reduced to 72 - 144 mT. Although the strength was de-
creased, it still remained in the desired range, therefore the new design were
accepted.
The magnetic field strength of the designed bio-reactor has then been validated
by a tesla meter, with results presented in Figure 3.10. The average magnetic
field strength at each point ranged from 90 to 129 mT, and they lie within the
range of the simulated results (72 - 144 mT at the centre and 144 - 215 mT at
the corner), which validated the simulation results. The differences between the
simulated and experimental results might be due to the the accuracy of instru-
mentation and the effect of the magnet field of the earth.
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(a)
(b)
Figure 3.8: Illustrations of (a) the CAD drawing of the magnetic bio-reactor, with
a magnet to magnet distance of 4 cm and a Petri dish platform in the centre of
the magnetic field and (b) final product, which was fabricated by SLS technique
with biocompatible Nylon PA 2200. The magnetic bio-reactor has an overall
dimension of 56mm, 68mm and 28mm in x, y and z dimension, respectively.
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Figure 3.9: Computational simulation of the magnetic bio-reactor, with magnetic
field strength of 72 -144 mT.
Figure 3.10: The magnetic fields measured by the Tesla meter is in the range of
90 - 129 mT.
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3.3 Discussion
The magnetic field strength is the most crucial factor that influences the cell
behaviours (who were exposed under SMFs). Degen & Stetsula [1971] firstly re-
ported the promoting effect of SMFs on fracture repair. Among all types of SMFs,
SMFs with 1 mT - 1T have been identified as capable of affecting a number of
biological behaviours of osteoblast cells, including cell proliferation, differentia-
tion and mineralisation. However, the results with regards to various strength
within that range are highly controversial. For example, Chiu et al. [2007] found
that the proliferation of MG-63 cells was inhibited by SMFs of 400 mT. Imaizumi
et al. [2007] demonstrated that the proliferation of MC3T3-E1 was decreased by
the exposure of 250 mT SMFs. On the other hand, in the study of Yamamoto
et al. [2003], they showed that SMFs of 160 mT stimulated bone formation by
promoting differentiation of osteoblasts (rat calvaria cell, ROS 17/2.8 and UMR-
106). Cai et al. [2015] further demonstrated that 100 mT SMFs was capable of
enhancing MC3T3-E1 cell differentiation. However, when low SMFs have been
employed (3, 4, 7 and 15 mT), either the cell attachment nor proliferation of
osteoblasts can be observed [Kim et al., 2005]. As can be concluded from these
studies, SMFs with field strength above 250 mT or below 15 mT were not been
able to promote osteoblasts to proliferate, whereas SMFs with field strength in
between 100 mT to 160 mT had a stimulating effect. Therefore the hypothesis
was to build a magnetic bio-reactor with magnetic field strength of 100 mT - 160
mT.
In order to build a magnetic field with desired strength (100 mT - 160 mT),
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several designs were simulated computationally firstly, with the results ranging
from 0.125 mT to 279 mT. The magnetic field strength is dependent on several
factors, for example, types of magnets, distance in between the magnets as well
as the relative position of the magnetic poles.
Among a wide range of permanent magnets, neodymium and samarium-cobalt
magnets are the most commonly used. Both types have been applied in clinical
applications [Bondemark et al., 1994; Darendeliler et al., 1995], whereas NdFeB
magnets showed negligible cytotoxicity and stronger magnetic strength during in
vitro tests. The computational simulation gave similar range of magnetic field
strength by using both types of magnets, due to bio-compatibility considerations,
neodymium magnets were chosen as the source of permanent magnets in this
study. Once the type of the magnets were decided, the magnetic field strength is
then dependant on the relative position of the magnets, i.e, the distance between
two magnets, the position of the magnetic poles (the poles are at the edges or
the faces of the magnets).
Placing the magnetic poles face to face, or edge to edge lead to different
strength. Taking all three distances simulated (2 cm, 4 cm and 8 cm), face to
face position induced larger magnetic field strength when compared to edge to
edge one. The magnetic field at any given point is specified by both direction
and magnitude (or strength) as such it is a vector field. When multiple magnets
are placed near to each other, they exert forces and torques on each other. The
forces are modelled as tiny loops of current, called magnetic dipoles, which pro-
duce their own magnetic field. Calculating the net force in between two magnets
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is complicated, as it is determined by summing up all these interactions between
the dipoles of the first magnet and that of the second. When magnetic poles are
placed face to face, the magnetic field in the middle is the same as that at the
edge. However, when two magnets are placed edge to edge, the magnetic dipoles
come from N to S of one magnet is in the opposite direction with that come from
the other magnets, resulting in a smaller magnetic field strength in the centre of
the field.
As for the distance between magnets, it can be concluded that the closer the
magnets, the stronger the magnetic field. Classically, the force between two mag-
netic poles is given by a formula,
F =
µqm1qm2
4pir2
(3.1)
where F is force, qm1 and qm2 are the magnitudes of magnetic poles, µ is the
permeability of the intervening medium and r is the separation distance. As can
be observed from the equation, given the same permeability, smaller separation
distance induces larger magnetic force in between.
In this study, a magnetic bio-reactor constructed with neodymium N35 mag-
nets with a separation distance of 4 cm was selected, which resultant in a magnetic
field strength of 72 - 144 mT (computational) and 90 - 129 mT (experimental).
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3.4 Summary
In this chapter, a magnetic bio-reactor was designed and validated. A static
magnetic field can be constructed by using the permanent magnets, and the field
strength of the bio-reactor is highly dependent upon the properties of the magnets,
the relative position of the magnetic poles and the separation distances. As can
be concluded from the results, when the magnetic poles are placed face to face,
the magnetic field in the centre is stronger than that when the magnetic poles are
placed edge to edge. Besides, the smaller the separation distance, the larger the
magnetic field strength. This can be explained by using the force between two
poles formula, where smaller separation distance lead to stronger magnetic force.
The final design of the magnetic bio-reactor was fabricated by SLS technique and
simulated to have a 72 - 144 mT magnetic field strength. The actual magnetic
field strength was measured by a tesla meter with result lying in the range of
90-129 mT. These data validated the simulation results from ANSYS.
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Chapter 4
Development of a 3D Collagen
Model for the In Vitro Evaluation
of Magnetic Stimulation on
Osteogenesis
4.1 Overview
A tissue model consists of three key components, the scaffold, the cells and the
biofactors. Collagen hydrogels have been widely used as tissue models/scaffolds.
However, conventional collagen hydrogels lack of mechanical strength and low in
collagen density (only containing 0.2 - 0.6 w/w % collagen protein). They can
be quickly resorbed in vivo [Tabata et al., 2000]. Plastic compression of collagen
gels can improve the collagen density and the mechanical properties, by expelling
the extra aqueous components, while maintaining the structure and cell viability.
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Compared to hydrated collagen gels, cells seeded within compressed scaffolds also
show increased proliferation, differentiation and mineralisation over time. Plastic
compressed hydrogels have been used as tissue models/scaffolds with the ability
to incorporate various types of cells, such as fibroblasts, osteoblasts, etc. The aim
of this project was to investigate the effects of SMFs on osteogenesis, therefore
osteoblasts will be the focus of the study.
One of the advantages of PC collagen models is that they offer the possibil-
ity of incorporating various bio-factors together with cells. It has been reported
by several studies that incorporating biofactors into the plastic compressed col-
lagen scaffolds, such as chitosan and bioactive glass particles, can promote the
differentiation and mineralisation of the cells. IONPs can be manipulated by an
external magnetic field without direct contact, therefore can be used to evaluate
and potentially enhance the effect of SMFs on osteogenesis. Besides, HA is one of
the most popular ceramic materials for bone repair, own to the fact that it is the
primary constitution of bone mineral [Cheema et al., 2011]. On the other hand,
infection is one of the reasons that causes fracture non-union. nZnO have been
demonstrated to have antimicrobial properties [Brayner et al., 2006] and can be
introduced into the system to enhance fracture non-union by reducing bacterial
growth.
The aim of this chapter was to design and evaluate a suitable in vitro model
for the investigation of SMFs on osteogenesis. The effects of SMFs on various
cell lines (MG-63, UMR-106 and MC3T3-E1), 2D/3D collagen models, as well as
the incorporation of IONPs, nHA and nZnO (concentrations of 1, 10, 100 and
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1000 µg/ml) will be studied. Alamar blue (AB) assays have been employed to
investigate the proliferation of cells.
4.2 Effects of SMFs on Cell Cultures
The effects of SMFs on the proliferation of three different cell lines, MG-63, UMR-
106 and MC3T3-E1 were tested by using AB assay. Cells were seeded in collagen
scaffolds for 1, 3, 7 and 14 days with a population of 1 × 104 cells, respectively,
and grow with/without the exposure of SMFs (shown in Figure 4.1a). Figure
4.1a compares the proliferation of three cells under conditions and with SMFs.
Without the exposing of SMFs, all cells were able to proliferate over time. MG-63
cells proliferated faster than the other two cell lines, whereas the lowest was found
with UMR-106 cells. MC3T3-E1 cells show a steady growth rate when compared
to the others. When subjected to SMFs, all cells were able to proliferate over
14 days. The proliferation of MG-63 cells peaked at day 14, whereas UMR-106
remained with the lowest. A comparison of the effects of SMFs on different cell
lines are illustrated in Figure 4.1b. As can be observed, all cells were stimulated
significantly by SMFs after 7 days.
4.3 Effects of SMFs on 2D/3D Models
2D model (cell monolayers) and 3D plastic compressed collagen scaffolds were
prepared and tested in the magnetic bio-reactor. A population of 1 × 104 MG-63
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(a)
(b)
Figure 4.1: Comparisons of cell proliferation of MG-63, UMR-106 and MC3T3-
E1 cell lines using an alamar blue assay with (M) and without (NM) SMFs (n=3,
∗p<0.05, ∗∗p<0.01, ∗ ∗ ∗p<0.001, ∗ ∗ ∗∗p<0.0001). (a) Cell proliferation with
and without SMFs. All three cell lines are able to proliferate under SMFs. (b)
Effects of SMFs on each cell lines compared at the same time point. As being
exposed under SMFs, MG-63 and MC3T3-E1 cell lines respond more significantly
as compared to UMR-106.
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cells was seeded onto/into the each sample. AB assays were performed at day
1, 3, 7 and 14 after culture with results presented in Figure 4.2a. As can be
observed, when being seeded in a 3D collagen model, MG-63 cells proliferated
faster when compared to 2D monolayers from day 3. When further subjected to
SMFs, the proliferation rate was enhanced. A peak growth reached after 7 days.
However, a decrease in proliferation was found at day 14. This could due to the
fact that cells are entering the stage of differentiation, therefore the proliferation
subsides. Figure 4.2b further compares the effects of SMFs on cell proliferation
with time. The stimulation effects of SMFs can be observed after 1 day in col-
lagen scaffolds. Significant cell growth continued until day 14 for both 2D and
3D samples. This demonstrates that the SMFs have a stimulating effect on the
cell proliferation of MG-63 cells, with higher proliferation in 3D collagen scaffolds.
4.4 Effects of SMFs on 3D Collagen Model with
Various Bio-factors
4.4.1 IONPs Incorporated Collagen Models
AB assay was conducted to evaluate the cell proliferation when in contact with
IONPs at different concentrations, 1, 10, 100 and 1000 µg/ml, as shown in Figure
4.3a and 4.3b.
Results indicate that MG-63 cell lines were able to proliferate within the
IONPs embedded collagen scaffolds at low concentrations (1, 10 and 100 µg/ml),
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(a)
(b)
Figure 4.2: Comparisons of cell proliferation of MG-63 on cell culture monolayers
(control) and collagen models using an alamar blue assay with (M) and without
(NM) SMFs. (a) Cell proliferation with and without SMFs. As can be observed,
cell proliferation can be affected by SMFs on all scaffolds. (b) Effects of SMFs on
cells seeded on each scaffolds. Collagen scaffolds stimulated higher cell growth
when compared to 2D monolayers (n=3, ∗p<0.05, ∗∗p<0.01, ∗ ∗ ∗p<0.001, ∗ ∗
∗∗p<0.0001).
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with an increasing growth rate over time. When high concentration of IONPs,
which is 1000 µg/ml in this case, a decrease in proliferation was observed. It
demonstrates that high IONPs concentration has an inhibition effect on MG-63
cell growth. Statistical results from day 1 and day 3 indicate that there is a sig-
nificant increase when 100 µg/ml IONPs are used (when compared to controls).
After 7 days, the cell growth in scaffolds incorporated with 10 µg/ml IONPs in-
creased significantly as well. Finally, after 14 days of culture, the increase in cell
proliferation was proven to be significant for all three concentrations, with the
peak value located at concentration of 100 µg/ml. Furthermore, the cell prolif-
eration at each time point increased with the IONPs content up to 1000 µg/ml,
suggesting a positive correlation between the magnetite content and the cell pro-
liferation up to a certain concentration. The IONPs incorporated scaffolds were
then placed under external SMFs to evaluate the effect of a magnetic field on cell
proliferation. When being exposed under SMFs, the growth of MG-63 cell lines
increased for all nanoparticle concentrations except 1000 µg/ml (shown in Fig-
ure 4.3b), which further confirmed the toxicity of IONPs at high concentration.
Again, 100 µg/ml resulted in the most significant effect when compared to other
concentrations.
4.4.2 nHA Incorporated Collagen Models
The cell proliferation on nHA incorporated collage scaffolds were also examined at
day 1, 3, 7, and 14, with concentrations of 1, 10, 100 and 1000 µg/ml, respectively.
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(a)
(b)
Figure 4.3: A comparison of cell proliferation of MG-63 cell lines using an alamar
blue assay when in contact with IONPs (a) under non-SMFs and (b) under SMFs.
0, 1, 10, 100 and 1000 µg/ml IONPs were incorporated for 1, 3, 7 and 14 days.
1000 µg/ml were proved to be toxic to the cells under both conditions, and 100
µg/ml demonstrates the highest enhancement of the proliferation of the cells
(n=3, ∗p<0.05, ∗∗p<0.01, ∗ ∗ ∗p<0.001, ∗ ∗ ∗∗p<0.0001).
120
4. DEVELOPMENT OF A 3D COLLAGEN MODEL FOR THE IN
VITRO EVALUATION OF MAGNETIC STIMULATION ON
OSTEOGENESIS
For cell cultured without the exposure to SMFs, significant increase in cell
proliferation was observed at day 3 for nHA concentrations of 10, 100 and 1000
µg/ml. For longer culturing times, all concentrations were identified to have a
stimulating effect, even for concentration as low as 1 µg/ml, with the results
shown in Figure 4.4a. This finding suggests that nHA has an stimulating effect
on MG-63 cell proliferation. It also demonstrates that the nHA used in this study
is bio-compatible up to a concentration of 1000 µg/ml. When external SMFs were
applied, the increase in proliferative activity with the presence of nHA was not
significant when compared to the control (as illustrated in Figure 4.4b). This
suggests that nHA do not response to SMFs significantly.
4.4.3 nZnO Incorporated Collagen Models
In order to examine the cell growth of MG-63 cells in nZnO incorporated scaf-
folds, AB assays were conducted at different time points, i.e, 1, 3, 7 and 14 days,
with concentrations of 1, 10, 100 and 1000 µg/ml. Figure 4.5a and Figure 4.5b
represents the data.
For non-SMFs treated samples, when adding in 1 and 10 µg/ml nZnO, positive
effects on cell growth were observed after 3 days. However, by further increasing
nZnO concentration, a significant reduction in cell metabolic activity was noticed
after 7 days. The cell proliferation with nZnO of 1000 µg/ml was halved when
compared to the controls. It can be concluded that the nZnO can only stimulate
MG-63 cell growth at low concentration for a shorter culture period, while being
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(a)
(b)
Figure 4.4: A comparison of cell proliferation of MG-63 cell lines using an ala-
mar blue assay when in contact with nHA (a) under non-SMFs, (b) under SMFs.
Without the exposure of SMFs, the nHA have a stimulating effect on the pro-
liferation of cells when compared to the control samples, however, when further
exposing them under SMFs, the effects of nHA on cell proliferation cannot be
observed (n=3, ∗p<0.05, ∗∗p<0.01, ∗ ∗ ∗p<0.001, ∗ ∗ ∗∗p<0.0001)
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toxic to the cells at higher concentrations for longer culture time.
Similarly, under the exposure of SMFs, nZnO demonstrated an unfavourable
effect on cell proliferation. This further proved the toxicity of nZnO on MG-63
cell lines when embedded within collagen substrates.
4.5 Discussion
4.5.1 Effects of SMFs on Various Cell Lines
While a number of osteoblastic cell lines have been well characterised, few studies
have directly compared their behaviour in order to determine their suitability for
use in a tissue model. In this chapter, the proliferation behaviour of MG-63,
UMR-106 and MC3T3-E1 cell lines were studied, with and without the exposure
to SMFs. Enhanced proliferation of all MG-63, UMR-106 and MC3T3-E1 cells
were demonstrated under SMFs. Indeed, the MG-63 cells respond to the SMFs
most significantly when compared to the others, the proliferation of MC3T3-E1
cells were promoted steadily, whereas UMR-106 cells were not influenced much.
It was proposed that on the cell culture surfaces, the saturation density is
influenced by the cell size. Smaller sizes of cells lead to high value of saturation
density, therefore it was expected to have higher proliferation in smaller cells
when compared to larger cells. A morphometric analysis of several osteoblastic
cell lines from Pautke et al. [2004] indicated that the sizes of MG-63 cells were
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(a)
(b)
Figure 4.5: A comparison of cell proliferation of MG-63 cell lines from alamar
blue assay when in contact with nZnO (a) under non-SMFs and (b) under SMFs.
The incorporation of nZnO have an inhibition effect on MG-63 cells, especially at
higher concentrations (n=3, ∗p<0.05, ∗∗p<0.01, ∗ ∗ ∗p<0.001, ∗ ∗ ∗∗p<0.0001).
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smaller than that of MC3T3-E1 cells, therefore they tend to proliferate faster than
other cell lines with bigger sizes. Furthermore, Czekanska et al. [2014] demon-
strated that the MC3T3E1 cells have a similar proliferation behaviour as primary
cells, whereas MG-63 cells proliferate much faster. Similar observations have also
bee reported by Pautke et al. [2004]. This explains the higher proliferation of
MG-63 when compared to the other two cell lines. When further exposing un-
der SMFs, enhanced proliferation of all three cell lines were observed. Although
contradictory results have been reported (as summarised in Chapter 1), the suc-
cessful demonstration of the effects of SMFs on cell proliferation in this study
are contributed to the magnetic field strength and the collagen/cell interactions.
Previous studies were focused on 2D or synthetic polymeric scaffolds, whereas 3D
collagen scaffolds were employed here.
Primary cells and different types of cell lines possess their own advantages and
disadvantages when used as in vitro cell models. Primary cells undergo the same
osteoblastic differentiation in vivo, therefore are the most representable cells for
in vitro use, as well as clinical studies. However, they exhibit several disadvan-
tages which limit their use. First of all, they have limited accessibility and have
to be prepared under long and complex isolation procedures. Second, the pri-
mary cells normally contain heterogeneous phenotype which may complicate the
model. In addition, primary cells are sensitive to donor related factors, such as
age and gender, which may rise inconsistent results. Therefore cell lines have been
widely applied on in vitro investigations. Cell lines are mostly used due to the
availability of unlimited number of cells, ease of culturing and higher phenotyp-
ical stability comparing to primary cells [Kartsogiannis & Ng, 2004]. Moreover,
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in the case of human derived cell lines, both normal and malignant, the concern
about the effect of species differences can be avoided [Czekanska et al., 2012]. One
example can be found as MG-63 cell lines. They have been reported to exhibit
no interspecies differences to human primary cells and express similar level of
ALP and collagen deposition. However, they may proliferate much faster when
compared to primary cells in vitro.
4.5.2 Effects of SMFs on 2D/3D Models
The effects of culturing cells in 3D collagen scaffolds have also been examined.
Compared to the 2D monolayers, collagen scaffolds provide a 3D, ECM-like en-
vironment, which promote the cell growth significantly both with and without
SMFs. Comparing to 2D monolayers, 3D plastic compressed collagen gels offered
more advantages. First of all, collagen scaffolds are self-assembled from natural
material. One of the advantages of using natural materials is that these molecules
are naturally recognised by cells and are more likely to stimulate physiological
responses in cells. Collagen, for example, has the structure same to the ECM
of bone, hence can better simulate the migration, proliferation, remodelling of
matrix of osteoblasts, which will be further discussed in Chapter 5. The other
main advantage of collagen as a scaffold material is its properties as a 3D cell
substrate. 3D in vitro collagen hydrogels models have the advantage of suspend-
ing collagen/cells in a tissue-like matrix, and also enables real-time assessment of
the accessible construct. Plastic compressed collagen scaffolds provide the desired
properties, including water retention capacity, nano/micro-porosity to allow cells
126
4. DEVELOPMENT OF A 3D COLLAGEN MODEL FOR THE IN
VITRO EVALUATION OF MAGNETIC STIMULATION ON
OSTEOGENESIS
to grow and arrange in 3D, biodegradability, and pore inter-connectivity that
would allow free flow of oxygen and nutrients [Dutta & Dutta, 2009]. Collagen
can also provide cells with native tissue like environment, mechanical properties,
topographical features and orientation cues.
4.5.3 Effects of SMFs on 3D Collagen Model with Various
Bio-factors
The effects of adding in IONPs, nHA and nZnO particles into cell seeded col-
lagen models have also been studied. Starting from the lowest nanoparticles
concentration employed in this study, which was 1 µg/ml, IONPs demonstrate a
stimulating effects on the proliferation of MG-63 cell lines, while this behaviour
was not observed with nHA and nZnO incorporated samples. Similar conclusions
can be drawn for the concentrations at 10 µg/ml. For concentrations beyond
100 µg/ml, the presence of nHA induced significantly enhanced cell proliferation,
whereas nZnO still showed a toxic effect to cells. IONPs has a significant stim-
ulating effect on cell proliferation under SMFs. As the concentration increased
to 1000 µg/ml, IONPs and nZnO demonstrated toxic effects to cells while nHA
significantly encouraged the cell growth. However, nHA do not respond to SMFs
significantly.
When incorporating IONPs into the collagen scaffolds without SMFs, growth
of MG-63 cell lines were enhanced up to a concentration of 100 µg/ml, which
peaked at 100 µg/ml at 7 days culture. However, toxicity effects were observed
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when a concentration of 1000 µg/ml was employed. By further employing exterior
SMFs, a promoting effect on cell proliferation can be observed when in contact
with IONPs, with the optimal concentration at 100 µg/ml. This suggests that
the applied SMFs played a positive role on the cell proliferation.
IONPs smaller than 20 nm in size behave with superparamagnetic properties
[Cornell & Schwertmann, 2003]. They are non-magnetic in the absence of an
exterior magnetic field. Once exposed under an exterior magnetic field, they will
be rapidly magnetised to saturation and respond to the exterior magnetic field
to provide magnetic properties. When introduced into the scaffolds and exposed
under SMFs, those particles can be attracted by the magnetic fields, leading to
movements inside the scaffolds. Although been embedded inside the collagen gel,
the particles tend to travel towards the magnetic poles, overcome the friction pro-
vided by the gels, resultant in a motion within the matrix. This motion caused
by the particles can potentially affect the cell behaviours during cell/particles
interactions. Therefore, due to the incorporation of IONPs, the SMFs is not only
providing a static field, it will also create a dynamic environment to the cells.
Besides, uncoated iron oxides are often negatively charged in water due to the
adsorption of OH− ions onto their surface. The resulting electric field may at-
tract counter ions and hence promote protein adsorption [Mahmoudi et al., 2010].
IONPs can be toxic to cells, and this is dependent on the concentration. For
example, Naqvi et al. [2010] studied the toxicity of IONPs (30 nm). Their results
indicated that IONPs do not show a toxicity effect at concentrations up to 100
µg/ml. By further increasing the concentration to 25-200 µg/ml, the cell viabil-
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ity reduced to 95 %. When the IONPs concentrations were increased to 300-500
µg/ml, the cell viability further reduced to 55-65 %. In this study, the average
size of the IONPs used was characterised to be 13 ± 5 nm (detailed characterisa-
tions are attached in Appendix), and the safe concentration was identified as 100
µg/ml. More importantly, this concentration can also promote cell growth. This
is partially due the culturing system. The toxicity of IONPs at high concentra-
tions can be explained as, the Cl− ions that present in the cell culture medium
can bind to the Fe ions, thus altering the pH of the medium together with the
surface characteristics of the nanoparticle. Such interactions with the cell culture
medium, resulting in alterations in the ionic concentration and protein function,
may cause cell detachment and subsequently may lead to cell death [Mahmoudi
et al., 2010].
By adding in nHA into the collagen scaffolds without SMFs, cell proliferation
can be enhanced at various concentrations up to 1000 µg/ml. This confirmed
the stimulating effect of nHA on osteoblasts. Studies by San Thian et al. [2008]
demonstrated that, by seeding human osteoblasts on nHA coated surfaces, the
number of cells growing increased with culturing time and tended to multiply
significantly. When samples were further exposed under SMFs, a slightly higher
proliferation can be observed when compared to non-SMFs treated samples. This
suggests that the exterior SMFs have a beneficial effect on stimulating the cell
proliferation in collagen scaffolds, but the effect was limited. This results can be
validated by Zeng et al. [2012]. Their study investigated the effects of exterior
magnetic field on MC3T3-E1 cells when in contact with IONPs and HA. Results
indicated that HA particles have no observable influence on the cell proliferation
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under magnetic fields, whereas this stimulating effect was magnified in the pres-
ence of IONPs.
Moreover, results demonstrated that nZnO with a concentration higher than
10 µg/ml are toxic to the MG-63 cell lines. It can be concluded that the nZnO
can only stimulate MG-63 cell growth at a low concentration, whereas being toxic
to the cells at a high concentration. Similarly, under the exposure of SMFs, nZnO
shows an unfavourable effect on cell proliferation. This further proved the toxic-
ity of nZnO on MG-63 cell lines when embedded within collagen substrates. In
the study of Bai et al. [2010], they demonstrated the toxicity of nZnO at con-
centrations of 50 - 100 µg/ml. In addition, Heng et al. [2010] found that nZnO
is toxic to human bronchial epithelial cells (BEAS-2B) above a concentration of
10 µg/ml, and this result also agreed with the study from Xia et al. [2008]. The
enhancement of cell proliferation when in contact with nZnO (on 2D substrates)
have been observed by Memarzadeh et al. [2015]. Therefore, due to the biocom-
patibility of nZnO (at low concentrations) and the well-established antimicrobial
properties, a controllable concentration of nZnO can be suggested as an antimi-
crobial agent in the scaffold.
4.6 Summary
Different cell types possess different properties, and they all have advantages and
disadvantages when used as in vitro cell models. Their use should be limited to
appropriate and specific research questions with careful extrapolation of results,
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rather than as widespread use for recapitulating general bone biology and disease
as is currently the case [Czekanska et al., 2012]. MG-63, UMR-106 and MC3T3-
E1 cells all respond to SMFs by increasing proliferation. Among which, MG-63
cells have the highest proliferation when compared to the others. When further
incorporating IONPs, nHA and nZnO, a stimulating effect of IONPs incorpo-
rated scaffolds can be observed under SMFs, up to a concentration of 100 µg/ml.
nHA can encourage the cell proliferation without the exposure of SMFs, with no
significant improvements under SMFs. nZnO demonstrates the lowest stimulat-
ing effects on cell proliferation, while being toxic to the cells at concentrations
above 10 µg/ml. Therefore, 100 µg/ml of IONPs were considered as the optimal
bio-factor to be added into the PC scaffolds for the evaluation of SMFs in vitro.
Apart from being a tissue model, this system developed here can also serve as a
novel scaffold for cell stimulation applications.
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Chapter 5
Cellular and Molecular Evaluation
of the 3D Collagen Model under
Static Magnetic Fields
5.1 Overview
In 1986, Cowin [1986] firstly hypothesised that bone remodels in response to stress
and strain through mechanotransduction (further details can be found in Chapter
1). This process involves the conversion of a biophysical force into a biochemical
response leading to changes in gene expression and cellular adaptation. Based on
the principle of mechanotransduction, magnetic stimulation has been proposed
for the applications of bone regeneration and fracture non-union.
SMFs have been demonstrate to have the ability to influence a number of
biological functions in osteoblasts, such as proliferation, differentiation, extra-
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cellular matrix synthesis and mineralisation [Cai et al., 2015; Chiu et al., 2007;
Meng et al., 2013; Rosen, 2003]. However, despite the success of SMFs stimula-
tions with several in vitro studies, there remains a concern that bone responds to
dynamic rather than static loading, it is believed that the stimulation is related
to the peak strain magnitude and the loading frequency [Rubin & Lanyon, 1985].
Therefore in many studies related to the SMFs stimulation, the promotion effect
on cell proliferation were not observed [Chionna et al., 2003; Chiu et al., 2007;
Cunha et al., 2012; Imaizumi et al., 2007]. However, the cell behaviours are not
only dependent on external physical stimulations, it is also dependent on the ef-
fect of other biochemical cues, as well as cell/ECM interactions. One hypothesis
is that the proliferation (as well as other cell behaviours, such as differentiation
and mineralisation) of osteoblasts can be stimulated when embedded inside the
3D bio-mimic collagen matrix, with the incorporation of additional IONPs, under
the exposure of SMFs. The mechanisms at molecular levels are also of interest to
be investigated. The hypothesis of the mechanisms is that, SMFs can affect the
reorientation of cell membrane phosphilipids, as well as the cell/matrix interac-
tions, hence activate the calcium ion channels in the cell membrane, encouraging
more calcium ion flux. During the interaction, the expression of Runx2, ON,
BMP-2 and BMP-4 can be stimulated by the combination of SMFs, IONPs and
dense collagen matrix, leading to an enhancement of the osteoblastic differentia-
tion process.
The objectives of this chapter are described as below. The effects of SMFs,
the collagen matrix and the incorporation of IONPs on the osteogenesis process of
MG-63 cell lines were studied firstly, this includes the examination of cell prolif-
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eration by alamar blue (AB) assay, the measurement of alkaline phosphatase pro-
duction by ALP assay, and then the assessment of cell mineralisation by alizarin
red s (ARS) staining. The next focus was to understand the mechanisms of SMFs
and IONPs on osteogenesis at molecular levels. Firstly, the expression of several
key genes, Runx2, ON, BMP-2 and BMP-4 will be investigated by PCR study.
Secondly, the histology of the cells/matrix exposed under SMFs will be evaluated.
Furthermore, a detailed microstructural analysis of the cell/ECM interaction will
be examined under TEM.
5.2 Cell Proliferation
The proliferation of MG-63 cells was tested by alamarBlue assay. The cells were
cultured for 1, 3, 7 and 14 days, under four conditions, with/without the expo-
sure of SMFs, and with/without the incorporation of IONPs. The results are
shown in Figure 5.1. From day 1, the incorporation of IONPs, the exposure of
SMFs and both jointly all had stimulating effect on cell proliferation, and this
effect continued until day 7. After 7 days, the cell proliferation with treatments
almost doubled to that found at day 1. This indicates the that the SMFs and
IONPs had a significant influence on the cell proliferation during day 1 and day
7. However, when further cultured up to 14 days, the SMFs or IONPs alone did
not have significant impact on cell proliferation when compared to that at day
7. However, it was observed that the proliferation of the cells incorporated with
IONPs and exposed to SMFs was up-regulated after 14 days.
134
5. CELLULAR AND MOLECULAR EVALUATION OF THE 3D
COLLAGEN MODEL UNDER STATIC MAGNETIC FIELDS
Figure 5.1: A comparison of cell proliferation of MG-63 cells when cultured
within collagen scaffolds with/without the incorporation of IONPs, with (M) and
without the exposure of SMFs. Cell proliferation can be enhanced under SMFs
with the incorporation of IONPs, indicating a stimulating effect (n=3, ∗p<0.05,
∗∗p<0.01, ∗ ∗ ∗p<0.001, ∗ ∗ ∗∗p<0.0001).
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5.3 Cell Differentiation
Alkaline phosphatase (ALP) activities of collagen scaffolds with/without SMFs,
and with/without the incorporation of IONPs were determined. As shown in Fig
5.2, no significant effect of SMFs, IONPs or a combination on ALP production can
be observed up to 14 days. By exposure to SMFs for 21 days, the ALP production
of the cells was up-regulated compared to the control, whereas little difference
was found with the incorporation of IONPs alone. When further combining the
effect of IONPs and SMFs, the ALP production was significantly stimulated.
Figure 5.2: A comparison of cell differentiation using the ALP assay with (M) and
without SMFs exposure. Cell-loaded collagen scaffolds were incorporated with
IONPs with a concentration of 100 µg/ml, results were collected at 7, 14 and 21
days of culture time. The combination of SMFs and IONPs stimulates the ALP
production of the cells (n=3, ∗p<0.05, ∗∗p<0.01, ∗ ∗ ∗p<0.001, ∗ ∗ ∗∗p<0.0001).
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5.4 Cell Mineralisation
Figure 5.3a, 5.3b, 5.3c, 5.3d, 5.3e and 5.3f represent the ARS staining results of
cell-seeded collagen scaffolds with and without SMFs. As can be observed in Fig
5.3a and 5.3b, the scaffolds were not stained at day 1, indicating the absence of
mineralisation. At day 21, early mineralisation can be observed in both samples,
more significantly in those samples which received the SMFs treatment (shown
in Fig 5.3c, 5.3d). After 6 weeks, the mineralisation was observed with all sam-
ples, as shown in Fig 5.3e, 5.3f. At this time point, significant differences were
not observed. ARS staining was also applied to the collagen scaffolds which in-
corporated IONPs, as shown in 5.4a, 5.4b, 5.4c, 5.4d, 5.4e and 5.4f. At day 1,
mineralisation was not observed for both conditions. After 21 days, significant
differences in the degree of mineralisation was identified, with a higher level for
scaffolds treated with SMFs. After 42 days, all samples were fully stained by ARS,
indicating complete mineralisation. Quantification of mineralisation was accom-
plished by using ARS extraction as shown in Fig 5.5. Results indicated that SMFs
can induce early mineralisation in vitro, with more significant simulation when
IONPs were incorporated. After 42 days, extraction levels remained, indicating
that the SMFs and IONPs were not able to promote mineralisation at this period.
The quantification of mineralisation was accomplished by using ARS extrac-
tion, with the difference in absorbance shown in Fig 5.5. Results indicated that
SMFs can induce early mineralisation in vitro, with more significant simulation
when incorporating the IONPs. After 42 days, the extraction remains at similar
levels, indicating that all samples achieved complete mineralisation.
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(a) (b)
(c) (d)
(e) (f)
Figure 5.3: A comparison of cell mineralisation by ARS staining of collagen
scaffolds at day 1 (a) without SMFs, (b) with SMFs, collagen scaffolds at day 21
(c) without SMFs, (d) with SMFs, and collagen scaffolds at day 42 (e) without
SMFs, (f) with SMFs (n=3). Scale bar = 100 µm.
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(a) (b)
(c) (d)
(e) (f)
Figure 5.4: A comparison of cell mineralisation by ARS staining of IONPs incor-
porated collagen scaffolds at day 1 (a) without SMFs, (b) with SMFs, collagen
scaffolds at day 21 (c) without SMFs, (d) with SMFs, and collagen scaffolds at
day 42 (e) without SMFs, (f) with SMFs (n=3). Scale bar = 100 µm.
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Figure 5.5: A comparison of cell mineralisation by extracting and quantifying
ARS staining from scaffolds treated with (M) and without SMFs exposure (n=3,
∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001, ∗∗∗∗p<0.0001). Cell-loaded collagen scaffolds
were incorporated with IONPs with a concentration of 100 µg/ml, results were
collected at 1, 21 and 42 days of culture time.
5.5 RNA Extraction
The total mRNA of samples cultured for 1, 7 and 14 days were isolated following
a standard protocol. Due to the low amount of RNA produced by samples cul-
tured for 1 day, this was not sufficient for quantifying. The mRNA yields (ng/µl)
were plotted against sample types and presented in Figure 5.6. After 7 days, the
effects of SMFs, IONPs alone, and the combination on the mRNA production
can be seen. The combination of SMFs and IONPs appear to have the strongest
influence, however, due to large deviations, the results are not sufficient to prove
the effects of IONPs and SMFs on RNA production. With a time increased to 14
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Figure 5.6: Total RNA isolated against samples with(M)/without SMFs, and
with/without the incorporation of IONPs (n=3, ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001,
∗ ∗ ∗∗p<0.0001). The combination of SMFs and IONPs has a stimulating effect
of the total mRNA production of osteoblasts-seeded collagen scaffolds.
days, significant influences of SMFs and the combination of both can be observed,
with a smaller standard deviation.
5.6 Gene Expression : Real-time Polymerase Chain
Reaction
To understand the responses of cell-seeded collagen scaffolds to IONPs and SMFs
at the molecular level, the expression of Runx-2, ON, BMP-2 and BMP-4 were
investigated by PCR. The expression of Runx2 normalised to GAPDH are illus-
trated in Figure 5.7. A 7 day treatment of SMFs alone had no significant effect
on the expression of Runx2, whereas increased expression can be found in the
SMFs and IONPs treated samples. After 14 days, the expression of Runx-2 in
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Figure 5.7: Relative expression of Runx2 normalised to GAPDH after 7
and 14 days of culture. Samples were cultured with(M)/without SMFs, and
with/without the incorporation of IONPs (n=3, ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001,
∗ ∗ ∗∗p<0.0001).
the control sample increased with increasing culture time. This demonstrates the
collagen matrix can mediate the Runx-2 expression during osteogenesis. When
compared to the controls, continuous treatment of both SMFs and IONPs en-
hanced the expression of Runx2, whereas this effect cannot be observed with
IONPs or SMFs alone.
The expression of ON normalised to GAPDH is illustrated in Figure 5.8. As
can be observed, after 7 days, the level of ON expression in the samples treated
with IONPs, SMFs and both are higher than that in the control. Particularly,
for the SMFs and IONPs combination treatment, the level of expression was the
most enhanced. After 14 days, all samples treated with different conditions were
increased to a similar level, and there were no significant differences between
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Figure 5.8: Relative expression of Osteonectin normalised to GAPDH after 7
and 14 days of culture. Samples were cultured with(M)/without SMFs, and
with/without the incorporation of IONPs (n=3, ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001,
∗ ∗ ∗∗p<0.0001).
samples. This shows that SMFs and IONPs can only enhance the expression of
ON within a short time period, and have no significant influence for longer time
periods.
Figure 5.9 and 5.10 represent the expression of BMP-2 and BMP-4, respec-
tively. When cultured for 7 days, the expression of BMP-2 in collagen, treated
with IONPs and SMFs alone, remained at a similar level to the control. However,
when treated with both IONPs and SMFs, significant enhancement was observed
when compared to the control. After 14 days, the expression of BMP-2 in the
control sample did not increase with time, whereas the effect of the combina-
tion of IONPs and SMFs was significant. This shows the combination treatment
can stimulate the expression of BMP-2 in collagen scaffolds. For BMP-4, the
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Figure 5.9: Relative expression of BMP-2 normalised to GAPDH after 7
and 14 days of culture. Samples were cultured with(M)/without SMFs, and
with/without the incorporation of IONPs (n=3, ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001,
∗ ∗ ∗∗p<0.0001).
treatment with SMFs did not affect the expression significantly, whereas the in-
corporation of IONPs, and further exposure to SMFs, the expression of BMP-4
increased significantly. The collagen scaffold itself may favour the production for
a short period (7 days), while this effect was not observed for a longer time du-
ration up to 14 days. The addition of IONPs or SMFs alone did not promote the
expression any further, whereas when combined together, an enhancement can be
observed up to 14 days. This demonstrates that the combination of IONPs and
SMFs have a strong positive influence on BMP-4 expression. It is also of interest
to note that the overall expression of BMP-4 was higher than that of BMP-2.
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Figure 5.10: Relative expression of BMP-4 normalised to GAPDH after 7
and 14 days of culture. Samples were cultured with(M)/without SMFs, and
with/without the incorporation of IONPs (n=3, ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001,
∗ ∗ ∗∗p<0.0001).
5.7 Cellular Responses
In order to examine the cellular responses of the cells embedded in the 3D scaf-
folds, histology samples were prepared and stained with H & E. Three different
sections were cut from each sample and examined with two magnifications (10X
and 40X). The cell numbers in each image were counted and plotted with average
number and standard deviation (n=3). Images were analysed by image analysis
software (Image J) to quantify cell numbers. Cellular responses of compressed
collagen gels seeded with MG-63 cell lines were obtained after 1, 3, 7 and 14
days of culture. As can be observed from Figures 5.11a, 5.11c, 5.11e and 5.11g,
an increase in cell number was found over time, with fibrous collagen structure
and healthy attached cells shown. As for the samples treated with SMFs, which
are presented in Figures 5.11b, 5.11d, 5.11f and 5.11h, cells multiply over time.
When further compared to the non-SMFs condition, a significant increase in cell
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number can be observed after 3 days. This can be regarded as a validation of the
cell proliferation measured by AB assay, that SMFs have a stimulating effect on
the proliferation of MG-63 cell lines. The IONPs incorporated collagen scaffolds
were then sectioned and stained. Figure 5.12a, 5.12c, 5.12e and 5.12g reveal the
cross-section of the scaffolds cultured without the presence of SMFs, and Figure
5.12b, 5.12d, 5.12f and 5.12h represent the scaffolds cultured under SMFs. Cell
number counted from these microscope images (shown in Figure 5.13) increased
with increasing culture time, with higher counts shown under SMFs. This finding
agrees with the AB assays that MG-63 cell lines were able to proliferate when in
contact with IONPs and SMFs, indicating a stimulating effect.
5.8 Microstructure of the Cell-Seeded Magnetic
Collagen Scaffolds
The microstructure of the cell loaded collagen scaffolds was examined after 1,
7 and 14 days under TEM. Figure 5.14a, 5.14b, 5.14c and 5.14d represent the
results from day 1. As can be observed, when compared to the controls, there are
no major changes in the cell shape or collagen structure with exposure to SMFs
or incorporating IONPs. This could potentially be due to the early stage of
treatment. Besides, the incorporation of IONPs can be identified, as being found
inside the cell in either agglomerated or separated state, close to the cell mem-
brane or inside the collagen fibrils (shown in Figure 5.15a, 5.15c, 5.15d and 5.15b).
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(a) (b)
(c) (d)
(e) (f)
(g) (h)
Figure 5.11: The effects of SMFs on cellular responses by histology at (a) (b)
day 1, (c) (d) day 3, (e) (f) day 7 and (g) (h) day 14 without and with SMFs,
respectively (n=3). Higher cell numbers were observed under SMFs, indicating a
stimulating effect. Scale bar = 100 µm.
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(e) (f)
(g) (h)
Figure 5.12: The effects of IONPs on cellular responses by histology at (a) (b)
day 1, (c) (d) day 3, (e) (f) day 7 and (g) (h) day 14 without and with SMFs,
respectively (n=3). Scale bar = 100 µm.
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Figure 5.13: A comparison of cell number of MG-63 cell lines from histology
for IONPs with and without SMFs. The cell number represents the average
from three sections of one sample. By incorporating additional IONPs, the cell
proliferation can be further enhanced (n=3, ∗p<0.05, ∗∗p<0.01, ∗ ∗ ∗p<0.001,
∗ ∗ ∗∗p<0.0001).
After 7 days, the change in cell/collagen matrix interactions can be observed,
as shown in Figure 5.16a, 5.16b, 5.16c and 5.16d. Under the exposure by SMFs,
the orientations of collagen fibres were affected. The fibres under SMFs show
no preferred direction, some of the fibres remain in the same direction with the
cells, whereas others tend to be perpendicular to the cells (indicated by red lines).
This re-orientation could be caused by the SMFs. It is also worth noting that the
incorporation of IONPs had a minimal effect on the re-orientation of the collagen
fibres.
The microstructure of cell-seeded scaffolds after 14 days are presented in Fig-
ure 5.17a, 5.17c, 5.17b and 5.17d. For the scaffolds treated with SMFs, it can be
observed that new matrices were built up around the cell membranes. Besides, a
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(a) (b)
(c) (d)
Figure 5.14: Microstructure of cell loaded collagen scaffolds examined under TEM
at day 1. (a) collagen scaffolds without SMFs, (b) collagen scaffolds with SMFs,
(c) collagen scaffolds incorporated with IONPs without SMFs and (d) collagen
scaffolds incorporated with IONPs with SMFs. The incorporation of IONPs can
be identified within the cell, at the edge of the cell membrane and inside the
collagen fibrils.
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(a) (b)
(c) (d)
Figure 5.15: Microstructure of cell loaded collagen scaffolds examined under TEM
at day 1. IONPs (a) agglomerate inside the cell, (b) spread out inside of the cell,
(c) near the cell membrane and (d) trapped inside the collagen fibrils.
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(a) (b)
(c) (d)
Figure 5.16: Microstructure of cell loaded collagen scaffolds examined under TEM
at day 7 (a) collagen scaffolds without SMFs, (b) collagen scaffolds with SMFs,
(c) collagen scaffolds incorporated with IONPs without SMFs and (d) collagen
scaffolds incorporated with IONPs with SMFs. A change in the orientation of the
collagen matrix can be observed.
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more clear relationship between the collage orientation can be obtained (Figure
5.18a and 5.18b), that the reorientation of collagen fibrils were caused by SMFs.
In order to identify whether this effect is directed by the direction of cells or vice
versa, microstructural analysis of collagen gels without the incorporation of cells
were investigated under SEM, as shown in Figure 5.19a and 5.19b. As can be ob-
served (indicated by red lines), without the exposure of SMFs, the collagen fibrils
experienced no preferred direction, but each of the fibre is straight and stretched.
However, when exposed under SMFs, the orientation of the matrix was rotated,
the fibres were in a relaxed format and tended to agglomerate into circles.This
demonstrates that the re-orientation of the collagen fibres is due to the external
SMFs, and not the cell regulation.
5.9 Discussion
5.9.1 Effects of SMFs on Cell Proliferation
The effects of SMFs, collagen matrix and the incorporation of IONPs on MG-63
cell behaviours were studied. By exposing with SMFs for 1, 3, 7 and 14 days,
a stimulating effects of SMFs alone on cell proliferation can be observed for up
to 7 days. Many studies demonstrated that the SMFs alone cannot promote
MG-63 cell growth over longer culturing time, and even have an inhibitory effect.
For example, Cai et al. [2015] observed increased cell proliferation of MC3T3-E1
cells when exposed under 100 mT SMFs between 4 hours and 7 days of culture.
However, cell proliferation decreased afterwards. Cunha et al. [2012] indicated
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(a) (b)
(c) (d)
Figure 5.17: Microstructure of cell loaded collagen scaffolds examined under TEM
at day 14. (a) collagen scaffolds without SMFs, (b) collagen scaffolds with SMFs,
(c) collagen scaffolds incorporated with IONPs without SMFs and (d) collagen
scaffolds incorporated with IONPs with SMFs. After 14 days, the changes in the
collagen matrix continued (indicated by red lines), with new matrices built up
around cell membranes when exposing under SMFs (circled with blue).
154
5. CELLULAR AND MOLECULAR EVALUATION OF THE 3D
COLLAGEN MODEL UNDER STATIC MAGNETIC FIELDS
(a)
(b)
Figure 5.18: Microstructure of cell loaded collagen scaffolds examined under TEM
at day 14. Collagen fibres (a) without SMFs and (b) with SMFs. The reorientation
of collagen fibres are contributed from the SMFs not IONPs.
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(a)
(b)
Figure 5.19: Microstructure of collagen fibres (a) without and (b) with SMFs.
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a reduced number of MG-63 cells by SMFs (320 mT) after 7 days. Imaizumi
et al. [2007] demonstrated that the proliferation of MC3T3-E1 was unchanged
after 1 day but decreased by the exposure to SMFs (250 mT) after 4 and 7 days.
It has been reported that bone and bone cells can only respond to SMFs for a
short period, once bone cells get adapted to the static environment, they will not
respond to the SMFs in terms of biological behaviour. The bone cells are more
likely to grow in a dynamic environment.
However, when combining the effects of IONPs and SMFs together, the stim-
ulating effect can be extended for a longer culture time (14 days). This can be
attributed to the combined effects of SMFs, IONPs and the collagen matrix in-
teractions. Meng et al. [2010] indicated that by introducing IONPs into polymer
films under a 1 mT SMFs, the growth of bone cells can be enhanced. Similar
observations have also been reported by Wei et al. [2011]. When incorporating
IONPs into polymer nano-fibrous membranes, the MG-63 cell proliferation in-
creased with increasing seeding time and IONPs loading. This can be caused by
the interactions between magnetic fields and magnetic nanoparticles. Magnetic
fields induce a high magnetic gradient, which causes displacement of the particles
along the gradient vector, when the particles are in touch with cells, this leads to
the production of compression and tensile forces on the cell membrane [Dobson,
2008], resulting in a range of cellular responses, including changes in intracellular
calcium levels. Therefore the biological behaviours of cells can be modified.
Histology was employed to examine the cellular responses. By visualising the
functional cells inside the collagen scaffolds, the effects of SMFs and IONPs on
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cell proliferation examined by AB assay can be validated. Histology samples
were prepared and examined under optical microscopy, and it was found when
exposure to SMFs, the cell number increased after 3 days. The quantitative data
obtained supported this finding, and this trend agrees with the AB assay results.
By employing SMFs alone, increased cell activity can be observed from 3 days
but falls slightly after 14 days. This suggests that the SMFs alone can influence
cell growth over short time periods, while are not effective for long duration. The
incorporation of IONPs can further the stimulation effects for 14 days. This sug-
gests that by incorporating IONPs, the effect of SMFs can be prolonged.
5.9.2 Effects of SMFs on Cell Differentiation
Cell differentiation was also investigated. The exposure to SMFs promoted ALP
production from MG-63 after 21 days, and the incorporation of IONPs further
stimulated ALP production at a later stage. ALP is one of the key substances
that indicate whether osteoblasts have entered the period of extracellular matrix
development and maturation. When proliferation subsides, differentiation takes
place, which explains why there is no significant increase in ALP level before
21 days. Previous studies have found that osteoblast-like cells expressed greater
ALP levels after SMFs exposure [Cai et al., 2015; Huang et al., 2006; Kotani et al.,
2002; Meng et al., 2010]. The effect of 400 mT SMFs on the expression of several
genes in MG-63 cells has been studied, the data suggests that the local regulatory
factors produced by SMFs treated cells, including collagen Type I, ALP and OP
were greater than those of the untreated ones after only 3 days [Huang et al.,
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2006]. The major effect of SMFs on osteoblasts differentiation can contribute
to the reorientation and distortion of cell membranes and therefore modify the
membrane properties, resulting in higher expression of growth factors associated
with differentiation hence leading to higher levels of ALP production.
5.9.3 Effects of SMFs on Cell Mineralisation
SMFs, and the combination of SMFs and IONPs promoted mineralisation at an
early stage (day 21) when compared to the control. This demonstrates that SMFs
have a stimulating effect on cell mineralisation. After 6 weeks, all samples reached
similar levels of mineralisation, indicating the completion of cell mineralisation,
which is an essential process in osteogenesis. Mineralisation occurs extracellu-
larly and involves the initial formation of apatite crystals in specific sites along
collagen fibres followed by the replacement of much of the water in the tissue
with mineral. Many theories have been advanced to explain the initiation of
mineralisation, including local elevations of phosphate via hydrolysis of organic
phosphates by alkaline phosphatase, enzymatic removal of inhibitors of mineral
deposition and direct nucleation of hydroxyapatite or other calcium phosphate
minerals onto the bone collagen fibres [Termine et al., 1981]. The transition from
proliferation stage to matrix maturation is suggested by the up regulation of genes
associated with matrix development, such as collagen synthesis and ALP activ-
ity. Calcium accumulation starts at the matrix development stage and reaches
its maximum during the mineralisation stage. The in vitro study from Hsu &
Chang [2010] showed that SMFs (290 mT) combined with osteogenic induction
159
5. CELLULAR AND MOLECULAR EVALUATION OF THE 3D
COLLAGEN MODEL UNDER STATIC MAGNETIC FIELDS
could enhance early extracellular calcium and bone mineralisation of dental pulp
cells.
5.9.4 Effects of SMFs on Gene Expression
It was shown that the combination of SMFs and IONPs can induce ostogenesis
in collagen scaffolds, however, the mechanisms at the molecular levels remain
unclear. Osteogenesis is a complex process mediated by succession of gene acti-
vation and expression. Runx2, ON, BMP-2 and BMP-4 are important markers
involved in this process (as detailed in Chapter 1).
Runx2 was up-modulated by the combination of IONPs and SMFs exposure
after 7 to 14 days of culture. Similar findings have been demonstrated by Tsai
et al. [2009]. By treating MSCs for 3, 7 and 10 days under a magnetic field,
significant higher expression of Runx2 has been observed, accompanied with the
up-regulation of ALP, collagen type I and OC [Yuge et al., 2003]. Runx2 is the
osteoblast-specific product of the Cbfa1 gene, and also a transcription factor that
is essential for osteoblast differentiation and bone formation. The expression of
Runx2 can also cause a stage dependent increase in the structural and functional
proteins, for example, ALP, collagen type I, osteopontin, BSP and osteocalcin
in osteoblasts. Many studies have demonstrated that Runx2 can induce in vitro
osteoblast differentiation and mineralisation as well as in vivo bone formation
[Selvamurugan et al., 2007; Tsai et al., 2009,?; Zhao et al., 2005]. In accordance
with the in vivo studies, in vitro studies have demonstrated that Runx2 is a pos-
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itive regulator that can up-regulate the expression of bone matrix protein genes,
allowing cells to acquire the osteoblastic phenotype while keeping the osteoblastic
cells in an immature stage [Komori, 2010]. Taken together, the results presented
in the current study suggest that SMFs exposure may induce an earlier osteogenic
induction in MG-63 cell lines by modulating early osteoblastic gene expression of
Runx2, hence accelerating the osteogenesis.
The expression of osteonectin was up regulated by the addition of IONPs un-
der SMFs after 7 days. However, after 14 days, the level of ON production in
the control group reached to a similar level to the other treated samples. One
possible explanation could be that collagen itself has a significant influence on
the expression of ON. ON is a glycoprotein in the bone that binds to both hy-
droxyapatite and collagen, therefore it plays a vital role in bone mineralisation,
cell-matrix interactions, and extracellular matrix regulation. When ON is bound
to insoluble type I collagen, the resultant complex binds synthetic apatite crystals
and free calcium ions. One study suggested that ON is a tissue specific protein
that exhibits several interesting activities, such as linking the bone mineral and
collagen phases, perhaps initiating active mineralisation in normal skeletal tissue
[Termine et al., 1981]. The IONPs incorporated model under SMFs was shown
to enhance the expression of ON over a 2 week period, which would explain the
enhancement in the mineralisation level.
Findings from the current study indicate that the expression of BMP-2 and
BMP-4 can be enhanced by the combination of SMFs and IONPs over 14 days of
culture. Both BMPs and Runx2 are able to stimulate osteoblast differentiation
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and bone formation and their interrelationships have also been examined. The
BMPs provide signals that enhance Runx2 dependent transcription and at the
same time, Runx2 provides information necessary for BMPs activity [Gersbach
et al., 2004]. It can be concluded that not only the transcriptional activity of
Runx2 in osteogenic precusor cells requires BMP signalling but also the sensitiv-
ity of cells to BMPs is enhanced in the presence of Runx2. Therefore, the up-
regulation of Runx2 and stimulation of the expression of BMPs, and the enhanced
expression of BMPs can further promote the production of Runx2. Another in-
teresting finding from this study is that, the expression of BMP-4 is higher than
that in BMP-2. Bodamyali et al. [1998] studies the effects of magnetic field on
the expression of several BMPs, including BMP-2 and BMP-4. They found that
magnetic fields can up-regulate the expression of BMP-2, and the up-regulation
of BMP-2 leading to an enhanced level of BMP-4. Taking all the effects together,
the expression of BMP-2 can be enhanced by SMFs, IONPs and Runx2, whereas
the expression of BMP-4 can be enhanced by the effects of SMFs, IONPs, Runx2
and also BMP-2. Therefore the expression of BMP-4 was comparably higher than
that of BMP-2.
5.9.5 Effects of SMFs on Cell/matrix Interactions
The stimulatory effects of SMFs and IONPs on the osteogenesis process were eval-
uated, and this can contribute to the expression of several key genes at molecular
level. However, the mechanism behind the up-regulation of the gene expression
needs to be further understood. Therefore, the microstructure of cells embed-
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ded in collagen scaffolds were examined. The cell/matrix interaction is a crucial
factor which affects cell behaviour. Previous investigations tried to study the
cellular responses of cells when seeded inside PC scaffolds, however, they have
not focused on the microstructural analysis of the cell/matrix interactions yet.
When being exposed under SMFs for 7 days, the reorientation of the fibres
can be observed, the fibres grow with no preferred direction, with some in line
with the cells while others against the cells. When collagen fibres are affected by
the SMFs, they move around their axis and produce friction forces. The collagen
fibres which are located near the cell membranes will pass the friction to the cells,
and this force could lead to changes in the cell membranes, such as to open up
more calcium ion channels, hence modify the membrane properties. In order to
determine whether this reorientation is caused by the SMFs or the cell regulation,
microstructural analysis on the collagen gels without cells were examined. With-
out SMFs, the collagen fibres show no orientated directions, but with stretched
and straight morphology. When subjected to SMFs, the collagen fibres tend to
be re-orientated. With the effects of SMFs, some of the fibres tended to shift
perpendicular to the direction of SMFs, however, the majority of the fibres were
still randomly distributed.
From the microstructural analysis, what can be observed was that the direc-
tion of collagen fibres were changed under SMFs. Many studies have focused on
exposing collagen solution to a strong static magnetic field with strength higher
than 1T during gelation [Dubey et al., 2001; Guido & Tranquillo, 1993; Kotani
et al., 2000; Torbet & Ronziere, 1984]. For example, Kotani et al. [2000] exposed
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bone collagen matrix under a SMFs of 8T to evaluate the effects of strong SMFs
on bone matrix. The collagen fibres oriented perpendicular to the direction of
the magnetic field after 1 hour of exposure, while they normally randomly orien-
tated without the exposure of SMFs. This can be explained by the liquid crystal
property of collagen. Procollagen molecules have been shown to undergo liquid
crystalline ordering in solution, prior to fibril assembly. This may provide an
explanation for the liquid crystal-like architectures of different connective tissues
[Hulmes, 2002]. One of the characteristic features of liquid crystals is that they
can be ordered in electric and magnetic fields [Brown et al., 1971]. Each collagen
molecule has a small negative diamagnetic susceptibility [Pauling, 1979; Worces-
ter, 1978]. The regular organisation of such molecules leads to a large enough
negative diamagnetic susceptibility along the fibres to effect such alignment. The
structural origins of diamagnetic anisotropy in proteins have been discussed in
detail by Worcester [1978], in which peptide bonds and aromatic residues are the
main potential sources of anisotropy. As there are relatively few aromatic groups
in collagen, the anisotropy must be dominated by the peptide contribution [Tor-
bet & Ronziere, 1984].
In the current study, the re-orientation of the collagen fibres can be observed,
however, the alignment of the fibrils cannot be observed as described in other
studies [Kotani et al., 2000]. Several explanations can account for not observing
the perpendicular alignment of the collagen fibres. First of all, the magnetic
field intensity used here is relatively small when compared to other studies (72
- 144 mT when compared to 8T). The degree of orientation for a particle with
diamagnetic anisotropy, ∆χ, in a magnetic field, H, is a function of the ratio:
164
5. CELLULAR AND MOLECULAR EVALUATION OF THE 3D
COLLAGEN MODEL UNDER STATIC MAGNETIC FIELDS
∆χH2 / 2kT (5.1)
Where k is the Boltzmann constance and T is the absolute temperature [Tor-
bet & Ronziere, 1984]. Therefore, given the same Boltzmann constance and abso-
lute temperature, the degree of orientation of each collagen fibre is highly depen-
dent upon the magnetic field strength. Smaller field strength induces smaller de-
gree of orientation. Here, the diamagnetic anisotropy of a particle having an axis
of rotational symmetry is the difference in magnetisation parallel/perpendicular
to the axis of symmetry. Secondly, the compressed collagen gels used here are
high in density when compare to other highly hydrated collagen gels, provide
higher mechanical stability but less space of freedom. Therefore it may prevent
some parts of the collagen fibres from rotating.
5.9.6 Effects of SMFs on Cell Membrane
Other explanations on the up-regulation of the Runx2, ON, BMP-2 and BMP-
4 can be contributed on the modification of cell membranes. Bilayer mem-
branes, which are composed of a number of protein and lipid molecules, possess
anisotropic diamagnetism in nature [Yamagashi et al., 1992]. Upon the exposure
to SMFs, the phospholipid molecules of the membrane can be rotated by virtue
of their collective diamagnetic properties. It also has been discovered that gradi-
ent magnetic field can unbalance the hydrostatic pressure across the bilayer lipid
membrane [Suda & Ueno, 1997]. Both of these effects can possibly result in over
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deformation of the cellular membrane, modification of the biological properties of
embedded receptors in the membrane and, thereby altering the proliferation kinet-
ics of the cells. Besides, it is generally known that morphological and structural
changes to the plasma membrane interfere with many functional and structural
features of the cells, leading, for example, to changes in cellular shape, cytoskele-
ton arrangement, ion flux, receptor distribution [Dini & Abbro, 2005]. To be more
specific, the reorientation of the membrane matrix will influence the embedded ion
channels, most likely by producing some degree of deformity of their intramembra-
nous segment, hence leading to the activation of calcium channels [Rosen, 2003].
Increased concentration of Ca2+ can also promote the formation of micro-vesicles
(MVs). MVs (100 - 1000 nm) are fragments of the plasma membrane, which play
a role in inter-cellular communication and can transport mRNA, miRNA, and
proteins between cells. MVs are able to enhance the regeneration of a number
of tissues by exerting an effect on target cells or inducing neighbouring cells by
the transfer of cytokines, such as transforming growth factor, hepatocyte growth
factor, or vascular endothelial growth factor [Muralidharan-Chari et al., 2010].
Influx and export of Ca2+ are the mechanisms that control the formation and
secretion of MVs. The results presented by Stratton et al. [2013] suggested that
the magnetic field accelerated cell membrane activity, allowing calcium influx,
which in turn initiated the release of MVs from stimulated cells. In the study of
Maredziak et al. [2015], they also demonstrated that magnetic fields can directly
stimulate and promote the secretion of membrane-derived MVs in mesenchymal
stem cells. The increase and mobilisation of Ca2+ during exposure of cells to
SMFs can cause a cascade of microfilament and microtubular reorganisation, cell
shape modifications, changes to surface carbohydrate residues [Bras et al., 1998].
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For example, as a result of SMFs of 0.4 T treatment, MG-63 cells became more
stellar shapes with extensive processes and appeared to form multiple layers on
the surface [Huang et al., 2006]. Matrix vesicles released from the plasma mem-
brane accumulated continuously around the SMFs exposed MG-63 cells have been
observed by Chiu et al. [2007].
5.10 Summary
This chapter demonstrates that the combination of SMFs and IONPs can enhance
several biological properties of MG-63 cells, including, proliferation, differentia-
tion and mineralisation. The proliferation can be up-regulated up to a period
of 14 days. When proliferation subsides, the ALP production level increased,
and this can be further promoted when subjected under SMFs. Mineralisation
normally happens at later stages of the cell cycle. Significant enhancement of the
mineralisation level caused by SMFs can be observed at day 21. This indicates
that SMFs and IONPs can lead to early mineralisation when compared to the
control condition. Then after 6 weeks, all the scaffolds are fully mineralised, the
effects of SMFs cannot be observed.
The effects of SMFs and IONPs at cellular and molecular level have then been
examined. First of all, SMFs encouraged the expression of Runx2, ON, BMP-2
and BMP-4, which mediate the osteogenesis of the cell, including proliferation,
differentiation and mineralisation process. Secondly, the cellular responses of
cells embedded in collagen were investigated. Results demonstrated that SMFs
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can stimulate cell growth within 7 days, while with the incorporation of IONPs;
the stimulation effect can be expanded to 14 days. When further evaluating the
influence of SMFs on the microstructure of cell/matrix, re-orientation of collagen
fibres can be noticed. This can be considered as one of the reasons promotes
biological behaviours. The interactions between the ECMs and the cells can
potentially influence the membrane’s phospholipid molecules; hence enhance the
calcium ion flux. In summary, the SMFs and IONPs can affect osteogenesis in the
following ways: The SMFs and the incorporation of IONPs can affect several cell
membrane properties (due to the diamagnetic property of phospholipids) and the
cell/matrix interactions (due to the the liquid crystal properties of the collagen
matrix), which lead to the up-regulation of several key genes, such as Runx2, ON,
BMP-2 and BMP-4, resultant in a stimulation effect of osteogenesis in vitro.
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Chapter 6
Conclusions and Future work
6.1 General Discussion and Conclusion
The key findings of the this study are summarised as below:
1. A magnetic bio-reactor with desired strength was designed and used for in
vitro studies. The magnetic field strength is dependent on the types and
the relative position of the magnets. Neodymium magnets induced larger
strength when compared to the samarium-cobalt magnets (given the same
dimensions). When placing the magnetic poles facing to and close to each
other, higher strength can be generated.
2. A 3D collagen based bone model was developed, which offers the possibility
of incorporating various biofactors and supports cell growth. This includes
the evaluation of using various cell lines, the comparison between 2D and
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3D models, and the investigation of incorporating bio-factors. MG-63 cells
have been affected by SMFs most significantly when compared to the other
cell lines (MC3T3-E1 and UMR-106). When comparing the cell prolifera-
tion cultured on 2D surfaces and 3D PC collagen hydrogels, a stimulation
effect can be observed for the 3D one. With the incorporation of IONPs,
the cell proliferation can be further promoted, however, nHA and nZnO can
not stimulate cell growth under SMFs.
3. With the incorporation of IONPs, the proliferation, differentiation and min-
eralisation of osteoblasts cultured in 3D collagen scaffolds have been stim-
ulated under SMFs.
4. The SMFs and the incorporation of IONPs can affect several cell mem-
brane properties (due to the diamagnetic property of phospholipids) and
the cell/matrix interactions (due to the liquid crystal properties of the col-
lagen matrix), which lead to the up-regulation of several key genes, such as
Runx2, ON, BMP-2 and BMP-4, resulting in a stimulation effect of osteo-
genesis in vitro.
In vitro models provide a platform to investigate the cell behaviours under
SMFs. Current tissue models exist in either 2D or 3D format. 2D models are
simple to access and low in costs. However, 2D models cannot represent the real
ECM structure in bone that is highly three dimensional. A desired model should
be non-toxic to cells, have ECM-like structure, allow cells to attach and grow, and
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have certain mechanical properties to maintain functionalities during the culture
time. 3D natural tissue models have the advantage of suspending biomaterials in
a tissue like matrix, and enable real time assessment of the accessible structure.
Although there are limitations of using these models, such as the over-simplified
system, they can still be useful to be employed as reliable in vitro testing plat-
forms, for the understanding of the toxicity and cell responses. Among a wide
range of natural materials, collagen type I is preferable as it is the main struc-
ture of extracellular matrix (ECM). Collagen hydrogels have been used as in vitro
models for cell/matrix interactions, however, the conventional hydrogels are weak
in mechanical stabilities. Plastic compression was used to increase the collagen
hydrogel density, and therefore increase the physiology relevance of the hydrogel
for local cells. In this study, gels were compressed into culture well-plate by the
upward flow method, and were easily reproduced. Furthermore, the ability to
incorporate cells and biofactors (growth factors, biocompatible materials) into
compressed scaffolds makes the scaffolds more versatile and multifunctional.
In order to provide the cell/tissue model an in vitro SMFs environment, a mag-
netic bio-reactor was designed. To quantify the magnetic filed strength was the
first step. The magnetic filed strength between two permanent magnets depends
on the properties of the magnets (type, dimensions) and their relative positions of
the magnetic poles (attraction or repulsion) and the separation distance. It was
shown when the properties of the magnets have been fixed, placing the magnets
face to face leads to a greater magnetic strength compared to the edge to edge
position. Besides, a smaller gap between two magnets results in larger forces
generated. The simulation and experimental results agreed with each other, how-
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ever, there are always discrepancies between the values. This could be due to the
experimental limitations or the effects of the magnetic field of the earth itself.
One of the hypotheses of this study is that the SMFs stimulate the fracture
healing by influencing the osteogenesis process. SMFs with desired intensity have
been shown to stimulate osteoblasts proliferation, differentiation and mineralisa-
tion in vitro [Cai et al., 2015; Chiu et al., 2007; Meng et al., 2013; Rosen, 2003].
However, the results can be inconsistent due to the variations in the SMFs inten-
sity, as well as the type of the cells seeded. In this study, three cell lines were
tested under SMFs, including MG-63 (human, osteosarcoma), UMR-106 (rat, os-
teosarcoma) and MC3T3-E1 (mouse, non-transfomred). The results showed that
all cells demonstrated an increased cell proliferation under the exposure of the
SMFs. The highest stimulation effect was observed when cultured with MG-63
cells. When further introducing IONPs, nHA and nZnO into the cell seeded col-
lagen scaffolds, a stimulating effect of IONPs incorporated scaffolds was observed
under SMFs up to a concentration of 100 µg/ml. Higher dosages of IONPs was
identified to be toxic to MG-63 cells in vitro both with and without SMFs. nHA
encouraged the cell proliferation without the exposure of SMFs, with no signifi-
cant improvements under SMFs. This demonstrated that nHA does not respond
to the SMFs significantly. nZnO demonstrates the lowest stimulating effects on
the cell proliferation, while being toxic to the cells at concentrations above 10
µg/ml.
The effects of SMFs and IONPs on other biological behaviours were then
evaluated. When exposing under SMFs, or incorporated with IONPs alone, the
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proliferation of MG-63 cells was only promoted up to 7 days. When further com-
bining two together, the proliferation can be up-regulated up to 14 days. The
short-time effect of SMFs on cell proliferation is not surprising, as it has been
documented that osteoblasts respond to dynamic environment rather than static
[Rubin & Lanyon, 1985]. By further incorporating IONPs, the particles were mag-
netised upon the exposure of SMFs, and hence were attracted to travel towards
the magnetic poles. This caused a dynamic motion inside the scaffolds, effectively
leaving the cells with a non-static environment. Therefore, the proliferation can
be further enhanced. When proliferation subsides, the ALP production level is
increased, and this can be further promoted by SMFs. The addition of IONPs
also favour this process. Mineralisation normally happens at later stages of the
cell cycle. Significant enhancement of the mineralisation level caused by SMFs
can be observed at day 21. This indicates that SMFs and IONPs can lead to early
mineralisation when compared to the control condition. However, after 6 weeks,
all the scaffolds are fully mineralised, the effects of SMFs cannot be observed any
more.
For the stimulating effects of SMFs on cell proliferation, differentiation and
mineralisation, one hypothesis is that, SMFs stimulate the osteogenesis process
by activating the calcium ion channels in the cell membrane, hence lead to the
up-regulation of several key genes, such as Runx2, osteonectin and BMPs. By
examining under TEM, reorientation of collagen fibres can be observed under
SMFs treatment (potentially due to the liquid crystal-like property of collagen
fibres). This reorientation caused changes in the cell/matrix interaction, which
can potentially influence the phospholipid molecules of the cell membrane, and
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hence enhance the calcium ion flux. Second, SMFs encouraged the expression
of Runx2, ON, BMP-2 and BMP-4. Runx2 is a key transcription factor during
cell cycle, the enhancement of Runx2 can lead to enhanced expression of ALP,
collagen type I, osteocalcin, etc. Those genes are beneficial to the differentiation
process of osteoblasts, as a result, a stimulation effect of SMFs on cell differ-
entiation was observed. Besides, the expression of ON has been measured to
demonstrate how SMFs influence cell mineralisation. ON is an important marker
for early mineralisation, and the enhanced expression of ON by SMFs indicates
the stimulation effects of SMFs on cell mineralisation. Many studies also demon-
strated that SMFs can induce early osteoblasts mineralisation. In addition, the
BMPs, especially BMP-2 and BMP-4 have been widely studied to enhance bone
formations. Results from current study suggested that the combination of SMFs
and IONPs can promote the expression of BMP-2 and BMP-4. The expression
of BMP-4 were higher than that in BMP-2. One possible explanation is that, the
expression of BMP-2 can be affected by SMFs, IONPs as well as Runx2, whereas
BMP-4 can receive treatments from SMFs, IONPs, Runx2 and also BMP-2. To
conclude, the cellular and molecular behaviours described above can contribute
to the stimulating effects of osteoblasts by SMFs and IONPs.
In this study, plastic compression (PC) collagen hydrogels have been em-
ployed as a 3D bone model. Human osteosarcamo cell line, MG-63, has been
selected as the cell model for human osteoblasts, and biocompatible iron oxide
nanoparticles (IONPs) have been synthesised and incorporated within the model
to further enhance the biological properties. A magnetic bio-reactor to support
cell growth under SMFs has been designed and fabricated by 3D printing, and
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used for in vitro studies. Results demonstrated that SMFs and IONPS can stimu-
late the proliferation, alkaline phosphatase production and level of mineralisation
of MG-63 cells in vitro. The cellular interactions of the cell/matrix have also
been examined under Transmission Electron Microscopy (TEM), where an reori-
entation of collagen fibres around cells have been observed. As for the molecular
level, real-time polymerase chain reaction (PCR) has been conducted to deter-
mine the effects of SMFs on the expression of Runx2, Osteonectin, BMP-2 and
BMP-4, in which stimulating effects have been identified with the combination of
SMFs and IONPs. In conclusion, SMFs and IONPs altogether can enhance the
proliferation, ALP production and mineralisation in the developed bone model
in vitro, potentially by influencing the matrix/cell interactions, hence activating
the calcium ion channels and encouraging the relative gene expressions. To this
end, the system established in this thesis can be served as a novel bone model for
in vitro evaluation of the effects of SMFs on osteoblasts, hence lead to a better
understanding of the mechanisms behind.
6.2 Future Work
The 3D collagen model developed in this project has successfully served as an in
vitro platform to evaluate the effects of SMFs on osteonegesis. In order to fur-
ther develop the system for more complicate studies, several improvements can
be attempted, as listed below.
First of all, the design of the magnetic bio-reactor can be improved. As the
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current study only focused on one type of magnetic field, the effects of SMFs with
varies strength are of interest to study. The effects of various intensity of SMFs
on the biological behaviours of cells, as well as the effects on the collagen matrix
orientation, can be further investigated. Besides, the magnetic bio-reactor devel-
oped here did not include auto media feeding system, the change of cell media
was done manually. This increased the possibility of infections.
A tissue model normally consists three key components, the scaffolds, cells
and biofactors. For the scaffolds fabrication, the current study was focused on
the use of rat tail type I collagen. This type of collagen is isolated from rat tails,
which is a different species other than human and may behave differently for in
vivo use. Therefore, other types of collagen sources should be considered. Be-
sides, in order to mimic the real bone structure, multilayers of the tissue model
would be optimal. The current study only focused on a simple platform on which
only single layer of collagen gel was employed.
As for the cell model, only one type of cell line, MG-63 was used to conduct
biological testing. MG-63 cell line are cells derived from human osteosarcoma,
they are not experiencing the same differentiation stages as human osteoblasts.
Thus, mesenchymal stem cells (MSCs), from which osteoblasts are originated,
can be suggested in the future studies.
As for the incorporation of biofactors, for example, IONPs, has only been em-
ployed at 4 different concentrations with a wide gap in between. IONPs with a
concentration of 100 µg/ml showed a positive effect on the cell proliferative activ-
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ity, whereas toxic effect was observed at concentrations of 1000 µg/ml. Therefore
it is necessary to investigate the concentrations in between 100 and 1000 µg/ml
to identify the threshold. In addition, although nHA and nZnO did not respond
to SMFs significantly, they still possessed great capabilities for bone healing ap-
plications. A mixture of IONPs, nHA and nZnO can offer a tissue model with
potential osteoconductive and antimicrobial properties.
Furthermore, more biological studies can be employed to investigate the ef-
fects of SMFs. For instance, the cell shape may have been influenced upon the
exposure of SMFs, and hence cause the change in cell/matrix interactions and
membrane properties. It is of interest to investigate whether the cells controlled
the orientation of the collagen fibres or vice versa. Therefore, the change in cell
morphology and cytoskeleton can be further studied.
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Appendix A: Characterisation of
Iron Oxide Nanoparticles
The phase purity of IONPs was examined under X-Ray diffraction (XRD). Pat-
terns revealed the presence of all the major peaks, 111, 220, 311, 400, 422, 511
and 440, with no secondary phases detected (Figure 7.1). The corresponding
Bragg angles were 17.05, 30.25, 35.7, 43.4, 53.55, 57.2 and 63.05, respectively.
The diffraction peaks corresponded well to magnetite Fe3O4 (JCPDS file, No.
00-011-0614), which suggests the particles are magnetite (Fe3O4) with a spinal
structure [Liu et al., 2006].
The microstructure of IONPs have been examined under Transmission Elec-
tron Microscopy (TEM) with results presented in Figure 7.2. The nanoparticles
are spherical structured and have an average diameter of 13 ± 5 nm (n = 50).
The parameters of crystal structure can also be calculated according to the
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Figure 7.1: X-Ray Diffraction patterns of IONPs nanoparticles compares to the
standard magnetite pattern (JCPDS file, No. 00-011-0614)
Figure 7.2: Microstructure of fabricated IONPs by co-precipitation method. The
average size of the particles were measured as 13 ± 5 nm (n = 50).
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wavelength and incidence angle of X-rays. This can be referred to as Bragg’s
equation:
nλ = 2d sin θ, (7.1)
where n is an integer, d is the inter-atomic spacing and θ is the incident
angle of the X-ray beam. In this study, λ is the X-ray wavelength (0.15406
nm), B is the full width at the half maximum (FWHM), θ is the corresponding
Bragg angle and K is the shape parameter, which is 0.89 for magnetite. Taking
the highest intensity peak, namely the (311) plane at 2θ = 35.7, and the half
maximum intensity width of the peak after counting for instrument broadening,
the calculated particle size was 11.5 nm.
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